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  Sekundärstruktur	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   Aufgabenstellung	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   Projekts	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  Aus	  dieser	  Arbeit	  gingen	  zwei	  Publikationen	  hervor,	  die	  strukturelle	  Aspekte	  von	   Hfq	   in	   E.	   coli	   beschreiben.	   Die	   Analyse	   jener	   Ergebnisse	   geschah	   im	  Kontext	  biophysikalischer	  und	   funktioneller	  Resultate,	  welche	  den	   intrinisch	  unstrukturierten	  Termini	   von	  E.	   coli	  Hfq	   Funktionalität	   zuweisen.	   Es	   konnte	  festgestellt	   werden,	   dass	   die	   Termini,	   ausgelöst	   durch	   die	   Interaktion	   mit	  RNA,	   Strukturen	   ausbilden.	   Die	   Interpretation	   dieser	   Resultate	   folgt	   dem	  „Entropietransfermodell“,	  welches	  vorschlägt,	  dass	   intrinisch	  unstrukturierte	  Sequenzen	   durch	   isothermische	   Enthalpie/Entropie-­‐Kompensation	   die	  Entfaltung	  von	  Zielstrukturen	  begünstigen	  können.	  Das	  Zusammenspiel	  von	  strukturierter	  und	  ungeordeter	  Sequenz	  in	  E.coli	  Hfq	  ermöglicht	  es	  diesem	  Protein,	  mit	  einer	  Vielzahl	  an	  RNAs	  zu	  interagieren	  und	  diese	   zu	   regulieren.	   Die	   zentrale	   Funktion	   von	   Hfq	   ist	   hierbei,	   die	   RNA	   in	  einem	   ungefalteten	   Zustand	   zu	   erhalten.	   Sie	   kann	   in	   folgendem	   Dogma	  zusammengefasst	   werden:	   Bindung	   fördert	   Entfaltung	   –	   Entfaltung	   fördert	  
Hybridisierung	  -­	  Hybridisierung	  fördert	  Loslösung	  von	  Hfq!	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English	  Abstract	  This	   dissertation	   was	   conducted	   at	   the	   University	   of	   Vienna,	   Max	   F.	  Perutz	   Laboratories	   in	   the	   years	   2005-­‐2011.	   Here	   is	   reported	   on	  research	  performed	  by	  Mag.	  Mads	  Beich-­‐Frandsen,	  supervised	  by	  Prof.	  Kristina	   Djinovic-­‐Carugo	   at	   the	   Department	   of	   Structural	   and	  Computational	   Biology,	   in	   collaboration	   with	   Prof.	   Udo	   Bläsi	   at	   the	  Department	  of	  Microbiology,	  Immunobiology	  and	  Genetics.	  	  The	   title	   refers	   to	   the	   biostructural	   investigations	   conducted	   for	   the	  RNA-­‐binding	  protein	  Hfq	  from	  Escherichia	  coli.	  Upon	  the	  understanding	  that	  only	  a	  fraction	  of	  a	  genome	  encodes	  protein,	  focus	  has	  been	  shifted	  to	   RNA-­‐based	   regulation	   in	   biology.	   With	   the	   increasing	   number	   of	  transcriptome	   profiles	   being	   completed,	   the	   Sm-­‐like	   protein	   Hfq	  emerges	  as	  the	  central	  switchboard	  of	  gene	  regulation,	  as	  mediated	  by	  small	  regulatory	  RNAs	  (sRNAs)	  in	  Bacteria.	  	  In	   E.	   coli	   and	   other	   gram-­‐negative	   pathogens,	   the	   conserved	   Sm-­‐like	  core	   of	   Hfq	   is	   extended	   30%	   in	   sequence	   length,	   by	   a	   C-­‐terminal	  domain.	   The	   short	   N-­‐terminal	   region	   of	   Hfq	   is	   conserved	   to	   higher	  degree.	  Both	  the	  N-­‐	  and	  C-­‐terminus	  of	  Hfq	  have	  been	  demonstrated	  of	  functional	   importance	   for	   the	   protein,	   and	   are	   characterized	   as	  intrinsically	   disordered.	   The	   key	   mechanism	   of	   Hfq-­‐mediated	  regulation	   is	  by	  annealing	   trans-­‐encoded	  sRNAs	  to	   target	  mRNA.	  Here	  Hfq	   acts	   as	   an	   RNA-­‐chaperone,	   with	   ability	   to	   alter	   the	   secondary	  structure	  of	  RNA.	  	  The	  scope	  of	  the	  project	  was	  to	  elucidate	  the	  function	  of	  E.	  coli	  Hfq	  from	  the	   perspective	   of	   structural	   biology.	   The	   research	   presented	   here	  employs	   X-­‐ray	   crystallography,	   Small	   Angle	   Scattering,	   Nuclear	  Magnetic	   Resonance,	   Synchrotron-­‐Radiation	   Circular-­‐Dichroism,	   in	   an	  integrated	  approach	  with	  bioinformatics	  and	  functional	  studies.	  The	  work	  resulted	  in	  two	  publications,	  reporting	  on	  structural	  aspects	  of	   E.	   coli	   Hfq.	   These	   results	   were	   analyzed	   in	   context	   of	   acquired	  biophysical	   and	   functional	   results,	   which	   annotates	   function	   to	   the	  intrinsically	   disordered	   N-­‐	   and	   C-­‐terminus	   of	   E.	   coli	   Hfq.	   Interaction	  with	  RNA	  was	  found	  to	  induce	  structure	  upon	  the	  termini	  of	  Hfq.	  This	  was	  interpreted	  in	  line	  of	  the	  ‘entropy-­‐transfer’	  model,	  which	  proposes	  intrinsically	  disordered	  sequence	  to	  have	  a	  function	  in	  unfolding	  targets	  by	  isothermal	  entropy/enthalpy	  compensation.	  The	   interplay	   between	   the	   structured	   and	   disordered	   sequence	   in	   E.	  
coli	  Hfq	  provides	  the	  protein	  with	  the	  ability	  to	  interact	  with	  and	  exert	  regulation	   on	   a	  wide	   variety	   of	   RNAs.	   Hfq	   functions	   to	   keep	   the	   RNA	  unfolded,	  following	  the	  dogma:	  Binding	  promotes	  unfolding	  –	  unfolding	  
promotes	  annealing	  –	  annealing	  promotes	  release	  of	  Hfq!	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1 Preface	  	  In	   the	   central	   dogma	   of	   molecular	   biology	   first	   proposed	   by	   Crick	   in	  19581,	  RNA	  is	  placed	  snug	  in	  between	  DNA	  and	  protein,	  providing	  this	  biopolymer	   a	   unique	   strategic	   position	   in	   cellular	   regulatory	   events.	  The	   regulatory	   systems	   on	   the	   level	   of	   RNA	   in	   higher	   eukaryotic	  organisms	  have	  been	  demonstrated	  to	  be	  incredibly	  diverse	  and	  highly	  developed,	   with	   multiple	   roles	   served	   by	   un-­‐translated	   non-­‐protein-­‐coding	  RNAs	  (ncRNAs).	  This	  is	  contrasted	  by	  the	  fact	  that	  only	  ~1.5%	  of	  the	   human	   genome	   encodes	   protein2,	   the	   remainder	   being	   a	   huge	  potential	   source	   of	   RNA	   genes.	   Though	   of	   a	   much	   simpler	   nature,	  bacteria	  have	  retained	  regulation	  on	  the	  level	  of	  RNA.	  At	  present	  stage,	  in	  E.	  coli	  around	  80	  small	  ncRNA	  have	  been	  verified	  as	  functional	  RNA-­‐genes	  with	   regulatory	   properties,	   comprising	   so	   far	   about	  ~2%	  of	   all	  genes	  in	  this	  organism3.	  
1.1 Small	  regulatory	  RNA	  in	  Bacteria	  Small	  regulatory	  RNAs	  (sRNAs)	  in	  Bacteria	  have	  been	  classified	  to	  three	  main	  groups3.	  RNA-­‐molecules	  that	  regulate	  by	  interacting	  with	  specific	  proteins	  make	  up	  a	  diverse	  group	  of	  conserved	  sRNAs,	  and	  the	  recently	  discovered	   DNA-­‐binding	   ‘clustered	   regulatory	   interspaced	   short	  palindromic	  repeats’	  (CRISPRs)	  sRNAs	  comprise	  the	  newest	  group.	  The	  third	   group	   classifies	   sRNAs	   acts	   through	   a	   process	   known	   as	  riboregulation,	   exerting	   regulation	   through	   base-­‐pairing	   with	   other	  RNAs.	   In	  addition	  to	  providing	  an	  energy-­‐efficient	  regulation,	   this	  also	  achieves	   a	   high	   degree	   of	   specificity	   due	   to	   the	   requirement	   of	   target	  sequence	  complementarity.	  Fig.1.1	  gives	  a	  graphic	  representation	  of	  the	  three	  groups	  and	  their	  respective	  functions.	  Protein	  binding	  sRNAs	  can	  act	  by	  two	  mechanisms,	  either	  by	  structural	  mimicry	   of	   nucleic	   acid	   targets	   by	   binding	   to	   regulatory	   proteins	   and	  sequestering	  them	  from	  their	  function,	  or	  as	  an	  essential	  component	  for	  catalytic	  activity	  of	  an	  RNA-­‐protein	  complex	  (Fig.1.1).	  The	  6S-­‐RNA	  will	  bind	   and	   sequester	   the	   σ70-­‐containing	   RNA	   polymerase	   by	  mimicking	  the	  open	  complex	  of	  promoter	  DNA4,	  and	  the	  regulation	  of	  E.	  coli	  carbon	  storage	   can	   be	   de-­‐repressed	   by	   sequestering	   of	   the	  master	   repressor	  protein	   CsrA	  by	   the	   CsrB/C	   sRNAs5.	   The	   4.5S	   sRNA	  of	  RNase	  P	   is	   the	  catalytic	  active	  component	  of	  this	  RNA-­‐protein	  complex,	  in	  which	  a	  fold	  that	   is	   conserved	   through	   all	   kingdoms	   of	   life	   coordinates	   the	   2’-­‐OH	  scissile	   ribonucleotide6.	   However,	   protein	   subunits	   are	   also	   essential	  parts	   of	   RNAse	   P,	   which	   provides	   possible	   insights	   to	   the	   evolution	  from	  the	  RNA-­‐world7.	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Recently	   it	   has	   been	   established	   that	   Bacteria	   contain	   an	   RNA-­‐processing	   system	   that	   targets	   DNA	   that	   is	  mechanistically	   similar	   to	  the	  eukaryotic	  RNAi-­‐pathway8.	   ‘Clustered	  regulatory	  interspaced	  short	  palindromic	   repeats’	   (CRISPRs)	   sRNAs	   are	   found	   in	   many	   bacterial	  strains	  and	  most	  of	  Archea.	  Comprising	  arrays	  of	  palindromic	  repetitive	  DNA-­‐elements	   interspaced	   by	   sequence	   homologous	   to	   DNA	   from	  phages	   and	   plasmids,	   the	   whole	   array	   is	   transcribed	   as	   a	   single	   long	  
	  Fig.1.1:	   Bacterial	   sRNAs	   are	   classified	   in	   three	   groups	   with	   distinct	  mechanisms	   of	   function	   (figure	   adapted	   by	   courtesy	   of	   Elisabeth	  Sonnleitner/Udo	  Bläsi).	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RNA	  (crRNA)	  and	  processed	  by	  specific	  CRISPR-­‐associated	  (CAS-­‐)	  gene	  functions	  to	  produce	  multiple	  short	  sRNAs	  (Fig.1.1).	  These	  sRNAs	  then	  recruit	   the	  CAS-­‐system	   to	   the	   foreign	  DNA	  by	  base-­‐pairing,	   leading	   to	  DNA-­‐degradation9.	   The	   DNA-­‐homologous	   spacer	   sequences	   are	  heritable,	   and	   new	   spacers	   are	   added	   to	   the	   5’-­‐region	   of	   the	   CRISPs	  after	  each	  new	  infection10.	  	  The	  regulatory	  strategies	  in	  the	  examples	  mentioned	  above	  have	  found	  to	  be	   conserved	   in	  multiple	  organisms	   (in	   the	   case	  of	  RNAse	  P	  across	  phyla),	  and	  these	  mechanisms	  are	  therefore	  considered	  to	  be	  of	  ancient	  origin.	  The	  group	  of	  sRNAs	  acting	  through	  base-­‐pairing	  is	  generally	  less	  conserved.	  However,	  different	  bacterial	  strains	  have	  developed	  similar	  mechanisms	  of	  riboregulation	  of	  specific	  events11.	  
1.2 Base	  Pairing	  sRNAs	  in	  Bacteria	  Genetic	   location	   with	   respect	   their	   target	   gene,	   divides	   bacterial	  riboregulatory	   sRNAs	   in	   two	   groups	   (Fig.1.1).	   Cis-­‐acting	   sRNAs	   are	  encoded	   anti-­‐sense	   to	   their	   target	   gene,	   are	   therefore	   fully	  complementary	  and	  their	  function	  is	  hence	  highly	  specific.	  Trans-­‐acting	  sRNAs	  are	  encoded	  distantly	  from	  their	  target	  genes,	  which	  provide	  less	  sequence	  complementarity,	  but	  allow	  a	  single	  trans-­‐acting	  sRNA	  to	  act	  on	  multiple	  specific	  targets.	  	  
1.2.1 Cis-­acting	  sRNAs	  The	  majority	  of	   the	  known	  cis-­‐acting	   sRNAs	  are	  encoded	   in	  accessory	  DNA-­‐elements	   like	   plasmids,	   transposons	   and	   phages.	   Though	   the	  known	   examples	   regulate	   important	   processes	   such	   as	   replication,	  conjugation,	  toxin-­‐antitoxin	  modules,	  transposition,	  mRNA	  degradation	  and	  translation	  initiation,	  few	  have	  yet	  been	  found	  to	  be	  chromosomally	  encoded12.	   This	   number	   though	   is	   expected	   to	   grow,	   as	   suggested	   by	  genomic	  SELEX-­‐studies13,14.	  Cis-­‐acting	  sRNAs	  are	  transcribed	  from	  convergent	  promoters,	  and	  due	  to	   their	   small	   size	   (50-­‐300	   nt)	   and	   high	   degree	   of	   homology,	   no	  complementary	   factors	   are	   needed	   to	   facilitate	   RNA-­‐RNA	   interaction.	  The	   specific	   mechanisms	   by	   which	   cis-­‐acting	   sRNAs	   function	   is	   as	  diverse	   as	   the	   regulatory	   events	   they	   target,	   and	   examples	   include	  transcription	   attenuation,	   translation	   inhibition,	   inhibition	   of	   primer	  maturation,	   promotion	   or	   inhibition	   of	   mRNA	   degradation	   and	  inhibition	   of	   RNA	   pseudoknot	   formation12.	   Recent	   advances	   have	  brought	   examples	   of	   cis-­‐acting	   sRNAs	   that	   overlap	  with	   the	   5’-­‐	   or	   3’-­‐untranslated	  region	  (utr)	  of	  target	  mRNAs	  and	  long	  (>1000	  nt)	  sRNAs	  that	   span	   multiple	   genes15,	   in	   addition	   to	   sRNAs	   that	   facilitate	  premature	   termination	   of	   transcription	   of	   the	   cis-­‐encoded	   mRNA	  target16.	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1.2.2 Trans-­acting	  sRNAs	  Trans-­‐acting	  sRNAs	  on	  the	  other	  hand	  are	  encoded	  distantly	  from	  their	  target	  gene,	  and	  therefore	  conserve	   less	  sequence	  homology.	  Whereas	  negative	   regulation	   dominates	   the	   known	   trans-­‐acting	   sRNAs,	   the	  relatively	   few	   examples	   of	   positive	   regulation	   act	   mainly	   by	   a	  mechanism	   of	   “anti-­‐antisense”-­‐regulation,	   alleviating	   inhibitory	  structures	   in	   the	   target	   mRNA.	   Of	   particular	   interest	   are	   the	   kind	   of	  sRNAs	  that	  are	  able	  to	  act	  on	  several	  different	  mRNA	  targets,	  especially	  those	   capable	   of	   both	   positive	   and	   negative	   regulation,	   turning	   these	  into	   regulatory	   junctions	   of	   the	   post-­‐transcriptional	   regulatory	  network.	  	  Trans-­‐acting	  sRNAs	  generally	  are	  involved	  in	  cellular	  stress-­‐response17,	  and	   are	   particularly	   transcribed	   under	   conditions	   of	   nutritional	  stress18.	  E.	  coli	  sRNAs	  have	  been	  shown	  to	  be	  specifically	  up-­‐regulated	  during	   changes	   in	   glucose	   concentration,	   elevated	   glucose-­‐phophate	  levels,	   elevated	   glycine	   levels,	   iron	   depletion,	   but	   also	   in	   oxidative	  stress	  and	  outer	  membrane	  stress19-­‐23.	  In	   negative	   regulation,	   trans-­‐acting	   sRNAs	   act	   by	   a	   mechanism	   of	  obstructing	   ribosome	   binding	   to	   the	  mRNA,	   as	   reviewed	   by	   Kaberdin	  and	   Bläsi	   200624.	   The	   sRNAs	   recognize	   complementary	   sequence	   in	  vicinity	  of	  the	  ribosomal	  binding	  site	  (rbs),	  and	  it	  has	  been	  shown	  how	  very	   few	   basepairs	   can	   be	   required	   for	   this	   interaction25.	   The	   sRNA	  prevents	   ribosome-­‐loading	   onto	   the	   mRNA,	   leading	   to	   rapid	  degradation	  of	  the	  mRNA.	  Conversely,	  in	  positive	  regulation	  sRNAs	  act	  by	  making	   the	   rbs	   available	   for	   ribosome-­‐loading.	  Mechanistically	   the	  sRNA	   will	   interact	   with	   the	   mRNA	   in	   an	   ‘anti-­‐antisense’	   manner,	   by	  basepairing	   with	   selfcomplementary	   regions	   of	   the	   mRNA	   5’-­‐utr.	  Hereby,	   the	   sRNA	   melt	   or	   compete	   with	   formation	   of	   inhibitory	  intramolecular	  secondary	  structures	  covering	  the	  rbs26-­‐28.	  	  Several	  trans-­‐acting	  sRNAs	  have	  been	  reported	  to	  have	  a	  promiscuous	  behavior	   in	   their	   ability	   to	   interact	   with	   multiple	   mRNA	   targets,	   as	  reviewed	  by	  Papenfort	  and	  Vogel	  200929.	  The	  best-­‐studied	  example	  of	  this	  type	  of	  sRNA	  is	  DsrA	  from	  E.	  coli,	  a	  particular	  interesting	  specimen	  in	  its	  ability	  to	  exert	  translational	  regulation	  on	  transcriptional	  systems.	  DsrA	   is	   an	   87-­‐nt	   global	   regulator	  with	   several	   specific	   riboregulatory	  properties	   due	   to	   discreet	   domains	   of	   its	   secondary	   structure,	   which	  comprises	   three	   stem-­‐loop	   structures	   termed	   domain	   1-­‐3	   (Fig.1.2).	  Through	   ‘anti-­‐antisense’	   regulation	   by	   domain	   1,	   DsrA	   up-­‐regulates	  translation	   of	   the	  mRNA	   rpoS	   that	   encodes	   the	   stress-­‐response	   RNA-­‐polymerase	  sigma-­‐factor,	  and	  genes	  upstream	  hereof.	  Domain	  2	  of	  DsrA	  binds	  and	  sequesters	   the	  hns	  mRNA	  through	  base-­‐pairing	  with	   the	  5’-­‐	  and	  3’-­‐regions	  of	  this	  mRNA,	  hereby	  down-­‐regulating	  expression	  of	  the	  major	   nucleoid	   structuring	   protein	   H-­‐NS.	   Domain	   3	   comprises	   the	  transcriptional	   terminator	   of	   DsrA,	   which	   is	   not	   directly	   involved	   in	  regulation.	   It	   has	   been	   shown	   that	   domain	   3	   can	   be	   substituted	   by	   a	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heterologous	  terminator	  sequence,	  and	  it	  is	  thought	  to	  be	  essential	  for	  proper	  fold	  of	  the	  DsrA	  sRNA30,31.	  	  Trans-­‐acting	  sRNAs	  are	  generally	  characterized	  by	  non-­‐continuous	  and	  low	   target	   sequence	   complementarity,	   a	   property	   that	   enables	   the	  above-­‐mentioned	   promiscuity	   among	   targets.	   The	   relatively	   low	  sequence	   complementarity	   provides	   the	   binding	   event	   with	   an	  enthalphic	  penalty,	  which	  can	  be	  alleviated	  by	  complementary	  binding	  factors,	  a	  role	  that	  in	  Bacteria	  for	  the	  majority	  of	  the	  trans-­‐acting	  sRNAs	  is	  carried	  out	  by	  the	  RNA-­‐chaperone	  protein	  Hfq.	  	  
1.3 Hfq	  as	  pleiotropic	  regulator	  When	  Hfq	  was	  first	  identified	  in	  E.	  coli	  by	  Franze	  de	  Fernandez	  et	  al.	  in	  196832,	  as	  being	  pre-­‐requisite	   for	  the	  replication	  of	   the	  bacterial	  RNA-­‐phage	  Qβ	   (hence	   the	  name	   “host	   factor	   I-­‐Q”	  –	  Hfq),	   the	  protein	  would	  co-­‐purify	   with	   RNA	   in	   a	   6:1	   molar-­‐ratio.	   Soon	   hereafter	   zone-­‐sedimentation	   experiments	   by	   ultracentrifugation,	   established	   the	  protein	  to	  adopt	  the	  quaternary	  structure	  of	  a	  hexamer33,	  which	  is	  the	  functional	  form	  of	  Hfq.	  	  The	   protein	   has	   been	   established	   as	   one	   of	   the	   most	   abundant	   in	  Bacteria	  with	  some	  30	  -­‐	  60000	  copies	  (5	  -­‐	  10000	  functional	  hexamers)	  per	  cell,	  therefore	  Hfq	  can	  be	  considered	  to	  be	  constitutively	  present	  in	  all	   regulatory	   events	   required34.	   The	   level	   of	   Hfq	   in	   the	   cell	   under	  different	  growth	  conditions	  has	  been	  disputed,	  and	  the	  hfq	  gene,	  which	  is	   located	   in	   a	   tightly	   regulated	   super-­‐operon,	   has	   been	   shown	   to	   be	  subject	  to	  both	  transcriptional	  and	  translational	  regulation35-­‐39.	  Knock-­‐out	   mutants	   of	   Hfq	   display	   diverse	   phenotypes,	   placing	   the	  protein	   at	   center	   in	   bacterial	   homeostasis40.	   Among	   the	   different	  observations	   made	   is	   decreased	   growth	   rates	   and	   yields,	   decreased	  negative	   supercoiling	   of	   plasmids	   in	   stationary	   phase,	   increased	   cell	  
	  Fig.1.2:	  (A)	  Secondary	  structure	  of	  the	  trans-­‐acting	  sRNA	  DsrA	  from	  E.	  
coli	   comprising	   domain	   1-­‐3.	   (B)	   Domain	   1	   exerts	   ‘anti-­‐antisense’	  regulation	  on	  the	  rpoS	  mRNA.	  (C)	  Domain	  2	  regulates	  by	  sequestering	  the	  hns	  mRNA	  (figure	  adapted	  from	  Lease	  and	  Belfort	  200030,31).	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size,	   osmosensitivity,	   increased	   oxidation	   of	   carbon	   sources	   and	  increased	   sensitivity	   to	   ultraviolet	   light.	   Subsequent	   studies	   have	  established	   that	   knock-­‐out	   of	   the	   hfq	   gene	   effectively	   attenuates	   the	  virulence	   of	   several	   gram-­‐negative	   pathogens,	   making	   the	   protein	   a	  potential	  target	  for	  antibiotics41-­‐43.	  In	  seminal	  studies,	  Hfq	  was	  implicated	  in	  positive	  regulation	  of	  the	  rpoS	  gene	   that	   encodes	   the	   RNA-­‐polymerase	   σ-­‐factor	   under	   stress	   (σS),	   a	  central	   regulator	   of	   stationary	   phase	   and	   general	   stress	   response44,45.	  Experiments	   suggested	   that	   Hfq	   most	   likely	   would	   alleviate	   an	  inhibitory	   secondary	   structure	   covering	   the	   rbs	   in	   the	   translation	  initiation	  region	  of	  the	  rpoS	  mRNA44,46,47.	  The	  discovery	  that	  Hfq	  binds	  the	  sRNA	  OxyS48,	  and	  that	  Hfq	  competes	  for	  binding	  to	  the	  rbs	  of	  ompA	  mRNA39,	   suggested	   that	   Hfq	   is	   involved	   primarily	   with	   post-­‐transcriptional	  regulation.	  Since	  then	  it	  has	  been	  established	  that	  Hfq	  is	  predominantly	   involved	   in	   sRNA-­‐mediated	   regulation,	   and	   a	   recent	  study	   employing	   deep-­‐sequencing	   analysis	   show	   Hfq	   to	   be	   involved	  with	   regulation	   of	   as	   many	   as	   20%	   of	   the	   genes	   in	   Salmonella	  
thypimurium49.	  The	   best	   studied	   Hfq-­‐dependent	   sRNA-­‐mediated	   regulation	   by	   far,	   is	  the	  riboregulation	  of	  rpoS	  by	  DsrA	  50-­‐53.	  Many	  other	  examples	  have	  also	  been	   well	   characterized,	   and	   the	   involvement	   of	   Hfq	   has	   been	  characterized	   in	   a	   variety	   of	   systems.	   For	   example	   the	   spot42	   sRNA	  mediated	   translational	   regulation	   of	   galK	   mRNA	   translation	   encoding	  galactokinase54,	   or	   the	   OxyS	   sRNA	   regulation	   of	   fhlA	   mRNA	   the	   gene	  product	  of	  which	  affects	  more	   than	  40	  genes	   in	   response	   to	  oxidative	  stress55.	   In	  response	   to	  phosphorsugar	  stress,	   silencing	   is	  enforced	  on	  
ptsG	  mRNA,	  encoding	  the	  membrane	  component	  of	  the	  glucose-­‐specific	  phosphoenolpyruvate	   phosphotransferase	   system,	   by	   the	   SgrS	   sRNA	  together	  with	  RNAseIII	   and	  Hfq25.	   Similarly,	   the	  RybB	  sRNA	  promotes	  degradation	   of	   mRNAs	   encoding	   outer	   membrane	   porins	   (OMP)21,56.	  Hfq	   has	   been	   shown	   to	   be	   involved	  with	  RyhB	   regulation	   of	   bacterial	  iron	   homeostasis,	   through	   silencing	   of	   the	   sodB	   mRNA57,	   and	   also	   in	  regulation	  of	  ABC-­‐transport	  systems,	  through	  the	  sRNA	  GcvB	  acting	  on	  the	  mRNAs	  oppA	   and	  dppA,	  which	   encode	  periplasmic	   components	   of	  major	   peptide	   transport	   systems58.	   Furthermore,	   Hfq	   has	   been	  demonstrated	   to	   autoregulate	   repression	   of	   its	   own	   translation	   by	  sequestration	  of	  its	  own	  mRNA38.	  	  Recently	   it	  was	  demonstrated	  how	  Hfq	  can	  be	  depleted	   in	   the	   cell,	  by	  sequestering	  of	  the	  protein	  by	  induced	  over-­‐expression	  of	  sRNAs59.	  The	  finding	   that	   despite	   Hfq’s	   abundance	   it	   can	   be	   in	   short	   supply	   for	  required	   regulatory	   events,	   leads	   to	   questions	   regarding	   the	  competition	  between	  RNA	  binding	  partners	  as	  a	  means	  of	  regulation.	  In	  addition,	   auto-­‐assembly	   of	   self-­‐associating	   sRNAs	   have	   also	   been	  considered	  as	  a	  possible	  method	  of	  regulation60,61.	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Hfq	   has	   also	   been	   shown	   to	   be	   binding	   DNA-­‐fragments	   of	   primarily	  membrane	  proteins62.	  However,	  further	  studies	  needs	  to	  be	  undertaken	  to	  establish	  a	  specific	  function	  for	  Hfq	  in	  this	  area.	  	  
1.4 Hfq	  as	  RNA-­chaperone	  As	  coined	  by	  D.	  Herschlag	  in	  199563,	  an	  RNA-­‐chaperone	  is	  a	  protein	  that	  aids	   in	   RNA-­‐folding.	   The	   original	   concept	   of	   a	   RNA-­‐chaperone	   arose	  from	   studies	   of	   the	   HIV	   nucleocapsid	   protein	   and	   hnRNP	   A1	   protein,	  both	   of	   which	   Herschlag	   et	   al.	   in	   1994	   characterized	   to	   enhance	   the	  hammerhead	  ribozyme	  reaction64.	  	  Similarly,	   Moll	   and	   co-­‐workers	   used	   stimulation	   of	   group	   I	   intron	  splicing	  in	  vivo65	  and	  a	  modified	  in	  vitro	  toeprinting	  assay,	  to	  assess	  the	  RNA-­‐chaperone	  activity	  of	  Hfq66.	  This	  demonstrated	  that	  Hfq	  facilitates	  refolding	  of	  a	  misfolded	  splicing	  defective	  T4	  phage	  td	  gene	  in	  vivo,	  and	  that	   Hfq-­‐induced	   structural	   changes	   in	   ompA	   mRNA	   are	   stable	   after	  proteolytic	   digestion	   of	   the	   protein.	   	   In	   the	   original	   definition	   of	   the	  term,	  this	  classifies	  Hfq	  as	  a	  bona-­‐fide	  RNA-­‐chaperone.	  	  Rajkowitsch	   and	   Schroeder	   further	   investigated	   the	   concept	   of	   RNA-­‐chaperone	   activity	   in	   2007,	   defining	   it	   as	   a	   functional	   property	   of	  “disrupting	   RNA-­‐RNA	   interactions	   and	   ‘loosening’	   RNA-­‐structure”,	  hereby	  giving	  emphasis	   to	   the	  assays	  employed	   for	  characterization67.	  In	   their	   definition,	   an	   RNA-­‐chaperone	   should	   be	   able	   to	   displace	  double-­‐stranded	   RNA,	   as	   well	   as	   promote	   the	   annealing	   of	  complementary	  sequence,	  and	  to	  do	  so	  on	  a	  wide	  variety	  of	  targets.	  In	  an	   effort	   to	   diversify	   the	   rather	   large	   group	   of	   RNA-­‐chaperones,	   they	  introduce	  the	  concept	  of	  an	  ‘RNA-­‐annealer’,	  to	  describe	  a	  protein	  which	  does	  not	  show	  general	  strand-­‐displacement	  activity.	  In	  the	  definition	  of	  Rajkowitsch	   and	   Schroeder	  Hfq	  does	  not	   display	   the	   required	   strand-­‐displacement	  to	  warrant	  the	  classification	  as	  RNA-­‐chaperone.	  	  However,	   the	   known	   biological	   function	   of	   Hfq	   is	   not	   to	   displace	   two	  annealed	   RNA-­‐strands.	   On	   the	   contrary,	   it	   is	   to	   facilitate	   annealing	   of	  complementary	   sequence,	   which	   in	   respective	   RNA-­‐molecules	   can	   be	  buried	  inside	  the	  intramolecular	  secondary	  structure.	  For	  annealing	  to	  occur,	   the	   complementary	   sequence	   of	   the	   binding	   site	   in	   both	   RNA-­‐molecules	  must	   be	   exposed.	   As	   the	   binding	   site	   is	   buried	   in	   a	   strand	  folding	   up	   on	   itself,	   the	   ‘un-­‐folding’	   or	   local	   strand-­‐displacement	  facilitated	   by	   the	   RNA-­‐chaperone	   activity	   of	   Hfq	   could	   therefore	   for	  example	  be	  done	  by	  pulling	   the	   two	  separate	  ends	  of	   the	   folded	  RNA.	  This	   event	   might	   actively	   involve	   the	   corresponding	   regulatory	   or	  target	  RNA-­‐molecule,	  which	  would	   then	  serve	   the	   role	  of	  an	   “RNA-­‐co-­‐chaperone”.	   In	   analogy,	   consider	   the	   definition	   of	   protein	   co-­‐chaperones	   as	   exemplified	   by	   DnaJ,	   which	   apart	   from	   having	   its	   own	  chaperone	   activity	   is	   involved	   in	   recruiting	   the	   DnaK-­‐chaperone	   to	  specific	  misfolded	  protein	  substrates68.	  Similarly,	  trans-­‐encoded	  sRNAs	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can	  also	  anneal	  to	  their	  target	  mRNA	  and	  function	  independently,	  some	  do	  not	  even	  need	  Hfq	  to	  do	  so69-­‐71;	  but	  most	  -­‐	   if	  not	  all,	  will	  accelerate	  their	  annealing	  when	  Hfq	  is	  recruited	  to	  the	  process72-­‐74.	  	  Speculation	  has	   been	   raised	   about	   the	  ATP-­‐binding	  properties	   of	  Hfq,	  and	   the	   purpose	   of	   a	   suggested	   ATPase	   activity.	   The	   ATPase	   activity	  was	   first	  proposed	  by	  Sukhodolets	  and	  Garges	   in	  200375	  and	   followed	  up	  by	  Arluison	  et	  al.	   in	  200776,	   in	  a	   study	  proposing	  ATP-­‐binding	  and	  hydrolysis	  to	  be	  involved	  in	  the	  chaperone	  activity	  of	  Hfq.	  In	  the	  study	  by	   Arluison	   et	   al.,	   data	   obtained	   from	   electron	   microscopy	   (EM)	  experiments	  indicated	  that	  ATP-­‐binding	  would	  cause	  a	  conformational	  change	   in	   a	   complex	   between	   Hfq	   and	   a	   heptameric	   A7-­‐RNA	   oligo-­‐nucleotide,	  disrupting	  the	  hexameri	  c	  symmetry	  of	  the	  complex.	  These	  findings	   could	  not	  be	   reproduced	  with	  non-­‐hydrolysable	  ATP-­‐analogs,	  linking	  the	  ATP-­‐hydrolysis	  to	  the	  disruption	  of	  symmetry	  suggested	  by	  the	  EM-­‐results.	  However,	  Hämmerle	  and	  Bläsi	  have	  studied	  the	  ATPase-­‐activity	   of	   Hfq	   extensively	   and	   found	   the	   hydrolysis	   to	   be	   caused	   by	  impurities	  in	  the	  preparation	  of	  Hfq	  (unpublished	  results).	  In	  addition,	  Hfq	   was	   shown	   to	   function	   in	   conjunction	   with	   the	   ATP-­‐dependent	  RNA-­‐helicase	  CsdA77.	  In	  the	  study	  by	  Arluison	  et	  al.76	  excess	  of	  ATP	  was	  also	  found	  to	  promote	  dissociation	  of	  Hfq	  and	  a	  longer	  oligo	  nucleotide,	  which	   incorporated	   a	   A18-­‐tail	   in	   its	   3’-­‐end	   that	   “..mimics	   the	   basic	  structures	  found	  in	  the	  3′-­‐termini	  of	  mRNAs”.	  Competition	  of	  ATP	  with	  binding	   of	   poly-­‐A	   RNA	   on	   Hfq	   is	   quite	   plausible	   given	   the	   chemical	  similarity	  of	  these	  ligands.	  	  
1.5 RNA-­binding	  to	  Hfq:	  the	  functional	  perspective	  As	  mentioned	  above,	  considering	  of	  the	  abundance	  of	  Hfq	  in	  the	  cell,	  it	  is	  reasonable	  to	  imagine	  Hfq	  to	  be	  present	  for	  all	  the	  events	  where	  it	  is	  required.	  Yet	  however,	   it	   is	  possible	  to	  deplete	  Hfq	  in	  un-­‐physiological	  extreme	   cases.	   This	   dualism	   provides	   an	   insight	   into	   a	   careful	   fine-­‐tuned	   network	   of	   trans-­‐encoded	   post-­‐transcriptional	   regulation,	   a	  network	  with	  Hfq	  at	  its	  center.	  Furthermore,	  the	  preference	  for	  binding	  of	  specific	  sRNAs	  has	  recently	  been	  implicated	  as	  a	  possible	  hierarchical	  approach	   to	   riboregulation78.	   One	   could	   think	   of	   Hfq	   as	   the	   major	  transcript	  structuring	  protein,	  being	  bound	  on	  either	  mRNAs	  or	  sRNAs	  and	  acting	  as	  a	  “molecular	  force-­‐field”,	  sampling	  for	  a	  suitable	  binding	  partner	  to	  induce	  a	  regulatory	  event.	  On	  occurrence	  of	  a	  suitable	  match,	  Hfq	   will	   dissociate	   from	   the	   RNA-­‐duplex	   to	   be	   recycled	   in	   a	   new	  regulatory	  event79.	  	  To	   add	   to	   the	   complexity,	   Hfq	   has	   also	   been	   implicated	   in	   both	  protection	   against	   and	   stimulation	   of	   RNA	   degradation.	   Hfq	   was	  demonstrated	   to	   turn	   poly(A)-­‐polymerase	   I	   (PAP-­‐I)	   into	   a	   processive	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enzyme,	  hereby	  enhancing	  poly-­‐adenylation	  and	   increasing	   the	   length	  of	   poly(A)	   tails.	   The	   length	   of	   poly(A)	   tails	   of	   bacterial	   mRNAs	   is	  thought	   to	   result	   from	   competition	   between	   PAP-­‐I	   and	  exoribonucleases	   like	   polynucleotide	   phosphorylase	   (PNPase)	   and	  RNase	   II,	  which	   target	   the	   3'	   ends	   of	  RNAs80-­‐82.	   Both	  Hfq	   and	  PNPase	  were	  shown	  to	  co-­‐purify	  with	  His-­‐tagged	  PAP-­‐I	  under	  native	  conditions,	  indicating	   a	   potential	   complex	   among	   these	   proteins	   that	   was	  confirmed	  by	  immunoprecipitation	  experiments83.	  In	  E.	   coli,	  Hfq	  has	  been	   found	   in	  complex	  with	  a	  wide	  variety	  of	  RNA-­‐binding	   proteins,	   implying	   a	   cooperative	   function	   for	   Hfq	   in	   these	  systems.	   Among	   the	   protein	   binding	   partners	   are	   RNA	   polymerase,	  ribosomal	   protein	   S175,	   RNAse	   E84	   and	   RNA-­‐helicase	   CsdA85.	   The	   C-­‐terminus	  of	  E.	   coli	  Hfq	   is	  highly	   enriched	   in	   serine	   residues,	   a	   feature	  also	   found	   in	   intrinsically	   disordered	   hub-­‐proteins	   that	   are	   central	   to	  eukaryotic	   interactomes86,	   and	   it	   has	   therefore	   been	   speculated	   that	  Hfq	  also	  serves	  to	  assemble	  and	  organize	  a	  variety	  of	  multi-­‐component	  RNA-­‐targeting	  protein	   complexes.	  However,	   focused	   studies	   could	  not	  find	   direct	   protein-­‐protein	   interactions	   between	   Hfq	   and	   RNase	   E87,	  ribosomal	  protein	  S188	  or	  CsdA77,	   leading	   to	   the	   likely	  conclusion	   that	  the	  observed	  complexes	  are	  RNA-­‐mediated.	  Hfq	  has	  also	  been	  shown	  to	  protect	  against	  endonucleolytic	  RNase	  E	  mediated	  RNA	  degradation,	  in	  that	  the	  Hfq	  binding	  site	  coincides	  with	  the	  AU-­‐rich	  recognition	  site	  of	  RNase	  E.	  This	  was	  shown	  specifically	  for	  the	  two	  sRNAs	  RyhB	  and	  DsrA,	  and	   is	   likely	   valid	   for	   all	   Hfq-­‐dependent	   uridine-­‐rich	   regulatory	  RNAs89,90.	  	  	  In	  a	  study	  by	  Møller	  et	  al.	   from	  200291,	  the	  binding	  site	  for	  Hfq	  on	  the	  spot42	   sRNA	   was	   probed	   by	   hydroxyl	   radical	   foot-­‐printing,	   which	  confirmed	  the	  previous	  findings	  that	  Hfq,	  similar	  to	  the	  Sm-­‐proteins	  of	  higher	   organisms,	   shows	   preference	   for	   binding	   to	   uridine-­‐rich	  sequence	   stretches.	   Brescia	   and	   co-­‐workers	   studied	   the	   interaction	  between	   Hfq	   and	   DsrA	   in	   detail	   in	   200392,	   and	   showed	   that	   Hfq	  recognizes	   U-­‐stretches	   adjacent	   to	   stem-­‐loop	   structures.	   	   The	   major-­‐groove	  of	  RNA	  stem-­‐loops	   is	  known	  to	  coordinate	  α-­‐helices93.	   In	  2004	  Geissmann	  and	  Touati	  found	  interaction	  with	  Hfq	  to	  specifically	  require	  a	   stem-­‐loop	   structure	   succeeding	   an	   A/U-­‐rich	   sequence,	   and	   to	  subsequently	  partly	  open	  the	  structure	  to	  allow	  for	  binding	  of	  the	  sRNA	  RyhB,	  which	  provided	  a	  novel	  functional	  mechanism	  for	  Hfq94.	  A	  second	  binding	  site,	  specific	  for	  poly(A)-­‐sequence,	  was	  characterized	  by	   Mickulecky	   et	   al.	   in	   200495.	   Mutations	   located	   at	   distance	   to	   the	  uridine-­‐specific	  binding	  site	  reduced	  the	  affinity	   for	  and	  translation	  of	  
rpoS	   mRNA,	   and	   established	   a	  model	   whereby	   two	   binding	   sites	   and	  dual	  binding	  of	   sRNA	  and	   target	  mRNA	   is	   required	   for	   the	   function	  of	  Hfq.	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In	   a	   study	   by	   Sonnleitner	   and	   co-­‐workers	   in	   2004,	   site-­‐directed	  mutagenesis	  showed	  how	  a	  single	  mutation	  of	  Lys-­‐3	  in	  the	  N-­‐terminus	  of	  E.	  coli	  Hfq	  is	  detrimental	  for	  the	  function	  of	  the	  protein,	  and	  also	  that	  the	  C-­‐terminus	  stabilizes	  DsrA	  sRNA	  when	  bound	  to	  Hfq96.	  In	  E.	  coli	  Hfq	  both	  the	  N-­‐	  and	  C-­‐terminal	  regions	  are	  intrinsically	  disordered,	  which	  is	  known	   to	   be	   an	   inherent	   property	   of	   RNA-­‐chaperone	   proteins,	   and	  probably	  related	  to	  refolding	  initiation	  by	  entropy-­‐transfer97,98.	  In	  2008,	  Vecerek	  et	  al.	  published	  studies,	   indicating	  that	  the	  C-­‐terminal	  domain	  of	  Hfq	  contains	  a	  previously	  unrecognized	  binding	  site	  with	  specificity	  for	  mRNA99.	  	  The	   mechanism	   of	   Hfq’s	   role	   in	   positive	   riboregulation	   has	   been	   the	  subject	  of	  extensive	  studies	  by	  Soper	  and	  Woodson,	  investigating	  Hfq’s	  involvement	   in	   the	   interaction	   between	   sRNA	  DsrA	   and	  mRNA	   target	  
rpoS.	   In	   a	   2008	   study53	   Hfq	   was	   demonstrated	   to	   bind	   both	   RNAs	  simultaneously	   and	   hereby	   increase	   their	   local	   concentration.	   Hfq	  interacts	  with	  and	  alleviates	  an	  inhibitory	  structure	   in	  the	  rpoS	  mRNA	  5’-­‐leader,	   and	   subsequently	   promotes	   annealing	   of	   DsrA.	   The	   Hfq	  binding	  site	   in	  DsrA	  coincides	  with	   the	  rpoS	   complementary	  sequence	  and	  contains	  a	  uridine-­‐rich	  stretch,	  providing	  DsrA	  to	  interact	  with	  Hfq	  according	   to	   this	  specificity.	  The	  Hfq	  binding	  site	   in	  rpoS	  was	  mapped	  by	  mutational	  analysis	  to	  an	  adenine-­‐rich	  stretch	  upstream	  of	  the	  DsrA	  complementary	   region,	   which	   is	   then	   expected	   to	   interact	   with	   the	  poly(A)-­‐specific	   binding	   site	   on	   Hfq,	   characterized	   by	   Mickulecky	   et	  
al.95.	   Upon	   annealing	   the	   RNA-­‐duplex	   dissociates	   from	   Hfq,	   although	  Hfq	  apparently	  remains	  bound	  to	  the	  mRNA.	  In	  a	  follow-­‐up	  study	  from	  2010100	   these	   observations	   were	   found	   to	   apply	   to	   three	   separate	  instances	  of	  positive	  sRNA	  mediated	  regulation	  of	  rpoS.	  These	  findings	  gives	   perspective	   to	   recent	   results,	   which	   suggest	   how	   competition	  among	   different	   sRNAs	   for	   binding	   on	   Hfq	   could	   be	   involved	   in	   the	  riboregulatory	  network78.	  	  In	   2011,	   two	   studies	   both	   applying	   fluorescence	   based	  methods	   have	  been	   published	   on	   the	   mechanistic	   aspects	   of	   Hfq’s	   interaction	   in	  DsrA:rpoS-­‐duplex	   formation.	   Arluison	   and	   co-­‐workers52	   for	   the	   first	  time	  applied	  single-­‐molecule	  fluorescence	  energy	  transfer	  (smFRET)	  to	  study	   the	   function	   of	   Hfq	   in	   real-­‐time,	   whereas	   Woodson	   and	   co-­‐workers51	   applied	   stopped-­‐flow	   fluorescence	   assays	   to	   measure	  kinetics	   of	   the	   individual	   steps	   in	   Hfq-­‐mediated	   duplex	   formation	  between	  DsrA	  and	  rpoS.	  The	  RNA-­‐substrates	  used	  in	  both	  of	  these	  studies	  are	  very	  short	  (16	  and	  37	  nucleotides),	  and	  none	  of	   the	  rpoS-­‐fragments	   include	  the	  upstream	  A-­‐rich	  region	  mentioned	  above.	  Interestingly,	  Arluison	  and	  co-­‐workers	  found	  that	  the	  DsrA	  and	  rpoS	  RNA-­‐fragments,	  which	  both	  include	  a	  U-­‐rich	   region	   natively,	   compete	   for	   the	  U-­‐specific	   bindingsite	   on	  Hfq.	   In	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the	   study	   by	   Woodson	   and	   co-­‐workers	   a	   RNA	   molecular-­‐beacon	  emulates	  the	  regulatory	  strand	  of	  rpoS,	  and	  is	  therefore	  complementary	  to	   the	   utilized	   DsrA-­‐fragment,	   and	   hence	   carrying	   an	   A-­‐rich	   region.	  Here	  no	  competition	  was	   found,	  and	   taken	   together	  with	   results	   from	  mutation	   studies,	   the	   authors	   concluded	   that	   the	   two	   RNA-­‐fragments	  simultaneously	   and	   independently	   interact	   with	   the	   two	   established,	  and	  respectively	  A-­‐	  and	  U-­‐specific,	  binding	  sites.	  	  The	   dualisms	   in	   these	   findings	   signify	   the	   recurring	   paradox	   in	   the	  pleitropic	  function	  of	  Hfq.	  In	  the	  recent	  fluorescence	  study	  by	  Woodson	  
et	   al.	   where	   it	   was	   reported	   how	   the	   Y25D	   mutation	   in	   the	   poly-­‐A	  bindingsite,	  not	  alone	  effect	  the	  binding	  of	  RNA,	  but	  also	  the	  annealing	  properties	  of	  E.	   coli	  Hfq.	  The	  oligomeric	  nature	  of	  Hfq	  means	   a	   single	  point-­‐mutation	   changes	   six	   aminoacids	   in	   the	   functional	   hexamer,	  effectively	   changing	   Hfq’s	   overall	   properties	   and	   possibly	   the	  interaction	   with	   RNA.	   This	   makes	   it	   virtually	   impossible	   to	   achieve	  results	  on	   single	   subunit	   resolution	   level	   from	  such	   studies.	  However,	  these	   fluorescence	   studies	   (and	   also	   other	   mutation	   studies)	   provide	  readily	  analyzable	  data.	  Despite	  the	  at	  times	  contradictory	  conclusions,	  these	   results	   can	   serve	   to	   provide	   circumstantial	   evidence	   for	   the	  molecular	  function	  of	  E.	  coli	  Hfq.	  In	  this	  regard,	  it	  could	  be	  interesting	  to	  see	   the	   result	   of	   these	   two	   fluorescence	   studies	   combined,	   in	   a	   study	  employing	  smFRET	  with	  E.	   coli	  Hfq	   labeled	  with	   specific	   fluorophores	  in	  one,	  maybe	  two	  monomers.	  From	  such	  a	  study	  one	  might	  be	  able	  to	  deduce	  how	  the	  two	  RNAs	  interact	  with	  E.	  coli	  Hfq,	   in	  what	  order	  and	  binding	   site,	   and	   if	   there	   is	   any	   coorporativity	   between	   the	  A-­‐	   and	  U-­‐specific	  binding	  sites.	  A	  number	  of	  crystal	  structures	  of	  Hfq	  have	  been	  solved,	  some	  in	  complex	  with	  RNA,	  and	  it	  would	  be	  very	  informative	  to	  see	  the	  crystal	  structure	  of	  a	  ternary	  complex,	  with	  both	  the	  A-­‐	  and	  U-­‐specific	  binding	  sites	  in	  E.	  coli	  Hfq	  occupied	  simultaneously.	  	  
1.6 RNA-­binding	  to	  Hfq:	  the	  structural	  perspective	  At	  time	  of	  writing,	  15	  crystal	  structures	  of	  Hfq	  were	  available	  form	  the	  Protein	   Data	   Bank	   (www.rcsb.org),	   with	   10	   more	   waiting	   to	   be	  released.	   The	   available	   structures	   represent	  Hfq	   homologs	   from	   eight	  different	   species,	   with	   four	   comprising	   complexes	   between	   Hfq	   and	  RNA	  oligo	  nucleotides.	  A	   general	   dogma	   of	  Hfq	   functionality	  was	   initially	   based	   on	   cryo	   EM-­‐studies101	  and	  subsequent	  crystal	  structure	  of	  the	  human	  spliceosomal	  U1-­‐snRNP102,	  demonstrating	  U1	  RNA	  to	  protrude	  from	  the	  central	  pore	  of	  a	  human	  Sm-­‐protein	  heptamer.	  Evidence	  for	  a	  similar	  function	  in	  Hfq	  has	  yet	  to	  be	  established.	  The	  structures	  of	  Hfq	  all	  reveal	  the	  protein	  to	  oligomerize	  as	  a	  hexamer,	  with	  an	  overall	  shape	  of	  a	  doughnut.	   	  The	  Hfq	  subunits	  adopt	  a	  fold	  in	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close	   resemblance	   to	   the	   classical	   (oligonucleotide/oligosaccharide	  binding)	  OB-­‐fold;	  a	  five-­‐stranded	  anti-­‐parallel	  bent	  β-­‐sheet	  forming	  an	  SH3-­‐like	   β-­‐barrel,	   capped	   by	   an	   N-­‐terminal	   α-­‐helix.	   By	   conserved	  backbone	   interactions	   between	   adjacent	   SH3-­‐like	   β-­‐barrel	   domains,	   a	  circular	   30-­‐stranded	   β-­‐sheet	   is	   formed,	  which	   in	   part	   can	   explain	   the	  high	  thermostability	  of	  this	  protein	  (Fig.1.3).	  
1.6.1 An	  Sm-­like	  fold	  In	   a	   difference	   to	   eukaryotic	   and	   archaeal	   Sm/Lsm-­‐proteins	   that	  function	  as	  hetero	  heptamers104,	  Hfq	  adopts	  the	  quaternary	  structure	  of	  a	  homo	  hexamer55,91.	  Lacking	  some	  distinct	  Sm-­‐protein	  features	  Hfq	  is	  classified	   as	   an	   Sm-­‐like	   protein,	   belonging	   to	   the	   Sm-­‐protein	  superfamily.	   Sm-­‐proteins	   conserve	   the	   Sm1-­‐	   and	   Sm2-­‐motifs	  comprising	  hydrophobic	  residues	  that	  maintain	  the	  core	  of	  the	  Sm-­‐fold	  and	   highly	   conserved	   residues	   that	   bind	  RNA.	   Clear	   homology	   can	   be	  found	  for	  the	  Sm1-­‐motif	  in	  Hfq,	  whereas	  identification	  of	  the	  Sm2-­‐motif	  is	  less	  obvious,	  and	  is	  the	  reason	  why	  Hfq	  initially	  evaded	  bioinformatic	  classification	   (see	   Fig.1.3).	   A	   hallmark	   difference	   of	   the	   Sm2-­‐motif	   in	  Hfq,	  is	  the	  YKHA-­‐segment	  that	  make	  up	  loop-­‐5	  between	  the	  β-­‐strands	  4	  and	   5105.	   Despite	   sequence	   variability	   (-­‐RGXX-­‐	   in	   the	   eukaryotic	   Sm-­‐proteins)	   this	   loop	  maintains	   its	   topology,	   likely	   due	   to	   its	   conserved	  involvement	   in	   RNA-­‐binding106.	   In	   addition,	   the	   Hfq-­‐family	   is	  characterized	   by	   a	   slightly	   longer	   N-­‐terminal	   α-­‐helix	   and	   an	   almost	  complete	  absence	  of	  the	  ‘variable	  region’	  that	  links	  the	  Sm1-­‐	  and	  Sm2-­‐motifs.	   Two	   residues	   extend	   the	   N-­‐terminal	   α-­‐helix,	   a	   feature	   that	   is	  only	  found	  in	  one	  of	  eight	  human	  Sm-­‐proteins,	  the	  human	  Sm-­‐D2.	  The	  
	  Fig.1.3:	   The	   hexameric	   oligomerization	   in	   Hfq	   forms	   a	   circular	   and	  continuous	   30-­‐stranded	   β-­‐sheet,	   which	   in	   part	   explains	   the	   high	  thermostability	   of	   this	   protein.	   Here	   the	   Hfq	   hexamer	   from	  
Pseudomonas	  Aeruginosa	   is	  shown	  from	  the	  distal	   face,	   in	  center	  the	  location	   of	   His-­‐57	   is	   noted	   by	   black	   dots.	   The	   secondary	   structure	  motifs	  of	  the	  Sm-­‐like	  fold	  are	  noted,	  blue:	  N-­‐terminal	  helix,	  red:	  Sm1-­‐motif,	  yellow:	  Sm2-­‐motif	  (figure	  adapted	  from103).	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eight	   variants	   of	   the	   human	   Sm-­‐protein,	  which	   dynamically	   form	   two	  compositions	   of	   hetero-­‐oligomers,	   are	   characterized	   by	   their	  uniqueness	  in	  the	  ‘variable	  region’107.	  
1.6.2 Hfq	  forms	  a	  compact	  RNA-­binding	  hexamer	  The	   hexameric	   oligomerization	   of	   Hfq	   has	   been	   suggested	   to	   be	  possible	   due	   to	   the	   absence	   of	   the	   ‘variable	   region’108.	   This,	   in	  combination	  with	   the	  YKHA-­‐segment	   of	   the	   Sm2-­‐motif	   that	   conserves	  an	   inter-­‐subunit	  hydrogen	  bond	  between	   the	   imidazole-­‐ring	  of	  His-­‐57	  and	   carbonyl-­‐oxygen	   of	   Ile-­‐59’	   of	   the	   adjacent	   subunit105,	   allows	   the	  subunits	  to	  pack	  closer	  compared	  to	  Sm-­‐proteins,	  giving	  preference	  to	  a	  hexameric	   organization	   for	   Hfq109.	   The	   quaternary	   structure	   is	  stabilized	  by	  a	  conserved	  hydrogen	  bonding	  pattern	  between	  β-­‐strand	  4	   and	   β-­‐strand	   5’	   of	   the	   adjacent	   monomer,	   further	   supported	   by	   a	  hydrophobic	   interface	  between	  the	  N-­‐terminal	  α-­‐helix	  and	  loop	  3’	  and	  between	  β-­‐strand	  2’	  and	  3’	  of	  the	  adjacent	  monomer.	  In	   Staphylococcus	   aureus	   Hfq	   (HfqSau)	   an	   additional	   H-­‐bond	   between	  Tyr-­‐56	  and	  Tyr-­‐63	  is	  found	  to	  stabilize	  the	  oligomer.	  In	  other	  common	  bacteria	  like	  E.	  coli,	  Tyr-­‐56	  (Tyr-­‐55	  in	  E.	  coli)	  is	  unpaired	  and	  thought	  to	  increase	  the	  RNA-­‐binding	  properties	  of	  Hfq105.	  The	   importance	   of	   His-­‐57	   for	   stabilization	   of	   the	   oligomer	   was	  investigated	   by	   mutational	   studies,	   which	   indicated	   that	   the	   H-­‐bond	  donor	   properties	   of	   His-­‐57	   could	   be	  mediated	   by	  water.	   In	   an	  H57T-­‐mutant	   of	  Pseudomonas	  aeruginosa	  Hfq	   (HfqPae),	   lower	   stability	   of	   the	  oligomer	   was	   measured	   by	   thermal-­‐melting,	   and	   the	   oligomer	   was	  further	   destabilized	   in	   a	   H57A-­‐mutant,	   where	   no	   water-­‐mediated	   H-­‐bond	  was	  possible103.	  	  	  
	  Fig.1.4:	  The	  residue	  His-­‐57	  is	  completely	  conserved	  in	  the	  Hfq-­‐family,	  and	  has	  been	  implicated	  in	  RNA-­‐binding.	  The	  Nε	  of	  His-­‐57	  H-­‐bonds	  to	  Ile-­‐59’,	   making	   the	   Nδ	   of	   His-­‐57	   more	   prone	   to	   act	   as	   a	   H-­‐bond	  acceptor,	   here	   shown	   to	   specifically	   coordinate	   the	   3’-­‐OH	   of	   a	  terminal	  uridine	  (figure	  adapted	  from	  110).	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In	   the	  most	   recent	   structure	  of	  Salmonella	   typhimurium	  Hfq	   (HfqSt)	   in	  complex	  with	  RNA,	   the	  highly	   conserved	  His-­‐57	  of	   the	  YKHA-­‐segment	  was	  identified	  as	  implicated	  in	  recognition	  of	  the	  terminal	  uridine	  3’-­‐OH	  of	   Rho-­‐independent	   transcripts,	   as	   an	   effect	   of	   its	   importance	   for	  oligomerization110.	   As	   can	   be	   seen	   in	   Fig.1.4,	   the	   interaction	   between	  His-­‐57	   and	   Ile-­‐59’	   stabilizes	   the	   imidazole	   ring	   of	   His-­‐57	   in	   a	  orientation	  suitable	  for	  H-­‐bonding	  to	  the	  3’-­‐OH.	  The	  Nε	  of	  the	  imidazole	  ring	   H-­‐bonds	   to	   the	   Ile-­‐59’	   carbonyl	   oxygen	   of	   the	   adjacent	   Hfq	  monomer,	   making	   the	   Nδ	   of	   His-­‐57	   more	   prone	   to	   act	   as	   a	   H-­‐bond	  acceptor,	  as	  a	  consequence	  of	  the	  dielectric	  properties.	  .	  This	  feature	  is	  completely	  conserved	  throughout	  the	  Hfq-­‐family,	  and	  gives	  emphasis	  to	  the	   importance	   of	   ring-­‐formation	   for	   the	   function	   of	   Hfq,	   other	   LSm-­‐proteins	  and	  possibly	  the	  dynamics	  of	  Sm-­‐proteins.	  	  
1.6.3 RNA	  binding	  sites	  in	  E.	  coli	  Hfq	  In	   Hfq	   two	   specific	   RNA-­‐binding	   sites	   have	   been	   characterized	  structurally,	   localizing	   respectively	   to	   each	   side	   of	   the	   doughnut	  hexamer73	   (Fig.1.6A),	   and	   both	   formed	   by	   residues	   from	   adjacent	  subunits.	  	  In	   accordance	   with	   the	   recognition	   that	   Hfq	   shows	   preference	   for	  binding	  of	  U-­‐rich	  RNA-­‐sequence,	  HfqSau	  was	  first	  crystallized	  in	  complex	  with	   a	   AUUUUUG-­‐oligo	   nucleotide,	   which	   was	   found	   to	   bind	   in	   a	  conserved	  A/U-­‐specific	  binding	  site	  on	  what	  came	  to	  be	  known	  as	   the	  proximal	  face	  of	  the	  doughnut108	  (Fig.1.5A+C-­‐D).	  Located	  on	  the	  rim	  of	  the	   central	   pore,	   the	   binding	   site	   is	   comprised	   primarily	   of	   residues	  from	   the	   loops	   between	   β-­‐strand	   2	   and	   3,	   and	   β-­‐strand	   4	   and	   5.	  Discrimination	  towards	  A/U-­‐nucleotides	  is	  governed	  by	  the	  completely	  conserved	  residue	  Gln-­‐8	   in	  the	  α-­‐helix	  (Fig.1.5B),	  which	  form	  H-­‐bonds	  with	  the	  uracil	  bases.	  A	  hallmark	  feature	  of	  the	  proximal	  binding	  site	  is	  the	   π-­‐stacking	   interaction,	   which	   coordinates	   the	   uracil	   bases	   in	   a	   π-­‐sandwich	   between	   Phe-­‐42	   (as	   numbered	   in	  HfqSt)	   from	   adjacent	  Hfq-­‐subunits	   (Fig.1.5B).	   The	   phosphate	   backbone	   of	   the	   RNA	   rests	   on	   a	  circular	   positively	   charged	   patch	   formed	   by	   His-­‐58	   (as	   numbered	   in	  HfqSau,	  His-­‐57	  in	  HfqSt)	  of	  the	  YKHA-­‐segment	  (Fig.1.5E+F).	  	  The	   proximal	   binding	   site	   has	   recently	   been	   suggested	   to	   also	  specifically	   recognize	   3’-­‐uridines	   present	   in	   the	   end	   of	   Rho-­‐independent	   transcripts,	   as	   described	   above.	   The	   high-­‐resolution	  crystal	  structures	  of	  HfqSt	  and	  its	  complex	  with	  an	  U6-­‐oligo	  nucleotide,	  was	  correlated	  with	  isothermal	  calorimetric	  (ITC)	  measurements	  of	  the	  proteins	  affinity	  for	  a	  variety	  of	  RNA-­‐substrates,	  and	  compared	  with	  the	  original	  HfqSau:RNA	  complex	  structure.	  	  	  
	  	  	  
	  	  15	  
	  
Fig.1.5:	   The	   proximal	   A/U-­‐specific	   binding	   site	   of	   HfqSt	   (A,	   B,	   C,	   E)	   is	  compared	   to	   that	   of	   HfqSau	   (D+F).	   (A)	   Clear	   density	   for	   an	   U6-­‐oligo	  located	   in	   the	   pore	   on	   proximal	   face	   of	   HfqSt.	   (B)	   Close-­‐up	   of	   a	   single	  uridine	   coordination	   in	   complex	   with	   HfqSt,	   which	   was	   crystallized	   in	  presence	  of	  thiocyanate	  (SCN-­‐).	  A	  similar	  coordination	  is	  found	  in	  HfqSau.	  
(C+D)	   The	   difference	   between	   the	   ‘constricted’	   and	   ‘dilated’	   modes	   of	  binding,	  as	  depicted	  by	  the	  structures	  of	  HfqSt:U6	  and	  HfqSau:AU5G.	  (E+F)	  The	   difference	   in	   phosphate-­‐backbone	   coordination	   and	   consequently	  conformation	  leads	  to	  either	  the	  ‘constricted’	  or	  ‘dilated’	  mode	  of	  binding	  (figure	  adapted	  from	  110).	  	  This	   led	   to	   the	   conclusion	   that	   there	   exist	   at	   least	   two	   modes	   of	  interaction	   for	   the	   proximal	   U-­‐specific	   binding	   site.	   The	   ‘constricted	  mode’	  (Fig.1.5C)	  that	  binds	  tight	  and	  possibly	  coordinates	  the	  3’-­‐end	  of	  the	   RNA,	   and	   the	   ‘dilated	   mode’	   (Fig.1.5D)	   that	   bind	   the	   RNA	   less	  specifically,	   but	   possibly	   allows	   for	   interaction	   with	   the	   internal	  sequence	  of	  RNA-­‐molecules110.	  In	  addition	  Hfq’s	   involvement	   in	  3’-­‐adenylation	  of	  mRNA,	   and	   specific	  binding	  of	  poly(A)-­‐RNA	  has	  been	  the	  subject	  of	  structural	  studies.	  The	  crystal	  structure	  of	  Hfq	  from	  Escherichia	  coli	  HfqEc	  in	  complex	  with	  A15-­‐oligo	  nucleotide	  RNA	  revealed	  a	  hitherto	  unknown	  ‘tri-­‐partite’	  mode	  of	  RNA-­‐protein	  interaction.	  Located	  on	  the	  opposite,	  distal	  face	  of	  Hfq,	  the	  RNA	   is	   recognized	   in	   A-­‐R-­‐N-­‐triplets	   (A=adenine,	   R=purine,	   N=any	  nucleotide),	   in	   a	   purine-­‐specific	   crevice	   (the	   R-­‐site)	   formed	   between	  adjacent	   monomers	   (Fig.1.6A+B).	   The	   specific	   recognition	   also	  incorporates	   an	   adenine	   recognition-­‐site,	   which	   is	   comprised	   by	  residues	   from	   a	   single	  monomer	   alone	   (the	  A-­‐site)111.	   In	   the	   complex	  between	   E.	   coli	   Hfq	   and	   poly(A)15-­‐oligo	   nucleotide,	   the	   RNA	   weaves	  back-­‐and-­‐forth	  as	  it	  traverses	  the	  distal	  face	  of	  the	  hexamer	  (Fig.1.6C).	  The	   same	   distal	   binding	   site	   has	   since	   been	   demonstrated	   to	   bind	   an	  
HfqSt:U6	   HfqSt:U6	  
HfqSt:U6	  
HfqSt:U6	  
HfqSau:AU5G	   HfqSau:AU5G	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AGAGAGA-­‐oligo	  nucleotide.	  In	  the	  crystal	  structure	  of	  Hfq	  from	  Bacillus	  







	  Fig.1.6:	   (A)	   The	   distal	   tri-­‐partite	   A-­‐R-­‐N	   binding	   site	   on	   HfqEc	   (in	   grey	  
cartoon)	   with	   the	   poly(A)15-­‐RNA	   (upper,	   in	   CPK)	   located	   opposite	   the	  proximal	  Sm-­‐site	  (lower,	  RNA	  modeled	  in	  CPK).	  Location	  of	  the	  three	  parts	  are	  noted	  by	  their	  specificity,	  A=adenine,	  R=purine,	  N=Any	  nucleotide.	  (B)	  Close-­‐up	   of	   the	   A-­‐R-­‐N	   sites	   with	   composite	   omit-­‐maps	   Fo-­‐Fc	   density	  contoured	   at	   0.8	   σ	   (blue),	   and	   2Fo-­‐Fc	   at	   1.0	   σ	   (white).	   Protein	   shown	   as	  grey	  surface.	  (C+D)	  Comparison	  between	  the	  modes	  of	  RNA-­‐interaction	  at	  the	   distal	   binding	   site	   in	   (C)	   HfqEc:poly(A)15	   (PDBid:3GIB)	   and	   (D)	  HfqBac:AGAGAGA	   (PDBid:3AHU).	   Figures	   was	   adopted	   from111,	   or	   made	  with	  MacPymol113.	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1.6.4 Flexible	  termini	  The	  C-­‐terminal	  domain	  of	  E.	  coli	  Hfq	  has	  been	  proposed	  as	  an	  additional	  RNA	   binding	   site,	   with	   specificity	   for	   mRNA99.	   Question	   remains	  however,	   to	   what	   extend	   the	   distinction	   between	   mRNA	   and	   sRNA	  molecules	  is	  conceivable	  on	  the	  level	  of	  chemical	  biology	  of	  interaction	  between	  protein	  and	  RNA.	  In	  addition,	  the	  C-­‐terminal	  domain	  of	  E.	  coli	  Hfq	  has	  recently	  also	  been	  implicated	  in	  the	  binding	  of	  DNA62.	  Only	  the	  β-­‐	  and	  γ-­‐proteobacteria	  carry	  Hfq	  proteins	  with	  an	  extended	  C-­‐terminal	  domain106,	  which	  Jousselin	  et	  al.	  suggest	  involved	  in	  bacterial	  riboregulation114.	  The	  functional	   importance	  of	   the	  termini	  of	  Hfq	  was	  first	  demonstrated	  by	  mutation	  and	  truncation	  studies,	  showing	  that	  a	  single	   lysine	  mutation	  (Lys-­‐3)	   in	   the	  N-­‐terminus	  of	  E.	  coli	  Hfq	   impairs	  the	  protein	  in	  complementing	  replication	  of	  the	  RNA-­‐phage	  Q/β96.	  	  Both	  the	  N-­‐	  and	  the	  C-­‐termini	  of	  Hfq	  have	  been	  characterized	  as	  intrinsically	  disordered99,	  with	   the	  N-­‐terminus	  of	  E.	   coli	  Hfq	  conserved	   to	  a	  higher	  degree	  than	  the	  C-­‐terminus.	  None	   of	   the	   published	   crystal	   structures	   of	   Hfq,	   account	   for	   the	   full	  sequence	   of	   the	   Hfq	   protein.	   Only	   an	   EM-­‐study	   by	   Arluison	   et	   al.	  provides	   information	   on	   the	   location	   of	   the	   C-­‐termini,	   correlating	   the	  crystal	   structure	   of	   C-­‐terminally	   truncated	   E.	   coli	   Hfq	   with	   EM-­‐micrographs115.	   This	   indicated	   that	   the	   C-­‐termini	   reside	   on	   the	  proximal	   face	   of	   the	   doughnut,	   on	   the	   interface	   between	   monomers,	  inferring	   a	   structural	   rearrangement	   on	   the	   Sm2-­‐motif	   of	   Hfq.	   The	  study	   also	   showed	   the	   C-­‐termini	   to	   increase	   the	   stability	   of	   the	  hexamer,	   and	   employed	   Fourier-­‐transformed	   infrared	   spectroscopy	  (FT-­‐IR)	  to	  show	  that	  the	  C-­‐termini	  increase	  the	  β-­‐strand	  content	  of	  the	  protein.	  Terminal	   extensions	   are	   common	   in	   the	   Hfq-­‐family,	   and	   Hfq	   from	  
Methanococcus	   jannaschii	   carry	   an	   extended	   and	   disordered	   N-­‐terminus	  preceding	  the	  α-­‐helix,	  as	  compared	  to	  E.	  coli	  Hfq.	  A	  PSI-­‐PRED	  analysis116	  predicts	  the	  N-­‐terminus	  of	  this	  protein	  to	  form	  an	  additional	  short	   helix	   interrupted	   by	   an	   extended	   region,	   similar	   to	   human	   Sm-­‐protein	  D2	  (hSm-­‐D2)	   in	  the	  crystal	  structure	  of	  the	  human	  U1	  snRNP-­‐complex102.	   This	   structure	   comprises	   a	   full	   Sm-­‐protein	   heptamer,	   and	  displays	  RNA-­‐induced	  folding	  in	  the	  intrinsically	  disordered	  N-­‐terminus	  of	  hSm-­‐D2.	  The	  N-­‐terminus	   forms	  a	  kinked	  α-­‐helix	   that	   is	   interrupted	  by	  a	  short	  loop,	  upon	  coordinating	  to	  the	  minor	  groove	  of	  the	  core	  helix	  H	  of	  the	  four-­‐helix-­‐junction	  of	  U1	  snRNA.	  This	  could	  suggest	  a	  degree	  of	  similarity	  of	  Hfq	  proteins	  and	  hSm-­‐D2.	  Furthermore,	  as	  the	  only	  human	  Sm-­‐protein,	   hSm-­‐D2	   and	   Hfq	   share	   the	   similarity	   of	   a	   two-­‐residue	  extension	   of	   the	  N-­‐terminal	   α-­‐helix	   as	   compared	   to	   other	   human	   Sm-­‐proteins105.	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  As	   mentioned	   above,	   the	   C-­‐terminal	   domain	   of	   E.	   coli	   Hfq	   shares	  features	   with	   eukaryotic	   hub-­‐proteins.	   In	   its	   intrinsically	   disordered	  character	   it	   could	   further	  be	   implicated	   in	  protein-­‐protein	   interaction.	  Intrinsically	   disordered	   protein	   sequence	   has	   been	   implicated	   in	  protein-­‐protein	  interaction117.	  Regulatory	  proteins,	  and	  especially	  RNA-­‐chaperones,	   tend	   to	   retain	   a	   higher	   amount	   of	   disordered	   sequence,	  which	  has	  a	  functional	  implication	  in	  an	  entropy-­‐transfer	  model98.	  The	  model	  describes	  how	  an	   intrinsically	  disordered	   chaperone	  binds	  and	  unfolds	   a	   (mis-­‐)folded	   target,	   utilizing	   intrinsic	   high	   entropy	   to	   gain	  thermodynamic	  control	  over	  a	  kinetically	  trapped	  target.	  
1.7 Aim	  of	  the	  study	  Studies	   have	   been	   undertaken	   to	   elucidate	   structural	   and	   biophysical	  aspects	  of	  the	  involvement	  of	  E.	  coli	  Hfq	  in	  riboregulation.	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2 Structural	  and	  biophysical	  study	  of	  E.	  coli	  Hfq	  
Synopsis	  A	  variety	  of	  structural	  and	  biophysical	  studies	  have	  been	  undertaken,	  to	  elucidate	  the	  functional	  behavior	  and	  structure	  of	   full-­‐length	  Hfq	  from	  
E.coli.	   Combining	   bioinformatics	   and	   functional	   studies	   (biochemical,	  FRET)	   with	   results	   from	   biophysical	   experiments	   (SR-­‐CD,	   NMR),	  function	  has	  been	  annotated	   to	   the	  disordered	  domains	  of	  E.	   coli	  Hfq,	  visualized	   by	   the	   solution	   structure	   established	   by	   SAXS-­‐experiments.	  Subsequently,	   the	   crystal	   structure	   of	   full-­‐length	   E.	   coli	   Hfq	   provided	  further	  insights	  to	  the	  function	  and	  behavior	  of	  the	  C-­‐terminal	  domain.	  This	   work	   resulted	   in	   two	   publications,	   which	   in	   common	   provide	  insights	   to	   the	  versatile	  nature	  of	   the	  C-­‐terminal	  domain	  of	   this	  partly	  disordered	  RNA-­‐chaperone.	  The	  papers	  are	  included	  in	  section	  8	  and	  9.	  
2.1 Summary	  paper	  I:	  Solution	  structure	  of	  E.	  coli	  Hfq	  The	  solution	  structure	  of	   full-­‐length	  E.coli	  Hfq	  has	  been	  reconstructed	  with	  P6-­‐symmetry,	  based	  on	  SAXS-­‐experiments.	  The	  model	   shows	   the	  C-­‐termini	  to	  be	  extending	  laterally	  away	  from	  the	  structured	  hexameric	  (L)Sm-­‐core	   of	   Hfq,	   with	   structural	   variability	   predominantly	   in	   the	  latter	   half	   of	   the	   C-­‐terminal	   domain.	   Functional	   studies	   indicate	   the	  latter	  half	  to	  be	  of	  functional	  importance,	  which	  bioinformatics	  predict	  to	  be	  intrinsically	  disordered.	  In	  accordance,	  the	  solution	  structure	  was	  complemented	   with	   studies	   by	   SR-­‐CD	   spectroscopy,	   recorded	   from	  constructs	   carrying	   C-­‐terminal	   truncations	   of	   decreasing	   lengths.	   The	  resulting	  spectra	  display	  an	  overall	  blue-­‐shift	  with	  increasing	  length	  of	  the	   C-­‐terminus,	   suggesting	   this	   to	   be	   completely	   disordered.	   Previous	  results	   from	   FT-­‐IR	   experiments	   indicated	   the	   C-­‐terminal	   domain	   to	  increase	   the	   β-­‐strand	   content	   of	   the	   protein,	   which	   would	   be	   in	  agreement	  with	   the	  deconvolution	  of	   the	  SR-­‐CD	  spectra.	  However,	   the	  deconvolution	  of	  SR-­‐CD	  has	  presently	  been	  interpreted	  as	  the	  result	  of	  an	   experimental	   artifact,	   due	   to	   the	   stronger	   signal	   of	   disordered	  protein	  compared	  to	  β-­‐strand.	  Furthermore,	  NMR-­‐experiments	  provide	  insights	   to	   the	   interaction	   between	   the	   C-­‐terminal	   domain	   and	   the	  (L)Sm-­‐core,	  and	  suggest	  a	  dynamic	  transition	  between	  an	  ordered	  and	  disordered	   state	   for	   the	   C-­‐terminal	   domain.	   Finally,	   SR-­‐CD	   spectra	  recorded	   in	   the	   presence	   of	   RNA-­‐fragments	   of	   increasing	   length	  support	  the	  hypothesis	  that	  the	  C-­‐terminal	  domain	  becomes	  structured	  upon	  interaction	  with	  RNA-­‐molecules	  above	  a	  certain	  length.	  	  	  
Beich-­Frandsen	   M	   et	   al.	   Structural	   insights	   into	   the	   dynamics	   and	  
function	  of	  the	  C-­terminus	  of	  the	  E.	  coli	  RNA	  chaperone	  Hfq.	  Nucleic	  Acids	  
Res.	  2011	  Jun;39(11):4900-­15.	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2.2 Summary	  paper	  II:	  Crystal	  structure	  of	  E.	  coli	  Hfq	  Following	   the	   study	   of	   solution	   behavior	   of	   E.	   coli	   Hfq,	   a	   crystal	  structure	  was	  obtained	  that	  indicates	  an	  additional	  mode	  of	  interaction	  for	   the	   C-­‐terminal	   domain.	   Despite	   problems	  with	   degradation	   of	   the	  full-­‐length	   protein,	   an	   optimized	   purification	   procedure	   enabled	   the	  crystallization	   of	   the	   non-­‐degraded	   full-­‐length	   protein.	   Little	   to	   no	  electron	   density	   of	   the	   C-­‐termini	   is	   visible	   from	   the	   resulting	   data,	  which	  was	  collected	  from	  a	  highly	  anisotropic	  P1-­‐crystal,	  thought	  to	  be	  due	   to	   a	   lattice	   translocation	   defect.	   However,	   the	   result	   appears	   in	  agreement	   with	   previous	   EM-­‐studies	   that	   suggested	   the	   C-­‐termini	   to	  reside	   ‘on	   top’	   of	   the	  proximal	   face	   of	  Hfq.	   Interestingly,	   compared	   to	  previous	  crystal	  structures	  of	  E.coli	  Hfq,	  the	  presence	  of	  the	  C-­‐terminal	  domain	   in	   the	   crystal	   appears	   to	   coordinate	   between	   adjacent	  hexamers,	   which	   could	   suggest	   residual	   structure	   to	   reside	   in	   this	  intrinsically	  disordered	  domain.	  	  
Beich-­Frandsen	   M,	   Večerek	   B,	   Sjöblom	   B,	   Bläsi	   U,	   Djinović-­Carugo	   K.	  
Structural	   analysis	   of	   full-­length	   Hfq	   from	   Escherichia	   coli.	   Acta	  
Crystallogr.	  Sect.	  F	  Struct.	  Biol.	  Cryst.	  Commun.	  2011	  May	  1;67(Pt	  5):536-­
40.	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3 Solution	  structure	  of	  Hfq:RNA-­complexes	  
Synopsis	  To	   investigate	   the	   interaction	   of	   Hfq	   with	   longer	   RNA,	   the	   solution	  structure	  of	  C-­‐terminally	  truncated	  E.coli	  Hfq	  in	  complex	  with	  a	  longer	  RNA-­‐oligonucleotide	   has	   been	   reconstructed.	   The	   initial	   study	   was	  based	  on	  SAXS-­‐data,	  which	  raised	  questions	  about	  the	  stoichiometry	  in	  the	   complex.	  NMR	   relaxation-­‐experiments	   could	   confirm	   the	   intended	  1:1	   stoichiometry	   of	   the	   complex,	   and	   comparative	   NMR-­‐analysis	  provided	  a	  chemical	  shift	  pattern,	   for	  which	  no	  disagreement	  with	  the	  proposed	   SAXS	   solution	   structure	   could	   be	   found.	   In	   addition,	   NMR	  indicated	   structuring	   of	   the	   N-­‐terminus	   of	  E.coli	   Hfq	   in	   complex	  with	  RNA.	  SANS-­‐experiments	  were	  performed	  with	  initial	  intent	  of	  showing	  a	   shape-­‐change	   in	   full-­‐length	   Hfq,	   under	   the	   hypothesis	   that	   the	  disordered	   sequence	   become	   structured	   in	   the	   presence	   of	   RNA.	   The	  sample	  preparation	  procedure	  was	  compromised	  by	  addition	  of	  D2O	  for	  contrast	   variation,	   and	   data	   could	   only	   be	   acquired	   from	   the	   RNA-­‐complex	  with	  the	  C-­‐terminally	  truncated	  protein.	  Analysis	  of	  the	  SANS-­‐data	   was	   done	   while	   taking	   the	   results	   from	   SAXS	   and	   NMR	   into	  account,	  and	  provided	  some	  proof	  of	  concept,	  in	  addition	  to	  elucidating	  aspects	  about	  the	  possible	  organization	  of	  a	  complex	  between	  Hfq	  and	  RNA.	  	  	  
3.1 Preamble	  In	   continuation	   of	   small	   angle	   X-­‐ray	   scattering	   measurements	   and	  shape-­‐reconstructions	   of	   the	   E.	   coli	   Hfq-­‐protein	   in	   its	   apo	   form	   as	  described	   in	   M.	   Beich-­‐Frandsen	   et	   al.	   2010118,	   we	   desired	   to	   study	  complexes	  of	  Hfq	  with	  specific	  RNAs.	  The	  overall	   aim	  of	   these	  studies	  was	   to	   identify	   a	   specific	  mode	  of	   interaction,	  which	   could	   sustain	   an	  understanding	  of	  the	  Hfq-­‐protein’s	  ability	  to	  process	  the	  wide	  variety	  of	  RNA-­‐molecules,	  with	  the	  high	  degree	  of	  specificity	  it	  is	  known	  for29.	  	  Crystal	   structures	   have	   elucidated	   interaction	   between	   RNA	   and	   Hfq	  from	   three	   different	   organisms.	   The	   structures	   of	  Escherichia	   coli	   Hfq	  (aa	  2-­‐69)	   in	   complex	  with	  poly-­‐A15	  RNA111,	  Bacillus	   subtilis	  Hfq	   (aa	  1-­‐73)	   in	   complex	   with	   RNA-­‐heptamer	   (5’-­‐AGAGAGA-­‐3’)112,	   and	  
Staphylococcus	   aureus	   Hfq	   (aa	   1-­‐77)	   in	   complex	  with	   poly-­‐U	  RNA	   (5’-­‐AUUUUUG-­‐3’)108	   all	   elucidate	   unique	   binding	   sites	   and	   modes,	   and	  explain	   important	   aspects	   about	   Hfq:RNA-­‐interaction,	   all	   commonly	  providing	  insight	  into	  the	  function	  of	  Hfq.	  However,	  none	  are	  conclusive	  with	  regards	  to	  the	  binding	  mode	  required	  for	  longer	  RNA-­‐molecules.	  
E.	   coli	   Hfq	   is	   thought	   to	   show	   preference	   for	   binding	   uridine-­‐rich	  stretches	  of	  RNA	  adjacent	  to	  a	  hairpin-­‐loop92.	  Studies	  have	  attempted	  to	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elucidate	  the	  binding	  of	  longer	  RNAs	  on	  Hfq	  by	  a	  mutational	  analysis95,	  and	   taking	   the	   crystal	   structures	   in	   view	   in	   light	   of	   these	   functional	  results	   provides	   a	   more	   nuanced	   picture73.	   Interpretation	   of	   such	  results,	   as	   well	   as	   those	   of	   a	   standard	   cross-­‐linking	   /	   mass-­‐spectrometric	   (MS)	   approach119,	   are	   compromised	   by	   the	   6-­‐fold	  symmetry	  of	  the	  hexameric	  Hfq	  protein.	  A	  single	  point-­‐mutation	  in	  Hfq	  effectively	   changes	   the	   chemical	   environment	   at	   six	   positions	   in	   the	  functional	   oligomeric	   molecule.	   Such	   results	   should	   be	   regarded	  keeping	  in	  mind	  the	  possibility	  that	  these	  mutations	  may	  alter	  the	  way	  the	  RNA	  molecule	  binds	  to	  Hfq.	  Additionally,	  when	  analyzing	  results	  of	  cross-­‐linking	  experiments	  by	  means	  of	  MS,	  the	  peptides	  resulting	  from	  protein	  digestion	  can	  essentially	  stem	  from	  six	  different	  positions	  in	  the	  assembled	  hexamer,	  complicating	  the	  analysis	  of	  such	  results.	  The	   solution-­‐structure	   of	   a	   longer	   RNA-­‐molecule	   in	   complex	  with	   the	  native	   protein,	   even	   with	   a	   fragment	   of	   a	   native	   RNA-­‐molecule,	   is	  regarded	  as	  a	  closer	  view	  on	  functional	  Hfq120.	  By	  shape	  reconstruction	  of	   the	   solution-­‐structure	   of	   RNA	   complexes	   with	   Hfq,	   we	   aimed	   to	  elucidate	   how	   RNA-­‐molecules	   bind	   on	   the	   oblate	   shape	   of	   the	  hexameric	  Hfq	  from	  E.coli.	  Hfq	   binding	   sites	   in	   RNAs	   are	   known	   from	   analysis	   of	   protection	  studies,	   combining	   chemical	   foot-­‐/toe-­‐printing79	   and	   enzymatic	  degradation90.	   These	   studies	   have	   revealed	   single	   RNA-­‐molecules	   to	  have	   several	   binding	   sites	   for	   Hfq.	   Based	   on	   this	   knowledge	   we	  designed	   fragments	   of	   specific	   mRNA	   and	   sRNA	   comprising	   single	  binding-­‐sites	   for	   Hfq	   (Branislav	   Vecerek;	   personal	   communication,	  and121,38,122),	  to	  achieve	  complexes	  of	  1:1	  molar	  ratio	  between	  RNA	  and	  hexameric	  Hfq-­‐protein.	  	  Small	   angle	   X-­‐ray	   scattering	   (SAXS)	   was	   performed	   for	   E.	   coli	   Hfq	   in	  complex	  with	  a	   range	  of	  RNA-­‐molecules.	  Complexes	  were	   formed	  and	  data	  acquired	  with	  two	  different	  construct	  lengths	  of	  the	  protein:	  with	  and	  without	  the	  C-­‐terminal	  domain,	  as	  described	  in	  Beich-­‐Frandsen	  M.	  
et	  al.	  2010118.	  Full-­‐length	  E.	  coli	  Hfq	  (HfqEc)	  was	  studied	  in	  complex	  with	  fragments	  of	  mRNAs	  hfq,	   rpoS	  and	  sodB,	  domain	  2	  of	   sRNA	  DsrA	  and	  the	  full-­‐length	  sRNAs	  DsrA	  and	  ryhB.	  The	  C-­‐terminally	  truncated	  E.	  coli	  Hfq	  (aa	  1-­‐65)	  (HfqEc65)	  was	  studied	  in	  complex	  with	  domain	  2	  of	  sRNA	  DsrA	  and	  the	  full-­‐length	  of	  the	  sRNAs	  DsrA	  and	  ryhB.	  Preliminary	   data-­‐analysis	   revealed	   the	   majority	   of	   the	   recorded	  datasets	   to	  be	   compromised	  by	  aggregation	  and	  polydispersity.	  These	  datasets	   could	   be	   analyzed	   only	   with	   respect	   to	   the	   oligomeric	  composition	   of	   the	   solution,	   but	   the	   overall	   goal	   of	   shape-­‐reconstruction	   could	   not	   be	   achieved,	   and	   analysis	   of	   these	   datasets	  was	  therefore	  not	  pursued.	  The	   SAXS-­‐data	   of	   the	   complex	   between	   HfqEc65	   and	   DsrA	   domain	   2	  (DsrA34)	   was	   of	   a	   quality	   allowing	   for	   shape-­‐reconstruction.	   The	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resulting	  model	  of	  the	  complex	  (HfqDsrA)	  is	  supported	  by	  data	  obtained	  by	   nuclear	   magnetic	   resonance	   (NMR),	   and	   the	   combined	   X-­‐ray	   and	  NMR	   data	   opened	   to	   the	   possibility	   of	   acquiring	   small	   angle	   neutron	  scattering	   (SANS)	   data.	   Through	   the	   methodological	   approach	   of	  contrast	   variation	   experiments,	   utilizing	   the	   innate	   differences	   in	  chemical	   composition	   of	   the	   two	   bio-­‐polymers123,	   SANS-­‐experiments	  have	   proven	   to	   be	   a	   powerful	   method	   for	   studying	   low-­‐resolution	  shapes	   of	   and	   interactions	   in	   dynamic	   protein:nucleic-­‐acid	  complexes124,125.	  	  	  Here	   are	   reported	   procedures	   and	   outcome	   model	   of	   a	   combined	  approach	  of	  SAXS,	  NMR	  and	  SANS,	  in	  studies	  of	  a	  complex	  between	  the	  C-­‐terminally	   truncated	   HfqEc65	   protein	   and	   a	   fragment	   of	   the	   trans-­‐encoded	  sRNA	  DsrA	  from	  E.	  coli.	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3.2 Methods	  &	  Materials	  
3.2.1 Experimental	  approach	  
3.2.1.1 Introduction	  to	  applied	  scattering	  theory	  In	  a	  scattering	  event	  the	  atoms	  interacting	  with	  the	  incident	  radiation,	  be	  it	  X-­‐ray	  or	  neutrons,	  become	  sources	  of	  spherical	  waves,	  scattered	  in	  all	  directions.	  In	  crystal	  diffraction	  these	  atoms	  are	  perfectly	  ordered	  in	  the	   crystal	   lattice,	   and	   when	   coherent	   radiation	   is	   scattered	   from	   a	  crystal,	   the	   ordering	   gives	   rise	   to	   constructive	   interference	   between	  waves	   scattered	   in	   perfect	   phase	   from	   ‘scattering	   planes’	   inside	   the	  crystal	   (Fig.3.1).	   By	   virtue	   of	   the	   constructive	   interference	   the	  amplitude	   of	   the	   scattered	   waves	   add,	   which	   result	   in	   discrete	  observations	  -­‐	  diffractions.	  	  	  
In	  solution	  scattering	  the	  molecules	  are	  oriented	  completely	  at	  random,	  and	   the	   scattering	   of	   the	   coherent	   radiation	   occurs	   from	   all	   possible	  orientations	   of	   the	  molecules,	   leading	   to	   no	   constructive	   interference.	  The	   observed	   result	   is	   a	   radially	   symmetric	   scattering	   around	   the	  center	   of	   the	   incident	   beam	   (Fig.3.2),	   leading	   to	   summation	   of	   the	  intensities	  of	   the	  scattered	  waves	  rather	   than	  their	  amplitudes126.	  The	  radial	  average	  of	  the	  scattering	  intensity	  is	  recorded	  as	  a	  function	  of	  the	  scattering	  angle	  with	  respect	  to	  the	  incident	  beam,	  expressed	  in	  terms	  of	  the	  momentum	  transfer	  (s)	  as	  described	  by	  s=(4π	  sinθ)/λ	  ;	  where	  λ	  is	  
	  Fig.3.1:	   Scattering	   in	   crystal	   diffraction.The	   small	   X-­‐ray	  wavelength	   (λ)	   allows	   atoms	   to	   become	   the	   origin	   of	  constructive	   interference	   of	   scattered	   X-­‐rays.	   Bragg’s	   law	  (nλ=2d	   sin	   θ)	   denotes	   that	   the	   inter-­‐atomic	   distance	   (d)	  should	   be	   exactly	   an	   integer	   (n)	   wavelength	   (λ)	   for	   this	   to	  occur	   at	   a	   given	   scattering	   angle	   (2θ)	   (adapted	   from	  www.wikipedia.com).	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the	   wavelength	   and	   (2θ)	   is	   the	   scattering	   angle.	   The	   experimental	  scattering	   curve	  will	   then	  be	   a	   semi-­‐logarithmic	  plot	   of	   the	   scattering	  intensity	  as	  a	  function	  of	  the	  momentum	  transfer.	  Small	   angle	   scattering	   is	   inherently	   a	   contrast-­‐based	   technique.	  Experiments	   are	   recorded	   for	   the	   solution	   containing	   the	  molecule	   in	  question,	   and	   subtracted	   by	   the	   scattering	   curve	   of	   the	   solvent	   alone.	  Hereby	  a	  scattering	  curve	  representing	  the	  excess	  scattering	  density	  of	  the	  molecule	  alone	  is	  obtained.	  The	  excess	  scattering	  density	  of	  a	  molecule	  is	  governed	  by	  its	  chemical	  and	   isotopic	   composition.	   Neutron	   and	   X-­‐ray	   radiation	   interact	  differently	  with	  matter,	  resulting	  in	  different	  potential	  of	  scattering	  for	  each	   chemical	   element,	   for	   each	   type	   of	   radiation.	   X-­‐ray	   scattering	   is	  dependent	  on	  the	  electron	  shells	  and	  orbital	  configuration	  in	  an	  atom,	  whereas	  neutron	  scattering	  is	  dependent	  on	  the	  isotopic	  composition	  in	  the	  nucleus126.	  The	  scattering	  length	  measures	  the	  scattering	  potential	  of	   the	  atoms	  and	  has	  been	  tabulated	  for	  common	  elements,	   the	  amino	  acids	   and	   the	   building	   blocks	   of	   other	   biopolymers,	   for	   both	   neutron	  and	  X-­‐ray	  radiation123.	   	  This	  allows	  for	  summing	  the	  theoretical	  excess	  scattering	  density	  of	  a	  specific	  protein	  or	  nucleic	  acid,	  with	  regards	  to	  the	  incident	  radiation.	  Table	  I	  show	  examples	  of	  the	  scattering	  lengths	  of	  some	  common	  chemical	  elements.	  As	  can	  be	  seen	  from	  Table	  I,	  hydrogen	  scatters	  X-­‐rays	  about	  an	  order	  of	  magnitude	   weaker	   than	   the	   other	   common	   biological	   elements.	   Most	  notable	   is	   the	   sign	   difference	   in	   scattering	   length	   with	   respect	   to	  neutrons,	  between	  hydrogen	  (1H)	  and	  its	  heavier	  isotope	  deuterium	  (2H	  ~	   D).	   Due	   to	   the	   high	   abundance	   of	   hydrogen	   in	   biological	   material,	  
	  Fig.3.2:	   Schematic	   diagram	   depicting	   the	   differences	   between	   diffraction	  and	   solution	   scattering	   experiments.	   The	   red	   circle	   denotes	   the	   same	  scattering	  angle	  with	  respect	  to	  the	  incidents	  beam,	  signifying	  the	  relative	  resolution	  achievable	  from	  either	  technique	  (adapted	  from	  127).	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neutron	  scattering	  from	  dilute	  solutions	  of	  macromolecules	  is	  governed	  hydrogen	   scattering,	   a	   phenomenon	   that	   is	   exploited	   in	   neutron	  scattering	  contrast	  variation.	  	  
3.2.1.2 Contrast	  variation	  experiments	  Fig.3.3	   shows	   a	   plot	   of	   the	   neutron	   average	   excess	   scattering	   density	  ( b )	  for	  some	  common	  biopolymers,	  as	  a	  function	  of	  the	  composition	  of	  the	  solvent,	   in	   this	  case	  a	  mixture	  of	  H2O	  and	  D2O.	  Note	  how	   for	  pure	  H2O	   the	   average	   scattering	  density	   is	   negative,	   reflecting	   the	  negative	  neutron	  scattering	  length	  of	  hydrogen	  (Table	  I).	  	  In	   following	   of	   the	   principle,	   of	   subtracting	   the	   ‘solvent	   scattering’	   to	  obtain	   the	   ‘solute	   sample	   scattering’	   (which	   is	   the	  difference	  between	  the	   average	   scattering	   density	   of	   the	   solvent	   and	   the	   cumulated	  scattering	   density	   of	   the	   solute),	   the	   difference	   in	   average	   scattering	  density	   is	   termed	   the	   ‘contrast’	   (denoted	   ρ ),	   quantifying	   the	   solute	  scattering	  length	  compared	  to	  the	  solution.	  In	  this	  regard,	  the	  solution	  
Table	  I.	  X-­‐ray	  and	  neutron	  scattering	  length	  of	  common	  elements.	   	  Atom	   H	   D	   C	   N	   O	   P	   S	   Au	  Atomic	  mass	   1	   2	   12	   14	   16	   30	   32	   197	  N	  electrons	   1	   1	   6	   7	   8	   15	   16	   79	  bX-­‐ray	  	  	  	  	  ,10-­‐12	  cm	   0.282	   0.282	   1.69	   1.97	   2.16	   3.23	   4.51	   22.3	  bNeutron	  ,10-­‐12	  cm	   -­‐0.374	   0.667	   0.665	   0.940	   0.580	   0.510	   0.280	   0.760	  	  Reprinted	  from	  Svergun/Koch	  2003	  126	  
	  Fig.3.3:	  Neutron	  average	   scattering	  density	  of	  protein	  and	  RNA	  compared	   to	   that	   of	   water,	   indicating	   the	   ‘match-­‐points’	   of	  ~40%	   and	   ~70%	   respectively.	   The	   contrast	   between	   protein	  and	  H2O	  is	  denoted	  by	   ρ .	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composition	   can	   be	   titrated	   to	   establish	   zero	   contrast	   between	   solute	  and	  solution,	  making	  the	  solvent	  scattering	  match	  the	  solute	  scattering,	  which	  by	  subtraction	  then	  cancels.	  Essentially	   this	  allows	  masking	  the	  scattering	   contribution	   by	   a	   specific	   component	   in	   solution.	   By	  experimentally	   establishing	   the	   sample	   “match-­‐point”	   of	   solution	  composition,	  it	  is	  then	  possible	  to	  retrieve	  scattering	  contribution	  from	  a	  specific	  solute	  component.	  Consider	   a	   given	   complex	   between	   protein	   and	   nucleic	   acid,	   where	  recording	   small	   angle	   neutron	   scattering	   at	  ~40%	  D2O	  will	  mask	   the	  protein	  scattering	  contribution.	  This	  allows	  recording	  in-­‐situ	  scattering	  from	   the	   nucleic	   acid	   alone	   (still	   in	   complex	   with	   protein).	   Similarly,	  recording	  scattering	  from	  the	  same	  sample	  at	  ~70%	  D2O	  will	  mask	  the	  nucleic	   acid	   scattering	   contribution,	   and	   retrieve	   scattering	   from	   the	  protein	   alone.	   With	   the	   same	   approach,	   and	   employing	   uniform	  deuteration	  of	  specific	  binding	  partners	  at	  specific	  contrast	  levels	  (D2O-­‐content),	   it	   is	   readily	   conceivable	   to	   acquire	   scattering	   curves	   from	   a	  complex	  between	  multiple	  proteins,	  or	  a	  protein	  in	  complex	  with	  one	  or	  several	  nucleic	  acid	  binding	  partners128,129.	  Recording	  scattering	  curves	  for	  the	  protein	  alone	  and	  in	  complex	  with	  different	  binding	  partners,	  at	  the	  D2O-­‐content	   (contrast-­‐level)	  matching	   the	  binding	  partner(s),	  will	  allow	   for	   evaluation	   of	   the	   effect	   the	   binding	   partner	   has	   on	   protein	  shape.	  Differences	  in	  the	  scattering	  curve	  between	  the	  apo-­‐state	  and	  the	  bound	  form	  will	  reflect	  a	  shape-­‐change,	  which	  can	  be	   interpreted	  as	  a	  change	  in	  conformation	  when	  bound	  in	  complex.	  	  Acquiring	   a	   similar	   H2O/D2O-­‐experiment	   with	   X-­‐rays	   will	   return	   a	  scattering	   curve	   representing	   both	   binding	   partners	   simultaneously,	  since	   there	   is	  no	   significant	  difference	   in	   the	   scattering	  density	  of	   the	  binding	  partners	  with	  respect	   to	  X-­‐rays	  –	   i.e.	  no	  contrast	  between	   the	  two	   components	   of	   the	   complex.	   Complexes	   between	   protein	   and	  nucleic	   acid	   can	   be	   studied	   by	   X-­‐ray	   scattering	   contrast	   variation.	   In	  place	  of	   titrating	   the	  D2O-­‐content	  of	   the	  solvent,	  a	  contrast-­‐generating	  component	   can	   be	   added	   to	   the	   solution,	   typically	   a	   stabilizing	   agent	  like	   glycerol	   or	   sucrose	   is	   employed.	  However,	   it	   is	   important	   to	   take	  into	  account	  that	  this	  compound	  will	  be	  present	  in	  increasing	  amounts	  through	   the	   contrast	   series,	  which	  potentially	   could	  have	   an	   affect	   on	  the	  sample	  under	  study.	  In	  present	  study	  SANS	  contrast	  variation	  experiments	  are	  employed	  to	  support	  the	  model	  of	  a	  complex	  between	  protein	  and	  RNA,	  which	  was	  obtained	  based	  on	  SAXS	  and	  NMR-­‐experiments.	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3.2.2 Preparation	  of	  Hfq:RNA-­complex	  Full-­‐length	   E.	   coli	   Hfq	   (HfqEc	   ;	   aa1-­‐102)	   and	   C-­‐terminally	   truncated	  construct	   comprising	   residues	   1-­‐65	   (HfqEc65)	   were	   expressed	   and	  purified	  as	  described	  previously118.	  Chemically	   synthesized	   RNA	   was	   generously	   provided	   by	   Ronald	  Micura’s	   group	   at	   Innsbruck	   University,	   and	   in	   larger	   quantities	  acquired	  commercially	  from	  Dharmacon.	  A	  minimal	  fragment	  required	  for	  binding	  of	  the	  sRNA	  DsrA	  to	  Hfq	  had	  previously	  been	  identified	  by	  Brescia	  et	  al.92,	  and	  further	  truncation	  led	  to	  a	  34-­‐nucleotide	  fragment	  of	  DsrA	  domain	  2,	  5’-­‐G24A-­‐A-­‐U-­‐U-­‐U-­‐U-­‐U-­‐U-­‐A-­‐A-­‐G-­‐U-­‐G-­‐C-­‐U-­‐U-­‐C-­‐U-­‐U-­‐G-­‐C-­‐U-­‐U-­‐A-­‐A-­‐G-­‐C-­‐A-­‐A-­‐G-­‐U-­‐U-­‐U59-­‐3’,	  which	  we	  termed	  DsrA34.	  The	  protein	  concentration	  was	  assessed	  prior	  to	  RNA-­‐addition	  to	  allow	  for	  a	  1:1	  molar-­‐ratio	  of	  HfqEc65	  (hexamer)	  to	  RNA.	  The	  protein	  and	  RNA	  were	  mixed	  at	  elevated	  temperature	  (~60˚C),	  and	  incubated	  5	  hrs	  in	  a	  65˚C	   incubator,	   and	   allowed	   to	   slowly	   cool	   to	   room	   temperature.	  Subsequently	  the	  complexes	  were	  centrifuged	  for	  1	  hour	  at	  10000	  x	  G,	  at	   room	   temperature.	   Prior	   studies	   by	   dynamic	   light	   scattering	   (DLS)	  performed	   on	   a	  Wyatt	   Dynapro	   DLS,	   had	   indicated	   this	   procedure	   to	  result	   in	   a	   highly	   monodisperse	   sample.	   Samples	   were	   temperature	  labile,	   and	   prone	   to	   aggregation	   on	   sudden	   temperature	   or	   pressure	  change.	  	  
3.2.3 Small	  Angle	  X-­ray	  Scattering	  Small	   angle	   X-­‐ray	   scattering	   experiments	   were	   acquired	   at	   beamline	  X33130,131	   at	   the	   DORIS	   III	   synchrotron	   storage-­‐ring	   (DESY,	   Hamburg,	  Germany),	  using	  a	  MAR345	  image-­‐plate	  detector	  and	  X-­‐ray	  wavelength	  of	   λ	   =	   1.5	   Å,	   with	   a	   sample	   to	   detector	   distance	   of	   2.7	  m.	   This	   setup	  covers	   a	   range	   of	  momentum	   transfer	   0.012	   <	   s	   <	   0.045	   Å-­‐1	   	   (s	   =	   4π	  sinθ/λ,	  where	   2θ	   is	   the	   scattering	   angle).	  Data	  were	   acquired	   at	   37˚C	  from	  four	  concentrations	  of	  a	  C-­‐terminally	  truncated	  Hfq	  core-­‐construct	  HfqEc65	   (19.0,	   9.5,	   4.8,	   2.4	   mg/ml),	   and	   five	   samples	   in	   complex	   with	  DsrA34	   (3.9,	   7.7,	   15.5,	   23.2,	   30.9	   mg/ml).	   Sample	   concentration	   was	  measured	   at	   260	   nm	   and	   280	   nm	   on	   a	   Nanodrop	   1000	   UV/VIS	  spectrophotometer,	   immediately	   prior	   to	   data-­‐acquisition.	   The	   data	  were	   averaged	   and	   normalized	   to	   the	   intensity	   of	   the	   incident	   beam	  prior	  to	  subtraction	  of	  buffer	  scattering.	  The	  data	  were	  processed	  in	  the	  ATSAS	   program-­‐package132.	   The	   difference	   data	   curves	   were	   scaled,	  merged	   and	   initial	   analysis	   performed	   using	   PRIMUS133.	   Invariants	  were	  derived	  by	  standard	  approaches	   for	  comparison127.	  The	   intrinsic	  scattering	   (I0)	   and	   radius	   of	   gyration	   (Rg)	   were	   derived	   by	   Guinier	  analysis	  for	  the	  data	  range	  s	  <	  1.3	  /	  Rg,	  approximating	  I(s)	  =	  I0	  exp(−(s	  Rg)2	   /3).	   The	   reverse	   transform	   program	   GNOM134	  was	   employed	   for	  calculation	  of	  the	  distance-­‐distribution	  function,	  under	  the	  assumption	  of	   correct	   estimation	   of	   the	   particle	  maximum	  dimension	   (DMAX).	   The	  program	   also	   outputs	   a	   value	   for	   I0	   and	   Rg.	   The	   particle	   excluded	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volume	  was	  calculated	  from	  the	  Porod	  equation135,	  where	  Iexp(s)	  is	  the	  experimental	  data.	  	  
	   ;	  (equation	  1)	  	  In	   addition,	   the	  program	  Dammif136	   run	  without	   symmetry	   restraints,	  outputs	   the	   particle	   volume.	   The	   solute	   molecular	   mass	   was	   further	  evaluated	   by	   the	   standard	   approach	   of	   comparison	   of	   the	   intrinsic	  scattering	   (I0)	  with	   that	   recorded	   from	  a	   reference	   solution	  of	   known	  molecular	  mass	  and	  concentration.	  In	  the	  present	  study	  a	  single	  sample	  of	  3.68	  mg/ml	  bovine	  serum	  albumin	  (Mr	  =	  66.4	  kDa)	  was	  used.	  Low	   resolution	   shape-­‐models	   of	   the	   SAXS	   data	  were	   generated	   using	  the	  program	  BUNCH137.	  Employing	  a	  combined	  rigid	  body	  and	  ab-­‐initio	  modeling	  approach,	  the	  program	  searches	  for	  a	  spatial	  arrangement	  of	  domains	   with	   known	   high-­‐resolution	   structure	   (in	   present	   study	   the	  Hfq	   protein),	   and	   probable	   conformations	   of	   the	   RNA	   best	   fitting	   the	  scattering	   curve	   are	   represented	   as	   dummy-­‐residues.	   Similar	   to	   the	  program	  Dammif136,	  the	  program	  represents	  the	  protein	  as	  a	  collection	  of	  densely	  packed	  dummy-­‐residues	   inside	  a	   sphere	  with	   the	  diameter	  DMAX.	  Each	  dummy-­‐residue	  belongs	  either	  to	  the	  particle	  or	  the	  solvent,	  and	  the	  shape	  is	  described	  by	  a	  binary	  string	  of	  length	  M.	  Starting	  from	  a	   random	   string,	   simulated	   annealing	   is	   employed	   to	   search	   for	   a	  compact	   model	   that	   fits	   the	   shape	   scattering	   curve	   I(s)	   to	   minimize	  discrepancy	  χ2:	  	  	  
	   ;	  (equation	  2)	  	  where	  N	  is	  the	  number	  of	  experimental	  points,	  c	  is	  a	  scaling	  factor,	  and	  Icalc(sj)	  and	  σ(sj)	  are	  the	  calculated	  intensity	  and	  the	  experimental	  error	  at	  the	  momentum	  transfer	  sj	  respectively.	  The	   N-­‐termini	   of	   HfqEc65	   was	   first	   reconstructed,	   utilizing	   the	   known	  structure	  of	  the	  HfqEc65	  monomer	  subunit	  (aa	  6-­‐65)	  (PDBid:	  1HK9).	  The	  Bunch	  program137	  was	  run	  with	  an	  overall	  P6	  symmetry,	  retaining	  the	  hexameric	  organization	  of	  the	  Hfq	  core.	  Theoretical	  scattering	  from	  Hfq	  core	   encompassing	   residues	   6-­‐65	   was	   calculated	   using	   the	   program	  CRYSOL138.	   Subsequently,	   the	   output	   model	   was	   used	   in	   shape	  reconstruction	   of	   complexes	   with	   RNA.	   The	   34-­‐nucleotide	   sRNA	  fragment	  DsrA34	  was	   represented	   as	   a	   chain	   of	   102	   dummy	   residues.	  Due	   to	   increased	   electron	   density	   in	   phosphate	   and	   hence	   the	   higher	  scattering	   length	   (see	   Table	   I),	   each	   nucleotide	   was	   represented	   by	  three	   dummy-­‐residues,	   which	   is	   acceptable	   for	   representation	   of	   an	  average	  nucleotide	  form-­‐factor	  (P.	  Konarev	  -­‐	  personal	  communication,	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and	   139).	   The	   program	   employs	   a	   simulated	   annealing	   procedure	   to	  manipulate	  the	  local	  arrangement	  of	  the	  chain	  representing	  the	  RNA,	  to	  minimize	  the	  χ2-­‐discrepancy	  as	  described	  in	  equation	  2.	  
3.2.4 NMR-­experiments	  All	  NMR	  experiments	  were	  performed	  at	  310	  K	  on	  a	  Varian	  Inova	  600	  MHz	   spectrometer	   equipped	   with	   5	   mm	   triple	   resonance	   cryo-­‐probe	  and	  pulsed	   field	  gradients,	   and	  a	  Varian	   Inova	  800	  MHz	  spectrometer	  equipped	   with	   5	   mm	   conventional	   triple	   resonance	   probe	   equipped	  with	   pulsed	   field	   gradients.	   NMR	   spectra	   were	   processed	   with	  NMRPipe140	   and	   analyzed	   with	   the	   Sparky	   software.	   The	   protein	  samples	   for	   NMR-­‐experiments	   were	   all	   prepared	   by	   size-­‐exclusion	  chromatography	   in	   50	   mM	   Na-­‐PO4	   pH~7.2,	   200	   mM	   NaCl,	   and	  concentrated	  to	  ~1	  mM	  HfqEc65	  (with	  respect	  to	  the	  monomer).	  Samples	  were	   supplemented	  ~10%	   (v/v)	  D2O	   to	  provide	   the	  deuterium	   signal	  for	  the	  field-­‐frequency	   lock,	  as	  well	  as	  0.1–0.2%	  (w/v)	  NaN3	  to	   inhibit	  bacterial	  growth.	  Titration	  experiments	  of	  Hfq	  by	  DrsA34	  monitored	  by	  NMR	  15N-­‐HSQC	  were	   conducted	   to	  map	  residues	   in	  HfqEc65	   affected	   in	  binding	   of	   DsrA34.	   By	   comparison	  with	   assignments	   for	   HfqEc65118	   the	  interacting	  residues	  could	  be	  identified,	  and	  3-­‐dimensonal	  HNCO141	  and	  HNCA142	  experiments	  were	  additionally	  employed	  to	  resolve	  ambiguity.	  	  NMR	  15N-­‐transverse	  relaxation	  experiments	  were	  conducted	  to	  validate	  the	   stoichiometry	   of	   the	   complex	   between	   HfqEc65	   and	   DsrA34.	   The	  measured	   relaxation	   rate	   (R2	   =	   1/T2)	   of	   a	   globular	   protein	   is	  approximately	   proportional	   to	   the	   rotational	   correlation	   time	   (τc),	   or	  inversely	   proportional	   to	   the	   rotational	   diffusion	   constant	   (Dr).	   The	  rotational	  diffusion	  constant	  and	  the	  hydrodynamic	  radius	  to	  the	  third	  power	  (i.e.	  the	  effective	  hydrodynamic	  volume,	  reflecting	  the	  molecular	  mass)	  are	  related	  to	  each	  other	  by	  the	  Einstein/Smoluchowski-­‐relation.	  	  	  
	   ;	  (equation	  3)	  	  	  
3.2.5 Small	  Angle	  Neutron	  Scattering	  Neutron	  scattering	  experiments	  were	  measured	  at	  beamline	  D22,	  at	  the	  high-­‐flux	   reactor,	   Institut	   Laue-­‐Langevin,	   Grenoble,	   France;	   in	  collaboration	   with	   Dr.	   Phillip	   Callow.	   Data	   was	   acquired	   from	   two	  instrument	   configurations	   (2	   m	   and	   5.6	   m	   detector	   distance)	   with	  incident	  wavelength	  λ=	  6	  Å,	  allowing	  for	  a	  range	  of	  momentum-­‐transfer	  of	  0.008	  <	  s	  <	  0.35	  Å-­‐1	  (s	  =	  4π	  sinθ/λ,	  where	  2θ	  is	  the	  scattering	  angle).	  Data	  was	  collected	  at	  37˚C,	  with	  a	  sample	  acquisition-­‐time	  of	  900	  and	  1800	  sec	  in	  the	  short	  and	  long	  distance	  respectively.	  	  Images	   were	   fitted	   with	   beamstop-­‐mask,	   radially	   averaged	   and	  integrated	   with	   the	   Grasp	   program	   (www.ill.fr/lss/grasp).	   Data	   was	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normalized	  to	  the	  respective	  neutron	  transmission,	  merged	  and	  buffer	  scattering	  subtracted	  using	  same	  program.	  Protein	   and	  RNA	  were	   purified	   in	  water,	   and	   the	   buffer	   changed	   into	  the	   designated	   D2O	   content.	   The	   protein	   was	   buffer-­‐changed	   by	   two	  consecutive	   runs	  over	  PD-­‐10	  desalting	   columns	   (GE	  Healthcare)	  prior	  equilibrated	   with	   designated	   D2O	   containing	   buffer.	   The	   RNA	   was	  lyophilized	   and	   re-­‐dissolved	   similarly.	   100%	  D2O-­‐buffer	  was	  made	   in	  H2O	  and	  pH	  titrated	  to	  6.8,	  subsequently	  lyophilized	  to	  dryness	  and	  the	  residual	   re-­‐dissolved	   in	  D2O.	   The	   kinetic	   isotope	   effect	   of	   substituting	  hydrogen	   for	  deuterium	  causes	   the	  pD	  to	   increase	  0.4	  units	  above	  the	  H2O	  nominal	  value143.	  The	  100%	  H2O-­‐buffer	  was	  treated	  similar	  at	  pH	  7.2.	   For	   performing	   contrast	   variation	   experiments,	   Protein:RNA	  complexes	  were	  then	  formed	  by	  same	  approach	  as	  for	  SAXS	  and	  NMR,	  using	  components	  of	  specific	  D2O-­‐content.	  Samples	   of	   HfqDsrA	   were	  measured	   at	   an	   intended	   concentration	   of	   7	  mg/ml.	   Concentration	   was	   assessed	   spectrophotometrically	   by	   the	  direct	   method	   after	   the	   scattering	   experiment.	   Data	   was	   acquired	   at	  three	   levels	   of	   contrast,	   0%,	   75%	   and	   100%	  D2O.	   For	   the	   purpose	   of	  experimental	  matchpoint	  determination,	  a	  concentration	  of	  2	  mg/ml	  of	  the	  DsrA34	  RNA-­‐fragment	  was	  measured	  at	  0%,	  40%	  and	  100%	  D2O.	  The	   data	   curves	   were	   scaled	   and	   initial	   analysis	   performed	   using	  PRIMUS133.	  A	   constant	  was	   subtracted	   from	  all	   data	   curves,	   to	   ensure	  homogenous	   scattering	   at	   high	   angle.	   The	   intrinsic	   scattering	   (I0)	   and	  radius	   of	   gyration	   (Rg)	   was	   derived	   by	   Guinier	   analysis	   for	   the	   data	  range	  s	  <	  1.3	  /	  Rg,	  approximating	  I(s)	  =	  I0	  exp(−(s	  Rg)2	  /3).	  The	  particle	  excluded	   volume	  was	   calculated	   from	   the	   Porod	   equation135,	   and	   the	  solute	   molecular	   mass	   was	   evaluated	   by	   the	   standard	   approach	   of	  normalization	  of	  the	  intrinsic	  forward	  scattering	  (I0)	  with	  that	  recorded	  from	  water144.	  The	  reverse	  transform	  program	  GNOM134	  was	  employed	  for	  calculation	  of	   the	   distance-­‐distribution	   function,	   under	   the	   assumption	   of	   correct	  estimation	   of	   the	   particle	   maximum	   dimension	   (DMAX),	   this	   program	  also	  outputs	  a	  value	  for	  I0	  and	  Rg.	  The	  program	  MONSA145,146	  was	  used	  to	  generate	  low-­‐resolution	  shapes	  
ab-­initio,	  based	  on	  the	  SANS-­‐data.	  MONSA	  is	  an	  extension	  of	  the	  original	  DAMMIN-­‐program	  allowing	   for	  simultaneously	   fitting	  multiple	  phases,	  represented	   in	   multiple	   scattering	   curves	   with	   specific	   contrast	  levels147.	   Here	   the	   particle	   is	   represented	   as	   a	   collection	   of	   densely	  packed	   dummy-­‐residues,	   each	   belonging	   to	   the	   solvent	   or	   to	   a	  designated	   particle	   phase.	   Imposing	   an	   overall	   symmetry	   inside	   the	  global	   parameter	   of	   DMAX,	   the	   program	   minimizes	   the	   discrepancy	  between	   the	   experimental	   scattering	   curve	   and	   calculated	   model	  scattering	  curve	  by	  means	  of	  simulated	  annealing	  (equation	  2).	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3.3 Results	  &	  Discussion	  
3.3.1 Preparation	  of	  Hfq:RNA-­complex	  A	  problem	   in	   forming	   the	   complex	   between	  HfqEc65	   and	  DsrA34	   is	   the	  inevitable	  occurrence	  of	  aggregation	  at	  room	  temperature	  when	  mixing	  protein	  and	  RNA.	  The	  components	  in	  the	  complex	  were	  therefore	  mixed	  from	   solutions	   of	   equal	  molar	   concentration	   in	   order	   to	  minimize	   the	  effect	  of	  the	  mixing.	  	  The	  desired	  1:1	  complex	  between	  Hfq	  and	  RNA	  dominates	  at	  elevated	  temperature.	  However,	  aggregation	  is	  an	  inherent	  problem	  that	  leads	  to	  loss	  of	  material	  by	  centrifugation.	  Furthermore,	  in	  the	  samples	  used	  for	  SANS-­‐experiments	  a	  ‘kinetic	  isotope	  effect’	  of	  the	  D2O	  in	  the	  samples	  for	  contrast	   variation	  measurements,	   caused	   the	  precipitation	   to	   increase	  as	  a	  function	  of	  the	  D2O-­‐content.	  In	   small	   angle	   scattering	   measurements	   it	   is	   important	   to	   know	   the	  concentration	  of	   the	  sample	  with	  high	  accuracy,	   in	  order	  to	  assess	  the	  molecular	  mass.	  Due	  to	  the	  unique	  sample	  composition	  of	  the	  complex,	  estimating	   the	   concentration	  by	  conventional	  methods	   is	   complicated.	  In	   spectrophotometric	   determination	   of	   the	   concentration,	   the	  extinction	  coefficients	  of	  components	  of	  a	  complex	  are	  cumulative,	  and	  under	   assumption	   of	   a	   correct	   stoichiometric	   ratio	   the	   complex	  extinction	   coefficient	   can	   be	   summed	   from	   those	   of	   the	   components.	  However,	   since	   nucleic	   acid	   absorbs	  much	   stronger	   than	   protein	   it	   is	  problematic	   to	  assume	  a	   stoichiometric	   ratio	  based	  on	   the	  absorption	  alone.	   Given	   the	   relatively	   very	   small	   absorption	   of	   the	   protein,	   it	   is	  impossible	  to	  assess	  whether	  a	  complex	  is	  formed	  in	  a	  1:1	  or	  a	  2:1	  ratio	  between	   RNA	   and	   protein.	   This	   will	   lead	   to	   dramatic	   changes	   in	   the	  extinction	   coefficient	   and	   orders	   of	   magnitude	   errors	   in	   the	  concentration	  of	  the	  complex	  –	  and	  subsequent	  errors	  in	  estimation	  of	  the	   molecular	   mass	   from	   scattering	   experiments.	   Conversely,	  experimental	  error	   in	  estimating	   the	  molecular	  weight	  of	   the	  complex	  from	  analysis	  of	  small-­‐angle	  scattering,	  which	  could	  be	  more	  than	  10%,	  can	  also	  lead	  to	  faulty	  assumptions	  about	  the	  stoichiometry.	  	  	  Based	   on	   prior	   studies,	   the	   complex	   between	   HfqEc65	   and	   DsrA34	  (HfqDsrA)	  was	  formed	  in	  a	  1:1	  molar	  ratio.	  Fig.3.4A	  display	  a	  gel	  result	  of	  an	   electrophoretic	   mobility	   shift	   assay	   (EMSA),	   in	   comparison	   with	  analytical	   gel-­‐filtration	   results	   (B-­‐F)	   of	   similar	   molar	   ratios	   between	  full-­‐length	  HfqEc	  and	  DsrA34.	  As	  can	  be	  seen,	  complexes	  form	  in	  different	  ratios	   as	   a	   function	   of	   the	   protein	   concentration.	   The	   reported	  molecular	  mass	  of	  the	  peaks	  are	  under	  assumption	  of	  a	  globular	  shape,	  and	   the	   increased	   size	   compared	   to	   the	   expected	   (Hfq:RNA	   1:1	   ~80	  kDa,	  1:2	  ~90	  kDa)	  was	  interpreted	  as	  anisometric	  shape	  of	  the	  complex.	  	  
	  	  	  
	  	  33	  









	  Fig.3.4:	  (A)	  8%	  PAGE-­‐gel	  of	  complexes	  of	  different	  molar	  ratios	  of	  HfqEc	  to	  fixed	   amount	   of	   DsrA34	   (EMSA).	   (B-­F)	   Chromatograms	   of	   similar	   ratios	  analyzed	  by	  gel-­‐filtration	  on	  a	  GE	  Healthcare	  Tricorn	  10/300	  Superdex	  200	  column,	  by	  reference	  to	  the	  GE	  Healthcare	  molecular	  mass	  standardization	  kit	  of	  globular	  protein	  standards.	  Absorption	  was	  detected	  at	  260	  nm	  (red	  curve)	   and	   280	   nm	   (blue	   curve),	   and	   plotted	   as	   a	   function	   of	   retention	  volume.	   The	   apparent	   increased	   size	   of	   the	   complex	   is	   the	   effect	   of	   an	  anisometric	  shape,	  of	  a	  complex	  of	  smaller	  molecular	  mass.	  	  	  	  	  Fig.3.5A	   shows	  EMSA-­‐results	   comparing	   the	   binding	   of	  DsrA34	   to	   full-­‐length	  HfqEc	   and	  HfqEc65,	   displaying	   a	   change	   in	   affinity	   on	   truncating	  the	   C-­‐terminal	   of	   the	   protein.	   The	   full-­‐length	   HfqEc	   appears	   to	   be	  binding	  DsrA34	  with	   increased	  affinity	  when	  compared	  to	  C-­‐terminally	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truncated	   HfqEc65,	   however	   the	   complex	   between	   HfqEc65	   and	   DsrA34	  was	   much	   less	   prone	   to	   aggregation.	   Dynamic	   light	   scattering	   (DLS)	  analysis	  performed	  on	  a	  complex	  between	  HfqEc65	  and	  DsrA34	  (Fig.3.5B)	  show	   a	   hydrodynamic	   behavior	   indicating	   a	   highly	   monodisperse	  sample,	   formed	   in	   batch	   –	   without	   purification.	   Similar	   samples	   of	  HfqEc65	   in	   1:1	   complex	   with	   DsrA34	   were	   used	   in	   all	   small	   angle	  scattering	  experiments.	  	  	  	  A	  
	  
B	  
	  Fig.3.5:	   (A)	   8%-­‐page	   gel	   analysis	   of	   EMSA-­‐studies	   depicting	   weaker	  interaction	   between	   the	   C-­‐terminally	   truncated	   HfqEc65	   compared	   to	   full-­‐length	   HfqEc.	   (B)	   DLS	   analysis	   of	   complex	   between	   HfqEc65	   and	   DsrA34	  displays	  high	  monodispersity	  at	  elevated	  temperature	  (37˚C).	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Fig.3.6:	   (A)	   Calculated	   SAXS	   scattering-­‐curves	   for	   HfqEc65	   (aa	   1-­‐65;	  green)	  and	  N-­‐terminally	  truncated	  Hfq	  similar	  to	  the	  crystal	  structure	  (aa	   6-­‐65;	   red)	   display	   good	   overall	   fit	   to	   experimental	   SAXS	   data	  recorded	   from	   HfqEc65	   (black).	   Inserted	   is	   the	   pair-­‐distribution	  function	  representing	  the	  experimental	  data	  of	  HfqEc65.	  (B)	  Models	  of	  HfqEc65	  (aa	  1-­‐65;	  green)	  and	  N-­‐terminally	  truncated	  (aa	  6-­‐65;	  red).	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The	  molecular	  mass	  was	  estimated	  to	  44	  ±5	  kDa	  for	  HfqEc65	  and	  54	  ±5	  kDa	   for	   HfqDsrA,	   by	   normalization	   of	   the	   intrinsic	   scattering	   (I0)	   to	   a	  single	   standard	   sample	   of	   bovine	   serum	   albumin	   (BSA)148.	   Based	   on	  primary	   sequence	  we	   can	   calculate	   the	  molecular	  mass	   for	  hexameric	  HfqEc65	   ~43.2	   kDa,	   and	   for	   the	   complex	   HfqDsrA	   ~54.0	   kDa.	   In	  corroboration	   with	   estimates	   of	   the	   solute	   excluded	   volume	   (Porod’s	  volume)	  for	  HfqEc65	  ~(70	  ±5)*103	  Å3	  and	  HfqDsrA	  ~(85	  ±5)*103	  Å3,	  this	  indicated	   the	   complex	   to	   be	   formed	   in	   the	   expected	   1:1	   molar-­‐ratio,	  between	   hexameric	   HfqEc65	   and	   DsrA34.	   In	   addition	   the	   program	  Dammif136,	   run	   without	   symmetry	   restraints,	   output	   the	   particle	  excluded	   volume,	   and	   for	   HfqEc65	   (73	   ±5)*103	   Å3	   and	   HfqDsrA	   (82	  ±5)*103	  Å3	  were	  retrieved,	  respectively.	  Under	  the	  assumption	  that	  the	  samples	  comprise	  a	  monodispersed	  1:1	  complex,	  the	  solution	  structure	  of	  HfqDsrA	  was	  then	  reconstructed	  by	  the	  program	  Bunch137.	  	  Utilizing	  the	  previously	  reconstructed	  solution-­‐structure	  of	  HfqEc65	  and	  the	   knowledge	   of	   uridine	   binding	   in	   the	   conserved	   core	   bindingsite	  (PDBid:	   1KQ2108),	   18	   dummy-­‐residues	   were	   manually	   placed	   in	   the	  input	   model,	   representing	   the	   6	   uridine	   nucleotides	   expected	   to	   be	  A	  	   B.1	  	  	  	  	  	  	  B.2	  	  	  	  	  	  	  B.3	  	  	  	  	  	  B.4	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bound	  in	  the	  core	  binding	  site	  of	  Hfq.	  The	  program	  Bunch	  would	  then	  model	  the	  remaining	  28	  nucleotides	  by	  representing	  each	  nucleotide	  by	  three	   dummy-­‐residues	   (a	   total	   of	   84),	   to	   satisfy	   the	   increased	  scattering-­‐length	  of	  the	  phosphate	  backbone	  (in	  accordance	  with	  other	  models	  of	  nucleic	  acid139;	  P.	  Konarev,	  personal	  communication).	  	  Fig.3.7A	  displays	   the	   fit	   to	   the	  experimental	  data,	   inserted	   is	   the	  pair-­‐distribution	   function	   for	   HfqEc65	   and	   HfqDsrA,	   indicating	   the	   dramatic	  increase	   in	   the	   particle	   dimensions	   in	   the	   presence	   of	   the	   RNA.	   The	  stages	  of	  model	  building	  are	  illustrated	  in	  Fig.3.7B.	  	  On	  average	  this	  modeling	  approach	  would	  fit	  the	  data	  with	  a	  best	  X2	  of	  1.7,	  to	  a	  momentum	  transfer	  of	  s	  =	  0.4	  Å-­‐1.	  Iterative	  modeling	  revealed	  no	   distinct	   shape	   of	   the	   RNA	   (Fig.3.7B.4),	   which	   could	   lead	   to	   the	  assumption	   that	   in	   complex	  with	   HfqEc65	   the	   DsrA34	   RNA	   is	   extended	  and	   lacks	   defined	   secondary	   structure.	   Overall,	   the	   fit	   shows	   the	  tendency	   to	   follow	   the	   behavior	   of	   the	   experimental	   data,	   displaying	  reasonable	  agreement	  between	  the	  shape	  of	  the	  model	  and	  that	  of	  the	  complex	   in	   solution.	   However,	   in	   this	   model	   each	   nucleotide	   is	  represented	   by	   three	   dummy-­‐residues,	  which	   establishes	   a	  maximum	  volume	   of	   the	   RNA.	   Careful	   inspection	   of	   the	   fit	   to	   experimental	   data	  reveals	  a	  lack	  of	  fit	  in	  the	  region	  of	  low	  momentum	  transfer,	  indicating	  that	   the	  model	   does	   not	   satisfy	   the	   intrinsic	   scattering	   of	   the	   sample.	  This	  would	  suggest	   the	  sample	  particle	   to	  contain	  more	  material	   than	  the	  reconstructed	  model.	  However,	  another	  interpretation	  could	  be	  that	  a	  small	  amount	  of	  aggregated	  material	  is	  present	  in	  the	  sample	  solution.	  
3.3.3 Analysis	  of	  NMR-­experiments	  support	  SAXS-­results	  NMR	   titration	   experiments	   are	   a	   powerful	   tool	   for	   investigating	  interactions	   in	   a	   protein.	   The	   change	   in	   resonance	   in	   a	   15N-­‐HSQC	  spectra	   in	   presence	   of	   increasing	   amounts	   of	   binding	   partner	   is	  significant	  for	  residues	  involved	  in	  the	  interaction.	  For	  a	  protein	  with	  a	  symmetric	   quaternary	   structure	   like	  Hfq	   this	   is	   particularly	   powerful.	  In	   its	   apo	   form,	   the	   residues	   in	   the	   six	   symmetrical	   subunits	   are	  equivalent,	  giving	  rise	  to	  a	  resonance	  pattern	  similar	  of	  a	  single	  subunit	  in	  the	  15N-­‐HSQC.	  In	  the	  presence	  of	  a	  binding	  partner	  the	  symmetry	  is	  broken	  and	  the	  monomers	  are	  no	  longer	  equivalent,	  which	  thus	  results	  in	  potentially	  multiple	  (theoretically	  up	  to	  six)	  different	  resonances	  for	  each	  residue.	  We	   recorded	   15N-­‐HSQC-­‐spectra	   of	   HfqEc65	   in	   the	   apo	   form	   and	   in	   the	  presence	  of	  increasing	  amounts	  of	  DsrA34,	  Fig.3.8	  shows	  the	  spectra	  of	  apo	  HfqEc65	   in	   red,	  overlaid	  onto	  spectra	   in	   the	  presence	  of	  one	  molar	  equivalent	  of	  DsrA34	  in	  green.	  For	  the	  apo	  spectra,	  sequential	  backbone	  resonance	   assignment	  was	  possible	   for	   residues	  6-­‐65.	  The	  N-­‐terminal	  residues	  1-­‐5	  were	  not	  observed	  due	  to	  exchange	  broadening,	  which	  can	  be	  reasoned	  by	  conformational	  flexibility	  in	  this	  region.	  	  
	  	  	  
	  	   38	  
Upon	  addition	  of	  RNA,	  additional	  shifted	  signals	  can	  be	  observed	  next	  to	   the	   original	   set	   of	   resonances	   (Fig.3.8),	   indicating	   a	   specific	  interaction	   between	   the	   RNA	   and	   the	   hexameric	   HfqEc65	   protein	  occurring	  with	  high	  affinity	  (slow	  exchange	  on	  the	  NMR	  timescale).	  We	   observed	   significant	   shifts	   in	   the	   region	   corresponding	   to	   the	  conserved	   uridine	   bindingsite	   around	   His-­‐57108,	   indicating	   the	   RNA	  indeed	  to	  be	  bound	  on	  the	  rim	  of	   the	  central	  pore	  as	  expected.	  Fig.3.9	  displays	  a	  plot	  of	  the	  15N-­‐1HN	  chemical	  shift	  differences	  in	  the	  presence	  of	  RNA.	  We	  observed	  multiple	  peak	  resonances	  for	  several	  residues	  in	  the	   region	   around	   Gly-­‐34	   and	   around	   Val-­‐50	   illustrating	   the	   before	  mentioned	  reduction	  in	  symmetry.	  However,	  no	  particular	  property	  for	  RNA	  interaction	  is	  known	  for	  glycines	  or	  valines149.	  Gly-­‐34	  is	  one	  of	  the	  completely	  conserved	  residues	  in	  the	  core	  Sm-­‐fold.	  Owing	   to	   its	   property	   of	   unrestricted	   dihedral	   angle,	   this	   residue	   is	  involved	  in	  forming	  the	  characteristic	  ‘bent’	  β-­‐stand	  2	  of	  the	  Sm1-­‐motif.	  Val-­‐50	   is	   located	   in	   the	   so-­‐called	   ‘variable	   region’,	   which	   in	   Hfq	  comprise	  only	  a	  short	  solvent	  exposed	  loop	  on	  the	  outside	  of	  the	  torus.	  Among	  the	  eukaryotic	  Sm-­‐proteins,	   insertions	  of	  up	  to	  25	  amino	  acids	  can	  be	   found	  here.	  Furthermore,	  an	  unusually	  strong	  shift	   is	  observed	  for	  Ala-­‐14,	  which	   is	  placed	   in	   the	  middle	  of	   the	  N-­‐terminal	  α-­‐helix.	   In	  Fig.3.10	   the	   chemical	   shift	   differences	   between	   apo	   and	   RNA-­‐bound	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protein	   has	   been	   mapped	   onto	   the	   proximal	   surface	   of	   the	   HfqEc65	  (PDBid:	  1HK9;	  aa	  6-­‐65).	  Most	   interestingly,	   some	   of	   the	   previously	   unobservable	   N-­‐terminal	  residues	  of	  HfqEc65	  become	  observable	  in	  the	  presence	  of	  the	  RNA.	  Ala-­‐2	  and	   Gly-­‐4	   are	   observed	   with	   unusual	   15N-­‐chemical	   shift	   values,	  probably	  due	  to	  aromatic	  stacking	  with	  the	  RNA-­‐bases.	  For	  Lys-­‐3,	   two	  non-­‐equivalent	   signals	   are	   observed,	   again	   in	   accordance	   with	   the	  broken	   symmetry.	   In	   the	   crystal	   structure	   of	  HfqEc72	   (aa	   1-­‐72;	   PDBid:	  1HK9)	   the	   N-­‐terminal	   of	   HfqEc	   is	   not	   observed,	   and	   this	   domain	   is	  characterized	   as	   intrinsically	   disordered118,105,150,99.	   This	   unexpected	  observation	   in	   the	   presence	   of	   RNA	   indicates	   an	   interaction	   between	  the	   RNA	   and	   the	   N-­‐terminal	   residues	   of	   Hfq,	   which	   results	   in	   a	  stabilization	  of	   their	   structure.	  As	  mentioned,	  a	   single	  mutation	   in	   the	  highly	   conserved	   N-­‐terminal	   of	   E.coli	   Hfq	   (Lys-­‐3	   to	   Ala)	   has	   proven	  detrimental	  to	  the	  protein’s	  function96.	  	  The	  spectra	  were	  closely	  examined	  for	  signals	  corresponding	  to	  nucleic	  acid	   imino-­‐hydrogens,	   the	   presence	   of	   which	   would	   indicate	   base-­‐pairing	   in	   the	   RNA.	   No	   signals	   could	   be	   found	   in	   any	   of	   the	   spectra	  recorded,	  which	   supported	  our	  hypothesis	   from	  SAXS	   that	   the	  RNA	   is	  without	   defined	   secondary	   structure.	   However,	   another	   possible	  explanation	  is	  that	  a	  dynamic	  behavior	  of	  the	  RNA	  broadens	  the	  imino-­‐signals.	  Recurrent	  formation	  and	  melting	  of	  secondary	  structure	  in	  the	  RNA	   would	   lead	   to	   line	   broadening	   of	   the	   imino-­‐hydrogen	   signals,	  causing	  signal-­‐reduction	  beyond	  detection.	  Part	  of	   the	  RNA-­‐chaperone	  function	  of	  Hfq	  is	  exactly	  to	  melt	  such	  secondary	  structure.	  
	  Fig.3.9:	  Comparative	  NMR-­‐analysis	  of	  HfqEc65	  in	  the	  absence	  and	  presence	  of	  DsrA34	  RNA-­‐fragment.	  1HN/15N-­‐	  chemical	  shift	  differences	  for	  assigned	  peaks	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  Furthermore,	   15N	   transverse	   relaxation	   experiments	   suggest	   the	  stoichiometry	  in	  the	  complex	  to	  be	  in	  agreement	  with	  a	  1:1	  complex	  as	  indicated	  by	  the	  SAXS-­‐experiments.	  For	  HfqEc65	  we	  measure	  a	  relaxation	  time	  T2	  of	  39.9	  ±2.1	  ms	  (R2	  =	  25	  ±0.5	  s-­‐1),	  and	  for	  HfqDsrA	  30.5	  ±6.5	  ms	  (R2	   =33	   ±0.2	   s-­‐1).	   The	   relaxation	   time	   increased	   by	   approximately	  ~25%	  in	  the	  presence	  of	   the	  RNA,	  reflecting	  a	  corresponding	   increase	  in	   particle	   size	   and	   thus	   molecular	   mass.	   Under	   assumption	   of	   a	  globular	  shape,	  the	  difference	  in	  molecular	  mass	  of	  25%	  would	  indicate	  complex	  between	  HfqEc65	  and	  DsrA34	  to	  be	  formed	  in	  their	  intended	  1:1	  molar	  ratio.	  	  
	  	  
(∆ω1H15N=25*(∆ω21H+∆ω215N)½)	  is	  plotted	  for	  residue	  position.	  
	  Fig.3.10:	   Interaction	   with	   DsrA34	   RNA	   mapped	   on	   the	  proximal	   surface	   of	   HfqEc65.	   Highest	   chemical	   shift	   change	  (ppm)	   is	   shown	   in	   red,	   going	   towards	   blue.	   Primary	  interaction	   site	   map	   clearly	   to	   the	   conserved	   uridine	  binding	  site	  in	  the	  center	  of	  the	  hexamer	  core.	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3.3.4 Speculations	  on	  Small	  Angle	  Neutron	  Scattering	  Small	   angle	   neutron	   scattering	   data	   were	   acquired	   for	   HfqEc65	   and	  HfqDsrA	   in	  0%,	  75%	  and	  100%	  D2O.	  Fig.3.11	   show	   the	   six	  data-­‐curves,	  shifted	  for	  clarity	  along	  the	  intensity	  scale	  in	  accordance	  with	  expected	  relative	  intensity.	  	  	  
Guinier	   analysis	   of	   the	   data	   using	   two	   different	   ranges	   of	  momentum	  transfer	  derived	  two	  unique	  sets	  of	  parameters,	  as	  summarized	  in	  Table	  II.	   In	  Fig.3.11.B	   is	   shown	   the	  Guinier-­‐plot	  of	  HfqDsrA	  at	  75%	  D2O	  using	  the	  two	  Guinier-­‐ranges.	  From	  the	  conventional	  approach	  of	  assuming	  a	  Guinier-­‐range	  (s	  x	  Rg)	  <	  1.3	  a	  set	  of	  values	  for	  Rg	  for	  the	  HfqDsrA	  complex	  was	  observed,	  which	   indicate	   the	  RNA	  to	  not	  be	  matched	  at	  75%	  D2O	  (Rg	  ~31.0	  ±1.3	  Å).	  At	  75%	  D2O,	  a	  value	  of	  Rg	  similar	  to	  that	  of	  the	  HfqEc65	  protein	  alone	  (Rg	  ~21.0	  ±0.7	  Å)	  would	  be	  expected,	  since	  the	  scattering	  contribution	  of	  the	  RNA	  is	  matched	  by	  the	  solvent,	   in	  accordance	  with	  experimental	  matchpoint	  determination	  (see	  above).	  Fig.3.12	  shows	  a	  plot	  of	  the	  experimental	  determination	  of	  matchpoints	  for	   the	   protein	   (HfqEc65)	   and	   RNA	   (DsrA34).	   By	   relating	   the	   intrinsic	  scattering	   (I0)	   to	   the	   sample	   concentration	   (c),	   sample	   transmission	  relative	   to	   that	   of	   H2O	   (T)	   and	   the	   pathlength	   (l),	   and	   plotting	   their	  square	  root	  as	  a	  function	  of	  the	  D2O	  content;	  the	  intersection	  with	  the	  value-­‐axis	  will	  denote	  the	  point	  (D2O-­‐content)	  where	  I0	  equals	  zero,	  and	  the	  specific	  component	  has	  been	  matched	  by	  the	  solvent	  scattering.	  For	  HfqEc65	   we	   find	   the	   matchpoint	   to	   be	   42%	   D2O,	   and	   for	   DsrA34	   the	  matchpoint	  is	  71%	  D2O.	  	  
	  Fig.3.11:	  (A)	  SANS-­‐data	  recorded	  at	  three	  contrast	  levels	  of	  0%,	  75%	  and	  100%	  D2O	   for	  HfqEc65	  and	  HfqDsrA.	  The	  curves	  have	  been	  shifted	  along	   the	   intensity	   scale.	   Notice	   the	   lower	   slope	   of	   the	   curve	   for	  HfqDsrA	  at	  75%	  D2O	  as	  compared	  to	  the	  same	  sample	  at	  0%	  and	  100%	  D2O.	  (B)	  Guinier-­‐plot	  of	  HfqDsrA	  at	  75%	  D2O	  showing	  the	  difference	  of	  deriving	  parameters	  from	  the	  ‘Normal’	  and	  ‘Extended’	  range	  of	  s	  x	  Rg.	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The	  neutron	  transmission	  values	  measured	  at	  75%	  D2O	  indicated	  that	  the	   experiment	   indeed	   was	   acquired	   at	   the	   desired	   contrast	   level.	  Taking	   the	   small	   size	   of	   the	  RNA	   into	   account,	  with	   subsequent	   small	  contribution	  to	  the	  overall	  scattering,	  and	  considering	  the	  experimental	  error,	   it	   is	   reasonable	   to	   assume	   that	   the	   DsrA34	   RNA-­‐fragment	   was	  matched	  at	  75%	  D2O.	  	  The	   low	   concentration	   and	   poor	   sample	   quality,	   due	   to	   increased	  precipitation	   caused	   by	   the	   kinetic	   isotope	   effect,	   resulted	   in	   low	  intensity	   data	   acquired	   for	   the	   complex	   in	   the	   presence	   of	   D2O.	  Assuming	   a	   Guinier-­‐range	   at	   slightly	   higher	   momentum	   transfer	  (GuinierExtended:	   1.0	   <	   s	   x	   Rg	   <	   2.0),	   the	   derived	   parameters	   display	   the	  expected	   tendency	   of	   indicating	   an	   Rg	  ~23	   Å	   for	   HfqDsrA	   at	   75%	  D2O,	  where	  the	  RNA	  is	  matched.	  Using	  the	  same	  extended	  Guinier-­‐region	  for	  HfqDsrA	  at	  100%	  D2O	  returns	  a	  value	  of	  Rg	  ~28.8	  ±0.2	  Å,	  which	  is	  similar	  to	   that	   of	   HfqDsrA	   at	   0%	  D2O	   Rg	   ~29.8	   ±0.3	   Å	   (Table	   II),	   as	   expected.	  However,	   Guinier’s	   law	   is	   by	   definition	   shape-­‐independent	   and	  applicable	  only	  in	  the	  low	  s-­‐range,	  where	  the	  particle	  form-­‐factor	  does	  not	  affect	  the	  scattering	  intensity.	  Therefore	  the	  parameters	  derived	  by	  assuming	  an	  extended	  Guinier-­‐range	  can	  serve	  only	  for	  speculation.	  
Table	  II.	  SANS	  Guinier-­‐analysis	  	   Rg	  Guinier	  (Å)	   I0	  Guinier	   Rg	  Extended	  (Å)	   I0	  Extended	  HfqEc65	  0%	   22.5	  ±1.2	   0.113	  ±0.01	   22.0	  ±0.3	   0.111	  ±0.01	  HfqEc65	  75%	   21.0	  ±0.7	   0.105	  ±0.01	   20.7	  ±0.5	   0.104	  ±0.01	  	  HfqEc65	  100%	   21.3	  ±0.2	   0.313	  ±0.02	   21.2	  ±0.2	   0.312	  ±0.02	  HfqDsrA	  0%	   34.1	  ±0.7	   0.117	  ±0.02	   29.8	  ±0.3	   0.104	  ±0.01	  HfqDsrA	  75%	   31.0	  ±1.3	   0.028	  ±0.01	   23.1	  ±0.7	   0.019	  ±0.01	  HfqDsrA	  100%	   31.6	  ±0.4	   0.055	  ±0.01	   28.8	  ±0.2	   0.050	  ±0.01	  Parameters	   derived	   from	   Guinier	   analyses	   based	   on	   conventional	  	  (s	  x	  Rg	  <	  1.3)	  and	  extended	  range	  of	  momentum	  transfer	  (1.0	  <	  s	  x	  Rg	  <	  2.0).	  
	  Fig.3.12:	   Experimental	  matchpoint	   determination.	   For	   HfqEc65	  we	  find	  ~42%	  D2O	  and	  for	  DsrA34	  ~71%	  D2O.	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3.3.4.1 Molecular	  mass	  estimate	  The	  molecular	  mass	  (Mw)	  of	  the	  sample	  molecule	  can	  be	  derived	  from	  contrast	   variation	  data	  by	   comparison	   to	   the	   scattering	  of	  H2O.	  When	  recording	   data	   at	   different	   contrast,	   the	   proportion	   of	   the	   scattering	  occurring	   from	   the	  different	   components	  of	   the	   complex	   changes	   as	   a	  function	   of	   their	   scattering	   length,	   governed	   by	   its	   chemical	  composition	  (see	  above).	  By	  normalizing	  the	  I0	  to	  concentration	  (c)	  and	  to	  the	  amount	  of	  neutrons	  transmitted	  relative	  to	  that	  of	  H2O	  (T),	  and	  combining	   with	   an	   instrument	   specific	   expression	   for	   the	   difference	  scattering	  density	  (which	  will	  change	  at	  different	  contrast	   levels),	   it	   is	  possible	  to	  estimate	  the	  molecular	  mass	  of	  the	  sample	  particle,	  relative	  to	  that	  of	  H2O144.	  	  Retrieving	   estimates	   of	   molecular	   mass	   from	   this	   approach	   for	   the	  HfqEc65	   protein	   alone	   at	   0%,	   75%	   and	   100%	   D2O,	   resulted	   in	   a	  reasonably	   stable	   value	   of	   38	   ±5	   kDa	   for	   the	   HfqEc65	   protein	   alone	  (HfqEc65	  Mw(Calc)	  =	  43.2	  kDa),	  again	  demonstrating	  the	  protein	  to	  exist	  as	  a	  hexamer	  in	  solution	  and	  establishing	  a	  proof	  of	  concept	  for	  the	  sample	  under	  investigation.	  For	  HfqDsrA	  no	  stable	  value	  for	  the	  molecular	  mass	  could	  be	   found	  for	  the	  three	  experiments	   in	  the	  contrast	  series.	  Based	  on	  the	  standard	  Guinier-­‐analysis	  we	  calculate	  the	  molecular	  mass	  at	  0%	  D2O	  ~73	  ±7	  kDa,	  75%	  D2O	  ~243	  ±35	  kDa	  and	  100%	  ~105	  ±13	  kDa.	  First,	  the	  problem	  of	  selecting	  the	  correct	  value	  of	  extinction	  coefficient	  for	   the	   correct	   stoichiometry	   of	   the	   complex	   could	   have	   resulted	   in	  significant	  deviations	  of	  measuring	  the	  sample	  concentration.	  Reasoned	  by	  the	  stable	  value	  of	  Rg	  across	  the	  contrast	  series,	  the	  stoichiometry	  of	  the	   complex	   appeared	   to	   be	   the	   same	   in	   all	   experiments,	   and	   the	  extinction	   coefficient	   was	   therefore	   considered	   to	   be	   constant.	   By	  rationale	   of	   Lambert-­‐Beer’s	   law	   (A	   =	   ε	   x	   c	   x	   l)	   the	   numerical	   value	   of	  absorption	  was	  then	  used	  directly	  as	  a	  measure	  for	  concentration	  when	  normalizing	   the	   intrinsic	   scattering.	  The	   concentration	  of	   the	   samples	  was	  assessed	  by	  direct	  measurement	  of	  the	  absorption	  at	  260	  nm	  and	  280	   nm	   on	   a	   Thermo-­‐Scientific	   Nanodrop-­‐1000	   spectrophotometer,	  which	   has	   a	   very	   large	   dynamical	   range	   for	   linear	   absorption	  measurements,	   due	   to	   its	   very	   short	   light	   path	   (l).	   	   Absorption	  measurements	   were	   found	   in	   the	   range	   of	   15	   absorption	   units	   (a.u.)	  (max.	  20	  a.u.)	  when	  normalized	  to	  a	  1	  cm	  light	  path,	  which	  is	  possible	  to	  measure	   accurately	   with	   this	   type	   of	   spectrophotometer.	   Despite	   the	  generous	   dynamic	   range	   of	   this	   instrument,	   it	   is	   possible	   that	   high	  content	   of	   nucleic	   acid	   in	   the	   samples	   has	   led	   to	   absorption	  measurements	   outside	   the	   linear	   range.	   This	   would	   lead	   to	   faulty	  assessment	  of	  low	  sample	  concentration,	  which	  would	  lead	  to	  increased	  molecular	  mass.	  Assuming	  a	  1:1	  stoichiometry	  for	  the	  three	  samples	  of	  HfqDsrA	  the	  concentration	  was	  found	  in	  the	  range	  of	  ~1-­‐3	  mg/ml,	  where	  the	  expected	  value	  was	  ~7	  mg/ml.	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Secondly,	   the	   Guinier-­‐analyses	   using	   different	   ranges	   of	   momentum	  transfer	   indicate	   a	   possible	   presence	   of	   precipitate	   in	   the	   complex	  sample	  at	  75%	  D2O.	  This	  would	  lead	  to	  increased	  scattering	  intensity	  in	  the	  low	  s-­‐region,	  resulting	  in	  higher	  Rg	  and	  I0	  for	  this	  particular	  sample	  (Table	  II).	  The	  sample	  properties	  and	  the	  preparation	  procedures	  taken	  into	   consideration,	   it	   is	   possible	   that	   similar	   precipitates	   could	   have	  also	   been	   present	   in	   the	   other	   samples	   of	   HfqDsrA,	  which	  would	   be	   at	  base	  of	  the	  low	  data	  quality	  for	  SAS-­‐experiments.	  
3.3.4.2 Interpreting	  scattering	  curves	  using	  perceptual	  criteria	  Modeling	   of	   scattering	   data	   is	   essentially	   an	   ill-­‐posed	   problem	   –	   as	  there	  will	  exist	  multiple	  models	  fitting	  the	  data	  equally	  well.	  Therefore,	  the	  approach	  is	  to	  make	  a	  priori	  assumptions	  about	  the	  sample	  particle.	  As	  proposed	  by	  Dmitri	  Svergun	  in	  1992,	  using	  a	  few	  perceptual	  criteria	  it	  is	  possible	  to	  derive	  real	  space	  distribution	  function	  from	  the	  relative	  intensities,	   representing	   the	   scattering	   particle,	   “…even	   with	   poor	  experimental	  data.”	  (line	  4,	  in	  151).	  	  For	   a	   monodisperse	   sample	   this,	   ‘distance’	   or	   ‘pair’	   distribution	  function	   (P(R)),	   will	   represent	   the	   probability	   (P)	   of	   finding	   two	  scattering	   bodies	   separated	   by	   given	   distance	   (R)	   inside	   the	   particle.	  The	  method	  has	  been	  implemented	  in	  the	  program	  GNOM151	  that,	  under	  assumption	   of	   a	   correct	   estimate	   of	   the	   particle	   largest	   dimension	  (DMAX),	   will	   optimize	   parameters	   for	   and	   carry	   out	   indirect	   Fourier	  transform,	  allowing	  for	  real-­‐space	  evaluation	  of	  scattering	  data.	  	  	  A	  
	  
B	  
	  Fig.3.13:	   Real-­‐space	   pair-­‐distribution	   functions	   P(R)	   calculated	   for	  SANS-­‐curves	   of	   HfqEc65	   and	   HfqDsrA	   using	   the	   program	   GNOM,	  restraining	   the	   function	   to	   zero	   at	   DMIN	   =	   0	   Å	   and	   DMAX	   =	   102	   Å.	  Inserted	  is	  the	  fit	  to	  the	  data	  in	  reciprocal	  space.	  (A)	  Overlay	  of	  P(R)	  of	  HfqEc65	   (grey)	   and	  HfqDsrA	   (green)	   at	   0%	  D2O.	   (B)	   P(R)	   of	  HfqDsrA	  calculated	  from	  data	  acquired	  at	  75%	  D2O.	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Notable	  difference	  can	  be	   found	  between	  the	  P(R)	  based	  on	  the	  SAXS-­‐data	  for	  HfqEc65	  and	  HfqDsrA,	  as	  can	  be	  seen	  from	  Fig.3.7A	  (above).	  Here,	  in	  Fig.3.13A	  the	  P(R)	  based	  on	  the	  SANS-­‐data	  at	  0%	  D2O	  for	  HfqEc65	  and	  HfqDsrA	   are	   shown,	   indicating	   a	   similar	   increase	   of	   the	   particle	  dimensions.	  The	  P(R)	  was	  restrained	  to	  zero	  at	  DMIN	  =	  0	  Å	  and	  DMAX	  =	  102	  Å,	  and	  the	  small	   insert	  display	  how	  the	  calculated	  real-­‐space	  P(R)	  fit	  the	  recorded	  data	  in	  reciprocal	  space.	  In	  Fig.3.13B	  the	  P(R)	  based	  on	  HfqDsrA-­‐data	   at	   75%	  D2O	   is	   shown,	   implying	   the	   same	   restraints.	   The	  shape	   of	   the	   curve	   resembles	   that	   of	   the	   complex	   at	   0%	   D2O,	   and	  together	   with	   the	   calculated	   particle	   Rg	   ~34.1	   Å	   that	   is	   increased	  relative	   to	   HfqEc65	   (compare	   to	   Table	   II),	   this	   could	   be	   another	  indication	  that	  the	  RNA	  was	  not	  matched	  at	  75%	  D2O.	  However,	  despite	  the	  good	  fit	  to	  the	  data	  in	  reciprocal	  space	  (from	  a	  visual	  inspection)	  it	  is	  important	  to	  take	  into	  account	  that	  the	  calculated	  P(R)	  for	  HfqDsrA	  at	  75%	  D2O	  was	  restrained	  to	  zero	  at	  0	  and	  102	  Å.	  When	  releasing	  these	  restraints	   this	   P(R)-­‐function	   for	   HfqDsrA	   at	   75%	   becomes	   un-­‐physical	  (i.e.	  P(R)	  deviates	   from	  zero	  at	  DMIN	  and	  DMAX),	   and	  no	  stable	   solution	  for	  can	  be	  found.	  	   	  
Fig.3.14:	   Stuhrmann	   plot	   of	   HfqDsrA	   data,	   based	   on	  parameters	   derived	   from	   standard	   Guinier-­‐analysis	   (o),	  and	  	  on	  parameters	  assuming	  	  extended	  Guinier-­‐region	  (x).	  	  Another	   approach	   to	   evaluate	   contrast	   variation	   data	   from	   a	   given	  complex	  structure	  was	  proposed	  by	  Heinrich	  Stuhrmann152.	  By	  plotting	  the	  square	  of	  Rg	  obtained	  at	  different	  contrast	  levels	  as	  a	  function	  of	  the	  designated	  contrast	  ( ρ ),	  a	  graphic	  representation	  for	  the	  effect	  of	  each	  component	   on	   the	   overall	   particle	   Rg	   is	   achieved153.	   In	   Fig.3.14	  
0%	  D2O	  75%	   100%	  D2O	  
	  	  	  
	  	   46	  
Stuhrmann	  plots	  of	  HfqDsrA	  assuming	  the	  two	  Guinier-­‐ranges	  are	  shown.	  The	  parameters	  derived	  from	  a	  normal	  Guinier-­‐analysis	  gives	  rise	  to	  an	  almost	   perfect	   linear	   behavior	   of	   the	   Rg	   inside	   the	   contrast	   series.	  Under	   the	   assumption	   that	  we	  match	   the	  RNA	   at	   75%	  D2O,	   this	   is	   an	  indication	   that	   the	   center	   of	   gravity	   of	   the	   particle	   remains	   stable	  throughout	  the	  contrast	  series.	  This	  interpretation	  of	  the	  data	  suggests	  that	   the	   RNA	   does	   not	   have	   an	   effect	   of	   the	   overall	   particle	   Rg	   (and	  shape),	   and	   is	   almost	   completely	   encased	   in	   the	   protein	   phase.	   Using	  the	  parameters	   from	   the	  extended	  Guinier-­‐region	   (1	  <	   s	   x	  Rg	  <	  2)	   the	  plot	  takes	  on	  a	  quadratic	  shape,	  indicating	  the	  RNA	  to	  affect	  the	  Rg	  (and	  shape)	   of	   the	   particle.	   However,	   in	   order	   to	   confirm	   this	   effect	   data	  must	  be	  acquired	  at	  more	  than	  three	  contrast	  levels.	  	  	  The	  direct	  analysis	  achieved	  by	  the	  Stuhrmann-­‐plot	  benefits	  from	  being	  based	  on	  a	  relatively	  simple	  Guinier-­‐analysis,	  estimating	  the	  particle	  Rg.	  The	   standard	  Guinier-­‐analysis	   for	  HfqDsrA,	   by	  virtue	  of	   the	   linear	   fit	   of	  the	  Stuhrmann-­‐plot,	  would	  indicate	  that	  the	  protein	  alone	  gives	  rise	  to	  the	  increased	  Rg	  in	  the	  complex.	  Considering	  the	  heat-­‐stable	  quartenary	  structure	   of	  HfqEc65,	   such	   increase	   of	   Rg	   in	   this	   system	  would	   only	   be	  possible	   in	   a	   complex	   comprising	   minimum	   two	   hexamers	   of	   Hfq.	  Proposing	   the	   complex	   to	   comprise	   more	   than	   one	   hexamer	   of	   Hfq	  leads	  back	   to	   the	  question	  regarding	   the	  stoichiometry	   in	   the	  particle,	  and	  would	  not	  be	  in	  agreement	  with	  the	  increase	  in	  molecular	  mass	  and	  volume	   observed	   by	   SAXS,	   or	   the	   relaxation	   properties	   measured	   by	  NMR.	  	  Furthermore,	  a	  P(R)	  calculated	  for	  a	  monodispersed	  sample	  where	  two	  domains	  of	  similar	  size	  (i.e.	  two	  hexamers)	  are	  connected	  by	  a	  narrow	  linker	  like	  RNA,	  would	  take	  the	  shape	  of	  two	  peaks	  of	  equal	  height.	  The	  first	  would	  represent	  the	  intra-­‐domain	  scattering	  from	  a	  single	  domain,	  the	   second	   the	   inter-­‐domain	   scattering.	   These	   two	   peaks	  would	   be	   of	  similar	  height	  because	  the	  domains	  are	  of	  similar	  size126.	  In	  the	  present	  P(R)	   for	   HfqDsrA	   (Fig.3.13A+B)	   we	   observe	   a	   large	   peak	   with	   a	   big	  shoulder,	  which,	   in	   following	  a	  similar	   line	  of	  arguments,	   represents	  a	  globular	   domain	  with	   a	   long	   appendix	   extending	   away.	   The	   shoulder	  has	  its	  own	  maximum,	  which	  could	  indicate	  a	  smaller	  globular	  domain	  to	  exist	  at	  the	  end	  of	  the	  appendix.	  This	  interpretation	  of	  the	  P(R)	  leads	  back	  to	  the	  initial	  study	  of	  Brescia	  et	  al.92,	  which	  indicated	  Hfq	  to	  prefer	  binding	   a	   fragment	   of	   the	   DsrA	   sRNA	   comprising	   a	   U-­‐rich	   stretch	  followed	   by	   a	   hairpin.	   This	   initially	   led	   to	   the	   selection	   of	   the	   DsrA34	  RNA-­‐fragment	   for	   study,	   which	   comprises	   the	   regulatory	   domain	   2	  hairpin	  preceeded	  by	  a	  short	  U-­‐rich	  stretch.	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In	   Fig.3.15	   secondary	   structure	   predictions	   for	   the	   DsrA34	   RNA-­‐fragment	  is	  shown,	  as	  calculated	  by	  the	  mFold	  web-­‐server154.	  Of	  the	  two	  proposed	  folds	  of	  DsrA34,	  which	  are	  about	  equally	  stable,	  only	  the	  one	  on	  the	  left	  has	  the	  5’-­‐end	  U-­‐rich	  stretch	  accessible.	  In	  conjunction	  with	  the	   P(R)	   suggesting	   a	   second,	   smaller	   globular	   domain	   to	   exist	   in	   the	  complex	   between	   HfqEc65	   and	   DrsA34,	   it	   is	   very	   satisfying	   to	   consider	  this	  fold	  of	  the	  RNA.	  The	  U-­‐rich	  stretch	  comprises	  the	  Hfq	  binding	  site,	  and	  in	  complex	  with	  Hfq	  this	  fold	  of	  DsrA34	  is	  therefore	  most	  likely	  to	  be	  the	  dominant	  species	  in	  solution.	  	  	  	  
	  	  
	  Fig.3.15:	   Secondary	   structure	   predictions	   of	   the	   DsrA34	   RNA-­‐fragment	   of	   equal	   stability	   (∆G),	   calculated	   by	   the	   mFold	   web-­‐server154.	  The	  5’-­‐uridine-­‐rich	  Hfq	  binding	  site	  is	  marked	  in	  yellow.	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3.3.4.3 Shape-­reconstruction	  assuming	  monodispersity	  Shape-­‐reconstruction	   assumes	   the	   sample	   to	   be	   perfectly	  monodisperse,	   and	   the	   scattering-­‐curve	   so	   to	   represent	   the	  density	  of	  the	   sample	   particle.	   Under	   the	   assumption	   of	   monodispersity,	   a	  proposed	   shape	   of	   same	   density	   can	   be	   reconstructed.	   If	   we	  were	   to	  assume	   the	   samples	   of	   the	   HfqDsrA	   complex	   to	   be	   monodisperse,	   a	  hypothetical	   shape	   of	   the	   sample	   particle	   can	   then	   be	   generated.	  However,	   it	   must	   be	   emphasised	   that	   due	   to	   the	   inconsistencies	   in	  deriving	  sample	  parameters,	  this	  can	  be	  regarded	  only	  as	  speculations	  on	  the	  overall	  model	  for	  the	  solution	  structure	  of	  the	  HfqDsrA-­‐complex.	  	  In	  Fig.3.16A	  a	  hypothetical	  model	   of	  HfqDsrA	   and	   its	   fit	   to	   the	   contrast	  variation	  data	   is	   shown.	  The	  model	  was	   generated	   ab-­‐initio	   assuming	  overall	   P1-­‐symmetry.	   The	   model	   incorporates	   the	   full	   six	   curves	  acquired	  for	  the	  protein	  and	  the	  complex	  at	  0,	  75	  and	  100%	  D2O,	  with	  the	  DMAX	  =	  102	  Å.	  It	  is	  important	  to	  emphasize	  the	  hypothetical	  nature	  of	  this	  model,	  which	  is	  reflected	  in	  the	  clearly	  speculative	  fit	  to	  the	  data	  for	  HfqDsrA	  at	  75%	  D2O.	  	  The	  model	  fit	  the	  SANS-­‐data	  for	  HfqEc65	  with	  X2	  ~1.38	  at	  0%,	  X2	  ~1.83	  at	  75%	   and	   X2	   ~1.44	   at	   100%	   D2O.	   For	   HfqDsrA	   the	   fit	   display	   higher	  discrepancy,	   with	   X2	   ~1.28	   at	   0%,	   X2	   ~3.53	   at	   75%	   and	   X2	   ~2.52	   at	  100%	   D2O,	   reflecting	   the	   samples	   increased	   complexity.	   In	   Fig.3.16B	  (from	  bottom	  to	  top)	  the	  development	  of	  the	  model	  can	  be	  followed.	  In	  the	   lower	  panel	  (Fig.3.16B.1)	  the	  crystal	  structure	  of	  HfqEc65	   is	  shown,	  with	   the	   N-­‐termini	   modeled	   by	   SAXS.	   In	   Fig.3.16B.2,	   HfqEc65	   is	  superposed	  onto	  the	  protein-­‐phase	   from	  SANS	  shown	  in	  blue	  spheres,	  as	  it	  appears	  when	  modeling	  the	  complex	  combining	  all	  six	  curves.	  The	  hexameric	  shape	  of	  the	  conserved	  Hfq-­‐core	  emerges	  clear	  in	  this	  model.	  In	  Fig.3.16B.3,	  green	  spheres	  on	  top	  of	  the	  protein-­‐phase	  represent	  the	  RNA	   extending	   away,	   satisfying	   DMAX	   of	   the	   particle.	   The	   modeled	  volume	   of	   protein	   and	   RNA	   was	   of	   equal	   size.	   In	   Fig.3.16B.4	   the	  resulting	  rigid-­‐body	  model	  of	  HfqDsrA	  from	  SAXS	  is	  superposed	  onto	  the	  ab-­‐initio	   model	   from	   SANS.	   Reasonable	   agreement	   indicates	   some	  stability	   of	   the	   overall	   shape	   of	   these	   two	   models,	   despite	   their	  independently	  speculative	  fit	  to	  respective	  data	  sets.	  The	   SANS-­‐models	   were	   calculated	   leaving	   the	   volumes	   parameters	  variable,	  keeping	  only	  restraints	  on	  the	  particle	  largest	  dimension	  DMAX	  and	  the	  Rg	  of	  the	  protein-­‐phase.	  	  In	   the	   outcome	  model	   the	   two	   phases	   of	   the	   particle	   are	   about	   same	  size,	   which	   is	   not	   consistent	   with	   a	   1:1	   complex.	   As	   estimated	   by	  tabulated	   values	   for	   the	   partial	   specific	   volume	   ( v )	   for	   globular	  protein	  (7.40*1023	  Å3	  g-­‐1)	  and	  nucleic	  acid	  (5.40*1023	  Å3	  g-­‐1),	   in	  a	  1:1	  complex	   between	   HfqEc65	   (43.200	   g/mol)	   and	   DsrA34	   (10.800	   g/mol),	  the	  protein	  should	  make	  out	  about	  85%	  of	  the	  total	  volume.	  As	  with	  the	  shape-­‐reconstruction	  of	  the	  SAXS-­‐data,	  the	  volume	  of	  the	  RNA-­‐phase	  in	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the	   SANS-­‐model	   appears	   rather	   large	   in	   comparison	   to	   the	   protein.	  When	  modeling	  HfqDsrA	  by	  SAXS-­‐data	  the	  protein	  is	  represented	  by	  the	  known	  crystal	  structure,	  as	  a	  rigid-­‐body.	  The	  RNA	   is	  represented	  by	  a	  number	   of	   dummy	   residues,	   which	   we	   increased	   to	   a	   maximum	   to	  improve	  the	  fit	  in	  the	  low	  s-­‐range.	  Similarly,	  in	  the	  present	  hypothetical	  ab-­‐initio	   P1-­‐model	   based	   on	   the	   SANS-­‐data,	   the	   protein-­‐phase	   is	  restrained	   by	   its	   known	  Rg,	   and	  without	   restraints	   on	   the	   volumes	   of	  the	   phases,	   the	   volume	  of	   the	  RNA-­‐phase	   is	   increased	   in	   the	   ab-­‐initio	  model	  to	  compensate	  a	  poor	  fit	  in	  the	  low	  s-­‐range.	  	  
3.3.4.4 Volume-­restrained	  shape-­reconstruction	  In	   Fig.3.17	   shape-­‐reconstructions	   assuming	  monodispersity	   of	   HfqDsrA	  enforcing	  volume-­‐restraints	   in	  accordance	  with	  a	  1:1	  stoichiometry	   in	  the	   complex	   are	   shown.	   The	   top	   panel	   shows	   the	   rigid-­‐body	   model	  based	  on	  SAXS-­‐data	  with	  the	  RNA	  represented	  by	  a	  total	  of	  68	  dummy	  residues,	   two	   per	   nucleotide	   instead	   of	   three	   as	   above.	   To	   the	   right,	  iterative	   modeling	   (10x)	   displays	   the	   RNA	   extending	   away	   from	   the	  
A	   	  	   B.4	  	  	  	  	  	  	  B.3	  	  	  	  	  	  B.2	  	  	  	  	  	  B.1	   	  
Fig.3.16:	   Neutron	   small	   angle	   scattering	   acquired	   for	  HfqEc65	   and	  HfqDsrA.	  
(A)	   The	   data	   shown	   in	   black	   dots	   acquired	   at	   three	   contrast	   levels	   0%,	  75%	   and	   100%	   D2O,	   overlaid	   with	   curves	   (blue:	   HfqEc65;	   green:	   HfqDsrA)	  representing	  hypothetical	  models	   from	  shape-­‐reconstruction.	  The	   curves	  were	   shifted	   along	   the	   intensity	   scale.	   (B.1-­4)	   Shape-­‐reconstruction	   of	  HfqDsrA	  assuming	  monodisperse	  samples,	  by	  the	  program	  Monsa.	  B.1:	  The	  crystal	   structure	   of	   HfqEc65	  with	   the	   N-­‐termini	   reconstructed	   from	   SAXS.	  
B.2:	   Crystal	   structure	   overlaid	   the	   protein	   phase	   from	   SANS	   in	   blue	  spheres.	  B.3:	  Model	  of	  HfqDsrA	  with	  RNA	  represented	  by	  green	  spheres.	  B.4:	  superposition	  of	  the	  resulting	  models	  of	  the	  complex	  from	  SAXS	  and	  SANS.	  
Χ2	  =	  1.44	  
Χ2	  =	  1.83	  
Χ2	  =	  1.38	  
Χ2	  =	  1.28	  
Χ2	  =	  3.53	  
Χ2	  =	  2.52	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protein,	  adopting	  a	  shape	  reminiscent	  of	  a	  horseshoe.	  The	  SAXS-­‐data	  for	  HfqEc65	  is	  fit	  with	  X2	  ~1.44	  and	  HfqDsrA	  X2	  ~3.98.	  The	  lower	  panel	  display	  	  an	   ab-­‐initio	   model	   based	   on	   SANS-­‐data	   restrained	   by	   the	   expected	  volume-­‐fraction	  of	  the	  protein	  (85%)	  and	  RNA	  (15%),	  DMAX	  ~102	  Å	  and	  the	  known	  Rg	  of	  HfqEc65	  ~23	  Å.	  In	  agreement	  with	  the	  model	  based	  on	  the	  SAXS-­‐data,	  the	  RNA	  can	  be	  seen	  emerging	  from	  the	  proximal	  face	  of	  the	  hexameric	  protein.	  This	  model	  fit	  the	  SANS-­‐data	  for	  HfqEc65	  with	  X2	  ~1.29	   at	   0%,	   X2	   ~2.11	   at	   75%	   and	   X2	   ~1.74	   at	   100%	   D2O;	   and	   for	  HfqDsrA	  with	  X2	  ~2.33	   at	   0%,	  X2	  ~3.48	   at	   75%	  and	  X2	  ~4.32	   at	   100%	  D2O.	   In	   Fig.3.18	   the	   fit	   to	   the	   SANS-­‐data	   of	   the	   two	  models	  with	   and	  without	  volume-­‐restraints	  are	  compared.	  The	  upper	  panel	  shows	  the	  fit	  of	  the	  model	  restrained	  by	  volume,	  displaying	  clear	  discrepancy	  in	  the	  fit	  to	  the	  data.	  In	  the	  lower	  panel	  the	  fit	  of	  the	  model	  generated	  without	  volume-­‐restraints	   is	  shown,	  displaying	  a	  better	   fit	   to	   the	  experimental	  data.	   However,	   none	   of	   the	  models	   fit	   the	   data	   at	   75%	  D2O.	  Whereas	  
	  Fig.3.17:	   Shape-­‐reconstruction	   of	  HfqDsrA	   implying	   volume	   restraints	   of	   a	  1:1-­‐complex.	   X2-­‐values	   for	   the	   data	   in	   H2O	   have	   been	   noted.	   Top-­panel:	  Rigid-­‐body	   model	   based	   on	   SAXS-­‐data.	   In	   grey	   is	   shown	   the	   crystal	  structure	   of	   HfqEc65	   with	   the	   N-­‐termini	   modeled	   by	   SAXS,	   with	   the	   RNA	  represented	   by	   68	   dummy	   residues	   (pink).	   To	   the	   right	   is	   shown	   how	  iterative	   modeling	   leads	   to	   a	   ‘horseshoe-­‐shape’	   of	   the	   RNA	   (black).	  
Bottom-­panel:	   Super-­‐position	  of	   ab-­‐initio	  model	  based	  on	  SANS,	  onto	   the	  SAXS-­‐models.	   Shown	   in	   blue	   spheres	   the	   protein-­‐phase	   resembles	   the	  crystal	  structure	  of	  hexameric	  HfqR65,	  and	  in	  green	  spheres	  the	  RNA-­‐phase	  agrees	  with	  that	  of	  the	  SAXS-­‐model.	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from	   a	   visual	   inspection,	   the	   two	   models	   display	   about	   equal	  discrepancy	  for	  the	  data	  at	  higher	  s-­‐range	  (s	  >	  1.5),	  especially	  in	  the	  low	  s-­‐range	  (s	  <	  0.1),	  the	  fit	  is	  improved	  with	  increased	  volume	  of	  RNA.	  This	  demonstrates	  how	  the	  increased	  density	  of	  RNA	  improves	  the	  fit.	  	  	  
	  Fig.3.18:	   Comparison	   between	   the	   SANS-­‐data	   for	   HfqDsrA	   (in	   blue)	   and	  theoretical	  scattering-­‐curves	  (in	  pink)	  calculated	  for	  the	  models	  generated	  with	   volume-­‐restraints	   of	   HfqDsrA	   (upper)	   and	   without	   (lower).	   The	   axis	  denotes	   momentum-­‐transfer	   (Å-­‐1)	   plotted	   against	   logarithm	   of	   scattering	  intensity.	  The	  X2-­‐values	  for	  HfqDsrA	  have	  been	  noted.	  	  
3.3.5 Summary	  &	  Concluding	  remarks	  From	  the	  complementarity	  of	  the	  results	  presented	  above,	  it	  was	  sought	  to	  meet	  the	  goal	  of	  establishing	  a	  shape-­‐model	  of	  RNA,	  binding	  on	  the	  C-­‐terminally	  truncated	  E.coli	  Hfq	  protein.	  	  The	   presented	   SAXS-­‐data	   support	   the	   expected	   ~25%	   increase	   in	  molecular	  mass	   and	  ~15%	   increase	   in	   particle	   excluded	   volume,	   in	   a	  complex	   of	   1:1	   stoichiometry	   between	   hexameric	   HfqEc65	   and	   DsrA34.	  However,	  the	  shape-­‐model	  based	  on	  the	  SAXS-­‐data	  does	  not	  satisfy	  the	  scattering	   at	   low	   angle,	   despite	   implying	   a	   generous	   volume	   for	   the	  RNA.	  Transverse	   15N-­‐relaxation	   experiments	   by	   NMR	   indicate	   a	   ~25%	  increase	   in	   hydrodynamic	   volume	   of	   the	   particle	   in	   the	   presence	   of	  RNA,	  which	  is	  in	  agreement	  with	  a	  1:1	  complex.	  Comparative	  analysis	  of	  15N-­‐HSQC	  NMR-­‐spectra	   for	  HfqEc65	   and	  HfqDsrA,	   as	   expected,	  maps	   the	  interaction	  of	  RNA	  primarily	  to	  the	  proximal	  face	  of	  HfqEc65.	  The	   SANS-­‐data	   recorded	   from	   contrast	   variation	   experiments	   lends	  further	   speculations	   to	   the	   validity	   of	   the	   proposed	   1:1	   model.	   The	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SANS-­‐data	   is	   of	   low	   quality,	   but	   interpretation	   of	   the	   data	   under	  assumption	  of	  established	  perceptual	  criteria	  sheds	  further	  light	  on	  the	  solution	  behavior	  in	  the	  HfqDsrA-­‐complex.	  	  In	   SAS-­‐experiments	   the	   recorded	   scattering	   is	   a	   synthesis	   of	   the	  scattering	   of	   all	   solute	   components	   in	   the	   sample,	   subtracted	   the	  solvent.	   The	   intensity	   of	   the	   scattering	   increases	   roughly	   with	   the	  power	  of	  six	  of	  the	  radius	  of	  the	  solute,	  and	  even	  a	  very	  small	  amount	  of	  aggregation	  can	  therefore	  potentially	  have	  a	  huge	  effect	  on	  the	  result.	  In	  the	   NMR-­‐experiments	   such	   aggregation	   will	   not	   be	   detected,	   and	   in	  consideration	  of	  the	  sample	  properties	  and	  preparation	  procedures,	  the	  NMR-­‐result	   is	   probably	   more	   reliable	   for	   evaluating	   the	   complex	  stoichiometry.	  	  Based	  on	   the	  SAS-­‐data	   two	  sets	  of	   shape-­‐models	  have	  been	  generated	  that	   are	   mutually	   in	   agreement	   independent	   of	   volume-­‐restraints.	  However,	  the	  shape-­‐model	  best	  fitting	  the	  SAS-­‐data	  does	  not	  agree	  well	  with	  the	  NMR	  relaxation	  experiments.	  Both	  sets	  of	  shape-­‐models	  could	  in	   principle	   agree	   with	   the	   chemical	   shift	   pattern	   from	   NMR,	   from	  which	  the	  most	  interesting	  observation	  undoubtedly	  is	  the	  structuring	  of	  the	  N-­‐terminus	  in	  complex	  with	  RNA.	  	  The	   N-­‐terminus	   of	   Hfq	   is	   widely	   conserved	   in	   bacterial	   species,	   and	  previous	   functional	   studies	   have	   suggested	   it	   to	   be	   involved	   in	   the	  function	   of	   Hfq46.	   The	   DsrA34	   RNA	   carries	   in	   its	   3’-­‐end	   a	   self-­‐complementary	   region	   that	   forms	   the	   domain	   2	   hairpin	   of	   the	   full-­‐length	   sRNA.	   The	   DsrA34-­‐fragment	   was	   selected	   for	   studies	   based	   on	  the	   assumption	   that	   the	   hairpin	   would	   be	   involved	   in	   the	   binding	   to	  Hfq,	  in	  following	  of	  the	  findings	  by	  Brescia	  et	  al.92.	  However,	  the	  mFold-­‐server154	   predicted	   an	   alternative	   secondary	   structure	   for	   the	  DsrA34-­‐fragment,	   with	   a	   shorter	   hairpin	   at	   its	   3’-­‐end.	   At	   distance	   to	   the	  expected	  U-­‐rich	  Hfq	  binding	  site,	  no	  steric	  hindrance	  would	  appear	   to	  be	   obstructing	   the	   formation	   of	   this	   3’-­‐hairpin	   while	   DsrA34	   is	   in	  complex	   with	   Hfq	   from	   the	   U-­‐rich	   5’-­‐end.	   Yet	   no	   imino-­‐signals	   was	  observed	   for	   the	   HfqDsrA	   complex	   by	   NMR,	   which	   could	   indicate	   a	  dynamic	  process	   in	   the	  RNA	   that	   lead	   to	   line	  broadening	  of	   the	  NMR-­‐signals.	  A	  process	  that	  could	  prevent	  detection	  of	  imino-­‐signals	  could	  be	  the	   reversible	   opening	   and	   closing	   of	   the	   RNA	   hairpin.	   concomitantly	  with	  the	  disordered	  N-­‐terminus	  of	  Hfq	  becoming	  structured,	  the	  hairpin	  of	   DsrA34	   unfolds.	   Such	   a	   model	   would	   be	   in	   agreement	   with	   the	  ‘entropy	  transfer	  model’,	  previously	  proposed	  by	  Tompa	  et	  al.98	  to	  be	  of	  particular	   application	   for	   RNA-­‐chaperones,	   and	   in	   a	   process	   of	  isothermal	   entropy/enthalpy-­‐compensation	   this	   is	   seemlessly	  reversible.	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Furthermore,	   that	   the	   RNA	   is	   self-­‐complementary	   could	   in	   principle	  lead	   to	  RNA	  oligomerization	  and	  nucleate	   the	  aggregation,	  which	  may	  potentially	   have	   compromised	   the	   quality	   of	   the	   all	   the	   SAS-­‐data	  recorded	   for	   the	  complex.	  SAXS	  experiments	  on	  the	  DsrA34	  RNA	  alone	  have	   previously	   demonstrated	   DsrA34	   to	   form	   large	   aggregates	   (data	  not	   shown),	   and	   recent	   experiments	   by	   DLS	   have	   demonstrated	   the	  RNA	   to	   most	   likely	   exist	   as	   a	   dimer	   at	   lower	   temperature,	   which	  dissociate	  as	  temperature	  increases	  (Dr.	  Euripides	  Almeida	  de	  Rebeiro;	  personal	  communication).	  	  	  From	   the	   present	   study	   it	   has	   been	   established	   that	   binding	   of	   the	  DsrA34	   RNA-­‐fragment	   leads	   to	   a	   structuring	   of	   the	   conserved	   N-­‐terminus	   of	   Hfq.	   The	   dynamic	   nature	   of	   the	   proposed	   protein:RNA	  complex	  can	  explain	  why	  attempts	  to	  crystallize	  the	  HfqDsrA	  complex	  so	  far	  have	  failed.	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4 Structure	  of	  HfqEc65	  complex	  with	  ATP	  
Synopsis	  The	   crystal	   structure	   of	   C-­‐terminally	   truncated	   E.coli	   Hfq,	   have	   been	  solved	   in	   complex	   with	   ATP.	   As	   expected	   ATP	   is	   coordinated	   in	   the	  distal	   R-­‐site,	   similar	   to	   the	   published	   structure	   of	   a	   complex	   between	  Hfq	   and	   poly(A)-­‐RNA.	   Two	   unique	   RNA-­‐binding	   sites	   have	   been	  identified	  on	  each	  face	  of	  the	  Hfq	  hexamer.	  On	  the	  proximal	  face	  resides	  the	   uridine	   specific	   binding	   site	   that	   has	   been	   speculated	   to	   also	  accommodate	   adenine	   and	   cytosine	   bases,	   and	   on	   the	   distal	   face	   the	  tripartite	  A-­‐R-­‐N-­‐site	  has	  been	  shown	  to	  accommodate	  more	  variability	  in	  the	  sequence.	  Intricate	  analysis	  of	  the	  present	  ATP-­‐complex	  structure	  and	   comparison	   with	   other	   published	   complex	   structures,	   together	  indicate	  degrees	  of	   freedom	  in	  the	  R-­‐site	  binding	  crevice	  and	  suggests	  possible	  alternative	  modes	  of	  RNA-­‐coordination	  to	  be	  conserved	  on	  the	  distal	  face	  of	  E.coli	  Hfq.	  	  
4.1 Preamble	  Hfq	  is	  classified	  as	  an	  Sm-­‐like	  protein,	  adopting	  the	  classic	  OB-­‐fold	  with	  a	   N-­‐terminal	   helix,	   followed	   by	   five	   anti-­‐parallel	   β-­‐strands	   forming	   a	  distinctly	  bent	  β-­‐sheet	  in	  an	  SH3-­‐like	  domain.	  It	  adopts	  a	  highly	  stable	  quaternary	   structure	   as	   a	   doughnut-­‐shaped	   homo-­‐hexamer	   around	   a	  central	   pore.	   A	   modified	   Walker-­‐A	   motif	   (-­‐GXXXXGKT-­‐)155	   was	  proposed	   identified	   to	   the	   sequence	   -­‐Gly29IKLQGQI36-­‐,	   residing	   on	   the	  distal	   face	   of	   the	   Hfq	   hexamer75.	   Further	   work	   by	   Arluison	   et	   al.50	  supported	  the	   location	  of	   the	  nucleotide	  binding	  pocket	  by	  mutational	  studies,	   demonstrating	   the	   importance	   of	   a	   π-­‐stacking	   interaction	  betrween	  Tyr-­‐25	  and	   the	  nucleotide	  base.	   In	   their	  proposed	  model	   of	  ATP-­‐binding,	   the	   ribose-­‐phosphate	   is	   pointing	   towards	   the	   rim	   of	   the	  hexamer,	  with	  no	  possibility	  for	  interaction	  with	  the	  modified	  Walker-­‐A	  motif.	  	  Here	  we	  report	  the	  crystal	  structure	  of	  adenosine-­‐tri-­‐phosphate	  (ATP)	  binding	  in	  the	  purine-­‐pocket	  (R-­‐site)	  of	  the	  tripartite	  binding	  site	  (A-­‐R-­‐N	  site),	  on	   the	  distal	   face	  of	  Hfq	  protein,	   as	   identified	  by	  Link	  and	  co-­‐workers111	   in	  the	  crystal	  structure	  by	  of	  Escherichia	  coli	  Hfq	  (HfqEc)	   in	  complex	   with	   poly-­‐A15	   RNA	   oligonucleotide.	   Baba	   et	   al.112	   further	  established	  the	  location	  of	  the	  bindingpocket,	  in	  the	  crystal	  structure	  of	  
Bacillus	   subtilis	   Hfq	   (HfqBac)	   in	   complex	   with	   a	   heptameric	   RNA	  oligonucleotide	   (5’-­‐AGAGAGA-­‐3’).	   The	   R-­‐site	   binding	   pocket	   is	  composed	   of	   residues	   from	  β-­‐strands	   of	   two	   adjacent	   subunits	   of	   the	  Hfq	   hexamer	   (Fig.4.1	   insert).	   It	   is	   comprises	   a	   crevice	   formed	   of	  hydrophobic	   and	   aromatic	   residues	   on	   its	   sides	   (Tyr-­‐25,	   Leu-­‐26’,	   Ile-­‐
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30’,	   and	  Leu-­‐32’;	   prime’	  denoting	   residues	   from	   the	  adjacent	   subunit)	  and,	  with	  H-­‐bond	  partners	  at	  the	  bottom	  and	  cervixes	  (Asn-­‐28’,	  Gly-­‐29,	  Gln-­‐52’,	  Ser-­‐60,	  Thr-­‐61).	  	  In	   complex	   with	   E.	   coli	   Hfq,	   every	   third	   nucleotide	   of	   the	   poly-­‐A15	  oligonucleotide	   is	   inserted	   into	   the	   bindingpocket.	   In	   complex	   with	  
Bacillus	   subtilis	   every	   second	   nucleotide	   of	   the	   (5’-­‐AGAGAGA-­‐3’)	  oligonucleotide	  is	  inserted	  in	  the	  crevice	  (see	  Fig.4.1	  insert),	  suggesting	  a	  similar	  bindingmode	  possible	  for	  E.	  coli	  Hfq.	  	  
4.2 Results	  &	  Discussion	  
4.2.1 R-­site	  coordination	  of	  ATP	  Crystals	   were	   obtained	   from	   a	   C-­‐terminally	   truncated	   fragment,	  comprising	   residues	   1-­‐65	   of	  E.coli	   Hfq	   (HfqEc65)	   in	   complex	  with	  ATP.	  Data	   collection	   and	   refinement	   statistics	   are	   summarized	   in	   Table	   III.	  Model	   coordinates	   and	   structure	   factors	   have	   been	   deposited	   in	   the	  PDB	  under	  the	  code	  3QO3.	  The	   crystal	   structure	   of	   HfqEc65	   in	   complex	   with	   ATP	   presented	   here	  does	  not	  support	  the	  model	  proposed	  by	  Arluison	  et	  al.75.	  In	  our	  crystal	  data,	   the	   adenine	   moiety	   is	   turned	   around	   180˚	   with	   the	   ribose-­‐phosphate	   pointing	   towards	   the	   central	   pore	   of	   the	   hexamer.	   Taken	  together	  our	  data,	  those	  of	  Link	  et	  al.111	  and	  Baba	  et	  al.112,	  confirm	  this	  mode	  of	  binding	  and	  rule	  out	  the	  alternative	  modeled	  binding	  mode.	  	  
	  Fig.4.1:	  A	  stereoview	  of	  the	  R-­‐site	  purine	  binding	  site	  between	  adjacent	  monomers,	   on	   the	  distal	   face	  of	  E.coli	  Hfq.	   Side-­‐chains	  of	   binding	   site	  residues	  are	  shown	  as	  sticks.	  A	  single	  ATP-­‐moiety	   is	  colored	  in	  green,	  with	   the	   triple-­‐phosphate	   protruding	   in	   the	   favored	   conformation	  (orange	   lines).	   Inserted	   in	   the	   upper	   right	   corner	   is	   the	  Hfq	   hexamer	  shown	   from	   distal	   face,	   with	   the	   two	   known	   binding-­‐modes	   of	   RNA	  overlaid,	   adopted	   from	   the	   structures	   of	   HfqEc:Poly-­‐A15	   (magenta;	  PDBid:	  3GIB)	  and	  HfqBac:-­‐AGAGAGA-­‐	  (yellow;	  PDBid:	  3HSB).	  	  
	  	  	  
	  	   56	  
Superposition	   of	   HfqEc65	   hexamer	   with	   the	   apo-­‐structure	  (PDBid:1HK9)105	   exhibits	   an	   overall	   r.m.s.d	   of	   0.53	   Å	   over	   360	  equivalent	  Cα	  atoms,	  thus	  suggesting	  no	  conformational	  changes	  upon	  ATP	  binding.	  Fig.4.1	  displays	  a	  single	  ATP-­‐unit	  inserted	  into	  the	  purine	  binding-­‐site	  (R-­‐site),	  on	  the	  distal	  face	  of	  the	  E.coli	  Hfq	  hexamer.	  	  In	  the	  present	  structure,	  density	  corresponding	  to	  ATP	  was	  observed	  in	  four	  of	  six	  binding	  sites.	  In	  three	  of	  the	  four	  occupied	  binding	  sites	  the	  ATP	  is	  bound	  similarly	  as	  in	  complex	  with	  poly-­‐A15,	  as	  reported	  by	  Link	  
et	  al.111.	  In	  the	  R-­‐site	  binding	  pocket	  the	  adenine	  nitrogens	  are	  engaged	  by	  two	  H-­‐bonds	  to	  side	  chains	  (exocyclic	  N6:Oε	  Gln-­‐52’	  and	  N1:Oγ	  Thr-­‐61)	   and	   one	   water-­‐mediated	   H-­‐bond	   to	   N3,	   coordinated	   by	   the	  backbone	  carbonyl	  of	  Leu-­‐26	  and	  the	  side	  chain	  of	  Asn-­‐28’	  (Fig.4.2).	  In	  addition,	   aromatic	   stacking	   interaction	   with	   Tyr-­‐25	   is	   supported	   by	  favorable	  hydrophobic	  contacts	  with	  the	  side	  chains	  of	  Leu-­‐26’,	  Ile-­‐30’,	  and	  Leu-­‐32’	  of	  the	  adjacent	  subunit	  (Fig.4.2).	  	  One	  of	  the	  adenosine-­‐units	  (one	  out	  of	   four	  occupied	  binding	  pockets)	  is	  tilted	  further	  towards	  the	  central	  pore	  formed	  by	  the	  hexamer,	  when	  compared	   to	   the	   poly-­‐A15	   structure.	   This	   gives	   rise	   to	   a	   different	  hydrogen-­‐bonding	  pattern	  (Fig.4.2).	  In	  this	  particular	  ATP	  binding	  site,	  the	   adenine	   exocyclic	   N6	   is	   H-­‐bonded	   by	   Thr-­‐61	   Oγ,	   while	   N1	   is	   H-­‐bonded	   to	   Ser-­‐60	   Oγ.	   Additionally,	   in	   the	   poly-­‐A15	   structure	   a	   tightly	  bound	   water	   molecule,	   coordinated	   by	   the	   carbonyl	   oxygen	   atom	   of	  Leu-­‐26	  and	  side	   chain	  of	  Asn-­‐28’,	  mediates	  a	  hydrogen	  bond	   to	  N3	  of	  the	  bound	  nucleotide	  (Fig.4.2;	  H2OPoly-­‐A).	  In	  the	  ATP	  binding	  site	  shown	  in	  Fig.4.2,	  this	  tightly	  bound	  water	  moves	  in	  concession	  with	  the	  tilt	  of	  the	  ATP	  moiety,	  apparently	  disrupting	   the	  hydrogen-­‐bonding	  network	  between	  the	  solvent	  molecule	  and	  N3	  atom	  of	  adenine	  (Fig.4.2;	  H2OATP).	  In	   the	   region	   of	   Gln-­‐52’	   (towards	   the	   rim	   of	   the	   hexamer)	   two	   new	  water	  molecules	  are	  observed,	  mediating	  contact	  to	  the	  exocyclic	  N6	  of	  the	  tilted	  ATP	  moiety	  (Fig.4.2;	  W1+W2).	  	  	  Common	   to	   all	   the	   binding	   sites	   is	   the	   formation	   of	   a	   hydrogen	   bond	  between	   the	   adenosine	   ribose	   2’-­‐OH	   and	   carbonyl-­‐group	   of	   Gly-­‐29	  (Fig.4.2).	  This	   interaction	  was	   reported	   to	   likely	  convey	  selectivity	   for	  RNA	   over	   DNA	   for	   this	   binding-­‐site111.	   Our	   results	   corroborate	   the	  importance	  of	  binding	  the	  2’-­‐OH	  of	  the	  ribose	  sugar	  to	  Gly-­‐29	  carbonyl	  oxygen	  atom.	  With	  its	  φ/ψ-­‐angles	  falling	  in	  the	  region	  around	  ~85˚	  and	  	  ~-­‐10˚	   respectively,	   Gly-­‐29	   adopts	   main-­‐chain	   conformation	   allowed	  only	  for	  glycine	  residues,	  which	  do	  not	  bare	  side-­‐chains.	  This	  suggests	  that	   any	   kind	   of	   substitution	   of	   the	   glycine	   residue	   at	   this	   position	  would	  dramatically	  reduce	  Hfq’s	  binding	  capacity	  to	  ATP.	  In	  all	  ATP	  units	  bound	  to	  HfqEc65	   the	  ribose	   is	  modeled	   in	  a	  staggered	  conformation.	  The	   tri-­‐phosphates	  have	   in	  all	  units	  been	  modeled	  with	  full	   occupancy,	   and	   several	  possible	   conformations	  were	  observed	   for	  the	  phosphates	  of	  each	   ligand.	  The	  conformation	  of	   seemingly	  highest	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electron	  density	  was	  chosen	  for	  all	  ligands,	  resulting	  in	  the	  phosphates	  of	   two	   ATPs	   to	   be	   involved	   in	   crystal	   contacts,	   binding	   to	   Arg-­‐19	   of	  symmetry	  related	  protomers.	  The	  general	  interpretation	  should	  though	  be	   that	   the	   tri-­‐phosphates	   are	   present	   (ie.	   not	   hydrolyzed)	   with	  variable	   conformations,	   and	   are	   not	   involved	   in	   specific	   interactions	  with	  HfqEc65.	  
4.2.2 Comparison	  to	  coordination	  of	  RNA	  The	  structure	  of	  the	  HfqBac	  in	  complex	  with	  a	  short	  RNA-­‐oligonucleotide	  (5’-­‐AGAGAGA-­‐3’)112	   has	   demonstrated	   new	   properties	   of	   the	   R-­‐site	   in	  binding	  of	  adenosine.	  With	  a	  sequence	  homology	  of	  45%	  and	  similarity	  of	  73%,	  the	  overall	  r.m.s.d.	  between	  E.coli	  and	  B.	  subtilis	  (calculated	  for	  Cα-­‐atoms	  aa	  8-­‐65	  of	  PDBid:	  3HSB	  and	  E.coli	  Hfq	   in	   complex	  with	  ATP	  over	  348	  equivalent	  Cα	  atoms)	  is	  0.54	  Å.	  This	  suggests	  a	  high	  degree	  of	  structural	   conservation	   of	   Sm-­‐like	   fold	   across	   strains,	   as	   well	   as	   no	  structural	  changes	  upon	  nucleotide	  binding.	  	  Comparing	   the	   structures	   of	   E.coli	   and	   B.	   subtilis	   Hfq	   (Fig.4.2),	   two	  amino	  acid	  substitutions	  are	  found	  in	  the	  distal	  R-­‐site	  binding	  site	  (Tyr-­‐25	  	  Phe-­‐24	  and	  Ile-­‐30’	  	  Phe-­‐29’),	  which	  upgrades	  the	  binding	  site	  π-­‐stacking	   properties	   to	   a	   π-­‐sandwich.	   Namely,	   while	   in	  E.	   coli	   Hfq	   the	  aromatic	  adenosine	   ring	   is	   flanked	  by	  Tyr-­‐25	  and	   Ile-­‐30’,	   in	  B.	   subtilis	  Hfq	   the	   nucleotide	   aromatic	  moiety	   is	   stacked	   between	   two	   aromatic	  side-­‐chains	  (Phe-­‐24	  and	  Phe-­‐29’	  as	  numbered	  for	  HfqBac).	  A	  calculated	  r.m.s.d.	  of	  0.53	  Å	  /	  0.53	  Å	  for	  Cα	  /	  Cβ	  for	  R-­‐site	  residues	  (E.coli:	  Tyr-­‐25,	  
	  Fig.4.2:	   A	   stereo	   view	   into	   the	   R-­‐site	   purine	   binding	   pocket	   from	   the	  perspective	   of	   Phe-­‐25	   (removed	   for	   clarity).	   ATP	   is	   represented	   as	  green	   sticks	   (phosphates	   removed),	   and	   the	   adenosines	  of	  HfqEc:Poly-­‐A15	   (magenta)	   and	   HfqBac:-­‐AGAGAGA-­‐	   (yellow)	   as	   thin	   sticks.	   Binding	  site	   residues	   are	   shown	   as	   wire-­‐frame	   in	   respective	   color.	   Residues	  coordinating	  ATP	  is	  noted	  by	  stipulations.	  The	  H-­‐bond	  mediating	  water	  in	   the	   HfqEc65:ATP	   structure	   is	   located	   between	   Leu-­‐26	   and	   Asn-­‐28’,	  with	   the	   equivalent	   water	   from	   HfqE.coli:Poly-­‐A15	   in	   the	   background.	  Behind	   the	   nucleotide	   moieties	   the	   Phe-­‐29’	   of	   HfqBac	   (yellow	   stick)	  overlaps	  with	  Ile-­‐30’	  of	  HfqEc.	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Leu-­‐26’,	   Asn-­‐28’,	   Gly-­‐29,	   Ile-­‐30’,	   Leu-­‐32’,	   Gln-­‐52’,	   Ser60,	   Thr61	   and	  B.	  
subtilis:	  Phe-­‐24,	  Leu-­‐25’,	  Asn-­‐27’,	  Gly-­‐28,	  Phe-­‐29’,	  Leu-­‐31’,	  Gln-­‐52’,	  Ser-­‐60,	  Thr-­‐61)	  indicate	  little	  to	  none	  structural	  changes	  in	  the	  binding	  site,	  upon	  introduction	  of	  an	  additional	  bulky	  aromatic	  group.	  Comparing	   the	   HfqEc65:ATP-­‐complex	   structure	   to	   the	   HfqBac:RNA	  oligonucleotide	  complex,	  a	  single	  ATP-­‐unit	   is	  coordinated	   in	  a	  manner	  similar	   to	  adenines	   in	  B.	   subtilis,	  which	  are	  all	  moved	   further	   towards	  the	   central	  pore	  of	   the	  hexamer	  when	  compared	   to	   the	  HfqEc:poly-­‐A15	  structure.	  This	  is	  possibly	  an	  effect	  of	  inter-­‐protomer	  crystal	  contacts	  in	  the	  B.	  subtilis	  structure	  mediated	  by	  the	  RNA	  oligonucleotide.	  The	  slight	  translation	  of	  the	  adenine	  disrupts	  the	  interaction	  between	  Oε	  atom	  of	  Gln-­‐52’	  and	  the	  adenine	  exocyclic	  N6,	  similar	  to	  ATP.	  The	  tightly	  bound	  water	  between	  Leu-­‐26	  and	  the	  side	  chain	  of	  Asn28’	  (Fig.4.2;	  H2OATP)	  is	  not	  observed	  in	  the	  B.	  subtilis	  structure.	  Overall	  comparison	  between	  the	  published	  structures	  of	  HfqEc:Poly-­‐A15	  (PDBid:	   3GIB)	   and	   HfqBac:-­‐AGAGAGA-­‐	   (PDBid:	   3HSB)	   in	   combination	  with	  the	  here	  presented	  HfqEc65:ATP	  co-­‐crystal	  structure,	  indicates	  that	  
E.coli	  Hfq	  possibly	  could	  bind	  RNA	  in	  a	  mode	  similar	  to	  that	  observed	  in	  the	  B.	  subtilis	  structure,	  with	  every	  second	  purine-­‐base	  inserted	  into	  the	  binding-­‐site	  crevice.	  	   Table	  III	  	  Data	  collection	  and	  refinement	  statistics	  Beamline	   ID14.1	  (ESRF)	  Wavelength	  (Å)	   0.934	  Resolution	  (Å)	   98.67	  -­‐	  2.15	  (2.21	  -­‐	  2.15)	  Space	  group	   C2	  Unit	  cell	  (Å,˚)	   a	  =	  104.30	  b	  =	  40.62	  c	  =	  100.81	  β	  =	  101.8	  	  Molecules	  /	  a.u.	   6	  Unique	  reflections	   21689	  (1484)	  Completeness	  (%)	   99.81	  (88.9)	  Rmeasb	   0.079	  (0.469)	  Rmergec	   0.111	  (0.432)	  Multiplicity	   5.61	  (5.62)	  I/sig(I)	   17.96	  (3.70)	  Rd/	  Rfreee	   0.2294	  /	  0.2573	  R.m.s.d.	  bonds	  (Å)	   0.008	  R.m.s.d.	  angles	  (º)	   1.22	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4.3 Methods	  &	  Materials	  
4.3.1 Protein	  expression	  &	  purification	  The	   C-­‐terminally	   truncated	   Hfq	   protein	   from	   Escherichia	   coli,	  encompassing	   residues	   1-­‐65	   (HfqEc65)	   out	   of	   102	   was	   cloned	   as	  described	   in99.	   The	   construct	   containing	   the	  hfq65	   gene	  was	   obtained	  by	   means	   of	   PCR	   using	   the	   forward	   primer	   (5′-­‐GCTCTAGAAATATAATAGTTTAACTTTAAGAAGGAGATATACATATGGCTAAGGGGCAATCTTTACAAGATCCGTTCCT-­‐3′),	   containing	   a	   XbaI	   site	  (italics),	   and	   the	   reverse	   primer	   (5′-­‐TTTTTTGAATTCTTACTA	  
AGACGGGACAACAGTAGAAAT	  CG-­‐3′),	  which	   contains	   two	   stop	   codons	  (underlined)	  after	  the	  triplet	  encoding	  Ser65	  (bold)	  as	  well	  as	  an	  EcoRI	  site	   (italics).	   The	   PCR	   product	   was	   cleaved	   with	   XbaI	   and	   EcoRI	   and	  ligated	   into	   the	   corresponding	   sites	   of	   plasmid	   pUC19	   (New	   England	  Biolabs	  Ltd.,	  USA.	  From	  the	  resulting	  plasmid	  pUHfq65,	  the	  hfq65	  gene	  was	  re-­‐isolated	  by	  cleavage	  with	  PvuII	  and	  then	  ligated	  into	  the	  EcoRV	  and	  NruI	   sites	   of	   pACYC184,	   yielding	   plasmid	   pAHfq65.	   The	   resulting	  plasmid	   was	   transformed	   in	   the	   expression	   strain	   E.coli	   BL21	   (DE3)	  (Invitrogen)	  by	  the	  heat-­‐shock	  method.	  	  Protein	   expression	   was	   done	   by	   inoculating	   1	   l	   Luria-­‐Bertani	   broth,	  replenished	   with	   100	   µg/ml	   ampicillin	   (Sigma-­‐Aldrich)	   for	   selection,	  with	  10	  ml	  over-­‐night	  culture.	  The	  expression	  culture	  was	  grown	  to	  an	  OD600~	  0.6	  -­‐	  0.8	  and	  over-­‐expression	  was	  induced	  with	  addition	  of	  0.5	  mM	   of	   isopropyl	   β-­‐D-­‐1-­‐thiogalactopyranoside	   (IPTG)	   for	   about	   3.5-­‐4	  hrs,	   at	   37˚C.	   Cells	  were	   harvested	   by	   centrifuging	   at	   4000	   x	   G	   for	   15	  min.	  Cells	  were	   lysed	  by	   french-­‐press	  at	  4˚C,	   into	  25	  ml	  /	  1	   l	   culture	  of	  50	  mM	   tris-­‐HCl	   pH	   ~	   7.4,	   1.5	   M	   NaCl,	   250	   mM	   MgCl2,	   1	   mM	  phenylmethanesulfonylfluoride	   (PMSF),	   0.5	   mM	   β-­‐mercaptoethanol	  (BME).	  After	   lysis	  25	  µg/ml	  of	  DNAse	   I	   (Sigma-­‐Aldrich)	  was	  added	  on	  ice	   for	  20	  min,	   and	   the	   lysis-­‐solution	  was	   cleared	  by	   centrifugation	  at	  45.000	  x	  G	  for	  15	  min.	  Further	   purification	   steps	   involved	   initial	   heat-­‐fractionation	   followed	  by	   a	   series	   of	   FPLC-­‐based	   chromatographic	   steps	   (hydrophobic	  interaction	   chromatography,	   immobilized	  metal	   ion	   chromatography)	  with	   a	   final	   step	   of	   size-­‐exclusion-­‐chromatography,	   as	   described	   in	  Beich-­‐Frandsen	  M.	  et	  al.	  2010118.	  The	  purified	  protein	  was	  concentrated	  in	   Centricon	   spin-­‐filters	   (Amicon)	   to	   final	   15	   mg/ml	   in	   a	   buffer	  containing	  50	  mM	  tris-­‐HCl	  pH	  7.4,	  200	  mM	  NaCl.	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4.3.2 Crystallization	  &	  Data	  collection	  Prior	   to	   crystallization	   the	   protein	   was	   mixed	   with	   adenosine-­‐triphosphate	  (ATP;	  Sigma-­‐Aldrich)	  in	  a	  1:1	  molar-­‐ratio	  with	  respect	  to	  one	  subunit	  of	  HfqEc65.	  The	  complex	  solution	  was	  centrifuged	  at	  44.000	  x	   G	   for	   1	   hr,	   to	   remove	   and	   macro-­‐scale	   impurities	   and	   protein	  aggregates.	   Nano-­‐litre	   crystallization	   trials	   with	   JSCG+-­‐screen	  (Qiagen156)	   were	   set	   by	   robot	   in	   96-­‐well	   vapor	   diffusion	   sitting-­‐drop	  format.	   Diffraction	   quality	   crystals	   were	   obtained	   directly	   from	   the	  JCSG+-­‐screen,	   and	   data	   was	   collected	   from	   a	   crystal	   grown	   in	   0.1	   M	  hepes	  pH	  ~7.5,	  10%	  (w/v)	  PEG-­‐8000	  and	  8%	  (v/v)	  ethylene	  glycol.	  Presence	   of	   ATP	   in	   the	   nano-­‐litre	   crystallization	   experiments	   had	   a	  dramatic	   effect	   on	   the	   success-­‐rate	   of	   crystallization,	  which	   increased	  roughly	   20-­‐fold.	  No	   other	   single	   nucleotide	   displayed	   the	   same	   effect,	  but	  did	  also	  not	  antagonize	  crystallization	  when	  compared	  to	  the	  apo-­‐protein.	  Crystals	  were	  also	  obtained	  in	  presence	  of	  GTP,	  CTP	  and	  UTP,	  but	  no	  electron	  density	   for	   the	   ligand	  could	  be	  observed	   in	  any	  of	   the	  structures.	  	  	  Crystals	   were	   harvested	   using	   cryo-­‐loops	   of	   suitable	   size	   (Hampton)	  and	   flash-­‐cooled	   in	   liquid	   nitrogen	   without	   usage	   of	   any	   additional	  cryo-­‐protectant.	   A	   complete	   dataset	   was	   collected	   at	   the	   beamline	  ID14.1	   at	   the	   European	   Synchrotron	   Facility	   (ESRF),	   and	   processed	  with	   the	   XDS-­‐suite157	   in	   space	   group	   C2,	   to	   a	  maximum	   resolution	   of	  2.15	  Å.	  Data-­‐collection	  and	  refinement	  statistics	  can	  be	  found	  in	  Table	  III.	  	  
4.3.3 Phasing,	  Model	  building	  &	  Refinement	  The	   structure	   was	   solved	   by	   molecular	   replacement,	   using	   Molrep158	  from	   the	   CCP4-­‐suite159,	   with	   one	   Hfq	   protomer	   subunit	   from	   the	   Hfq	  hexamer	   as	   search-­‐model	   (PDBid:	   1HK9,	   aa	   5-­‐65)105.	   The	   rotation	  function	   had	   six	   distinct	   solutions,	   corresponding	   each	   to	   one	   of	   the	  subunits	  in	  the	  hexamer.	  	  Refinement	   was	   performed	   by	   phenix.refine	   in	   the	   Phenix-­‐suite160	  employing	   simulating	   annealing	   and	   energy	   minimization	   cycles.	  Initially	   tight	   geometry	   restraints	   were	   applied,	   releasing	   them	  gradually	   as	   the	   R	   and	   Rfree	   factors	   diverged.	   After	   several	   rounds	   of	  iterative	  refinement	  and	  model	  building	  with	  COOT161,	  clear	  density	  for	  ATP-­‐molecules	  was	  found	  in	  four	  of	  six	  binding-­‐sites.	  Addition	  of	  ATP	  to	  the	  model	  (with	  occupancy	  fixed	  at	  1)	  caused	  the	  R	  and	  Rfree	  factors	  to	  converge,	   and	   refinement	   was	   continued	   with	   increasing	   restraints,	  until	   no	   significant	   change	   in	   R-­‐factors	   was	   obtained.	   A	   final	   step	   of	  refinement	  by	  Refmac162,163	  in	  the	  CCP4-­‐suite159,	  was	  done	  to	  polish	  the	  weighting	  between	  X-­‐ray	  and	  stereochemical	  terms	  for	  minimizing	  the	  residual.	   Final	   validation	   of	   the	   models	   was	   performed	   with	  MOLPROBITY164.	  	  
	  	  	  
	  	  61	  
4.3.4 Structural	  analysis	  and	  Superpositions	  Structural	   comparison	   and	   superposition	  was	  done	   in	  Pymol113,	   using	  algorithms	   herein.	   Pymol	   was	   also	   used	   for	   generation	   of	   figures.	  Analysis	   of	   the	   R-­‐site	   binding	   pocket	   was	   performed	   using	   the	  	  Protorp	   server	   (http://www.bioinformatics.sussex.ac.uk/protorp/)165.	  Homology	  between	  E.	  coli	  and	  B.	  subtilis	  Hfq	  sequences	  was	  quantified	  using	  EMBOSS166.	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5 Discussion	  &	  Perspectives	  Due	   to	   its	   versatile	   nature	   the	   E.	   coli	   RNA-­‐chaperone	   Hfq	   is	  characterized	  as	  a	  pleiotropic	  regulator,	  a	  quality	  that	   likely	  resides	   in	  its	  partially	  disordered	  and	  flexible	  C-­‐terminal	  domain.	  In	  contrast	  to	  a	  completely	   disordered	   protein,	   Hfq	   has	   a	   structured	   Sm-­‐like	   core	   as	  scaffold	   to	   support	   its	  ubiquitous	   function.	  The	  very	   stable	  oligomeric	  assembly	  provides	  an	  overall	  doughnut	  shape	  that	  is	  conserved	  in	  many	  bacteria	   without	   significant	   terminal	   extensions,	   and	   is	   per-­se	   alone	  sufficient	   for	   certain	   riboregulatory	   events.	   With	   high	   entropy	  disposition	   and	   the	   ability	   to	   adopt	   multiple	   conformations,	   the	  terminal	   domain	   allows	   the	   E.coli-­‐type	   of	   Hfq	   additional	   abilities	   for	  interaction.	  	  The	  work	  presented	  in	  this	  thesis	  has	  shown	  how	  E.	  coli	  Hfq	  can	  change	  shape,	  demonstrating	   its	  rheomorphic	  nature.	  The	  SAXS-­‐model	  of	   full-­‐length	   Hfq	   displays	   the	   C-­‐termini	   extending	   laterally	   away	   from	   the	  structured	   Sm-­‐core118.	   The	   crystal	   structure	   of	   HfqEc	   indicates	   the	   C-­‐termini	   to	   reside	   on	   top	   of	   the	   proximal	   face167,	   in	   agreement	   with	  previous	  EM-­‐results115.	  Together	  with	  NMR-­‐results	  that	  showed	  the	  C-­‐terminus	   to	   interact	  with	   specific	   residues	   in	   the	  hexameric	   core,	   this	  suggests	  a	  possible	  dynamic	  transition	  of	  the	  whole	  C-­‐terminal	  domain,	  from	   lateral	   to	   proximal	   position,	   with	   possible	   implications	   for	  function.	   Interestingly	   the	  C-­‐terminal	  domain,	  which	   is	   required	   for	  E.	  
coli	   Hfq	   to	   bind	   RNAs	   above	   a	   certain	   length,	   only	   attains	   structure	  when	   interacting	   with	   such	   long	   RNAs,	   as	   demonstrated	   by	   the	  presented	  SR-­‐CD	  studies118.	  So	  far	  no	  structural	  information	  is	  available	  on	   the	   C-­‐terminus	   alone	   or	   in	   complex	   with	   RNA.	   However,	   NMR-­‐studies	  presented	  here	  indicated	  that	  the	  C-­‐terminus	  switches	  between	  a	   partially	   structured	   and	   disordered	   state,	   which	   demonstrates	   how	  the	  amino	  acid	  composition	  fine-­‐tunes	  the	  structural	  propensity	  of	  the	  C-­‐terminal	   domain.	   The	   structural	   and	   functional	   studies	   of	   HfqEc	  showed	  the	  structural	  variability	  in	  the	  latter	  half	  of	  the	  C-­‐terminus	  to	  correlate	  with	   function99,	   indicating	  higher	  entropic	  potential	   residing	  in	  the	  end	  of	  the	  C-­‐terminus	  is	  important	  for	  function118.	  The	  N-­‐terminus	  of	  Hfq	  was	  reconstructed	  by	  SAXS,	  demonstrating	  how	  the	  shorter	  and	  highly	  conserved,	  intrinsically	  disordered	  N-­‐termini	  of	  HfqEc65,	  which	  are	  important	  for	  the	  proper	  function	  of	  Hfq,	  also	  have	  an	  effect	   on	   the	   overall	   shape	   of	   the	   protein.	   Furthermore,	   small	   angle	  scattering	  studies	  of	  the	  complex	  between	  HfqEc65	  and	  DsrA34	  (HfqDsrA)	  showed	   the	   RNA	   interacts	   mainly	   by	   the	   proximal	   uridine	   specific	  binding	   site,	   and	   indicates	   the	  RNA	   is	   flexible	   and	  extends	   away	   from	  Hfq,	   excluding	   the	   possibility	   of	   additional	   interactions	   with	   the	   Sm-­‐core.	  The	  initial	  purpose	  of	  this	  study	  was	  to	  expand	  our	  knowledge	  of	  the	   interactions	   between	   E.	   coli	   Hfq	   and	   RNA	   by	   crystallographic	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methods.	   The	   regulatory	   domain	   2	   of	   the	   sRNA	   DsrA	   (DsrA34)	   was	  selected	  for	  this	  study	  due	  to	  its	  secondary	  structure	  and	  sequence,	  as	  previous	  studies	  had	  indicated	  that	  Hfq	  prefers	  to	  bind	  to	  a	  uridine	  rich	  stretch	   of	   RNA	   adjacent	   to	   a	   hairpin-­‐loop92.	   The	   reconstruction	   of	  shape-­‐models	   from	   small	   angle	   scattering	   studies	   of	   the	   HfqDsrA	  complex	   was	   probably	   compromised	   by	   low	   sample	   quality	   and	  polydispersity.	  The	  models	  do	  not	  display	  the	  desired	  precise	  fit	  to	  the	  SAXS-­‐data	  at	  low	  scattering	  angle,	  and	  the	  SANS-­‐data	  for	  the	  complex	  is	  further	   compromised	   by	   a	   low	   signal	   to	   noise	   ratio.	  When	   fitting	   the	  scattering	   at	   low	   angle	   the	   excluded	   volume	   of	   the	   resulting	   model	  raises	  questions	  about	  the	  precise	  stoichiometry	  of	  the	  complex,	  which	  was	  determined	  to	  be	  the	  expected	  1:1	  by	  NMR	  relaxation	  experiments	  and	  supported	  by	  Guinier	  analysis	  of	  the	  SAXS-­‐data.	  However,	  the	  two	  resulting	  sets	  of	  shape-­‐models	  are	  in	  mutual	  agreement	  independent	  of	  whether	   volume-­‐restraints	   are	   applied	   or	   not.	   This	   suggests	   some	  degree	   of	   consistency	   for	   the	  models,	   both	   of	  which	   could	   agree	  with	  the	  NMR	  data,	  although	   interpretation	  of	   such	  models	  should	  be	  done	  with	   caution	   given	   the	   ill-­‐posed	   nature	   of	   reconstructing	   3D-­‐models	  from	  2D-­‐data.	  Together	  the	  data	   indicate	  that	   in	   the	  complex	  between	  HfqEc65	  and	  DsrA34,	  the	  RNA	  is	  protruding	  from	  the	  proximal	  face	  of	  Hfq.	  Intricate	  analysis	  applying	  perceptual	  criteria	  to	  the	  SAS-­‐data	  suggest	  a	  small	  hairpin,	  that	  is	  subject	  to	  a	  dynamic	  transition	  between	  structure	  and	  disorder,	   to	   form	  in	  the	  3’-­‐terminal	  of	   the	  DsrA34	  RNA	  in	  complex	  with	  Hfq.	  The	  transition	  from	  structured	  to	  disordered	  state	  of	  the	  RNA	  happens	  in	  conjunction	  with	  the	  structuring	  of	  the	  N-­‐terminus	  of	  Hfq	  –	  a	  feature	  that	  was	  clearly	  demonstrated	  by	  the	  presented	  NMR-­‐studies.	  	  The	  mechanism	  of	  action	  of	  RNA-­‐chaperones	  has	  been	  proposed	  to	  be	  explained	  by	  the	  entropy-­‐transfer	  model,	  in	  which	  inherent	  entropy	  of	  a	  disordered	   chaperone	   infers	   partial	   unfolding	   of	   its	   target	   upon	  binding98.	   Correspondingly,	   the	   N-­‐termini	   of	   HfqEc65	   becomes	  structured	   when	   binding	   to	   DsrA34.	   The	   entropic	   gain	   from	   the	  interaction	   allows	   the	   target	   to	   overcome	   an	   enthalpy	   barrier	   to	  unfolding,	   and	   to	   refold	   upon	   release	   from	   the	   chaperone.	   Similarly,	  DsrA34	   is	   tethered	   to	   HfqEc65	   by	   tight	   binding	   in	   the	   proximal	   uridine	  specific	   binding	   site,	   and	   the	   3’-­‐terminal	   hairpin	   of	   the	   RNA	   changes	  between	  two	  states:	  partially	  folded	  as	  a	  hairpin-­‐loop,	  and	  unfolded	  in	  complex	  with	  the	  N-­‐terminus.	  	  Also	  the	  C-­‐terminus	  of	  HfqEc	  becomes	  more	  structured	  in	  complex	  with	  RNA,	   as	   described	   above.	   Due	   to	   its	   greater	   length	   the	   disordered	   C-­‐terminus	  possess	  an	  larger	  entropic	  potential,	  as	  compared	  to	  the	  short	  N-­‐terminus	  of	  Hfq.	   Interestingly,	   as	   shown	  by	  SR-­‐CD,	   the	   full	   entropic	  potential	   must	   be	   satisfied	   by	   the	   unfolding	   interaction	   with	   RNA	  before	   the	   C-­‐terminus	   can	   attain	   structure,	   which	   only	   occurs	   in	  complex	  with	   long	   RNAs.	   The	   binding	   and	   unfolding	   of	   the	   long	   RNA	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continues	   until	   equilibrium	   between	   the	   entropic	   potential	   and	   the	  enthalpy	   cost	   of	   unfolding	   is	   reached,	   an	   equilibrium	   that	   also	   must	  take	  account	  of	  the	  enthalpy	  contribution	  from	  the	  interaction	  between	  RNA	   and	   protein.	   However,	   no	   specific	   RNA-­‐interaction	   could	   be	  identified	   by	   mutational	   analysis	   (Branislav	   Vecerek/Udo	   Bläsi	   -­‐	  personal	   communication).	   The	   first	   half	   of	   the	   C-­‐terminus	   is	   mostly	  positively	   charged	   due	   to	   pair-­‐wise	   distribution	   of	   histidine	   residues,	  whereas	   the	   latter	   half	   that	   is	   flexible	   and	   necessary	   for	   Hfq	   to	  accelerate	   annealing	   is	   negatively	   charged.	   Interaction	   between	   the	  acidic	  and	  flexible	   latter	  half	  and	  the	  RNA-­‐bases	  will	   infer	  an	  enthalpy	  contribution,	  which	  compensates	   for	   the	   loss	  of	  entropy	  upon	  binding	  and	   structuring.	   Such	   isothermal	   enthalpy/entropy-­‐compensation	   has	  been	   proposed	   as	   a	   method	   to	   moderate	   the	   affinity	   of	   tight	  interactions,	   effectively	   rendering	   them	   reversible168.	   When	   multiple	  diverse	   binding	   partners	   are	   available,	   which	   is	   the	   case	   for	   the	  pleiotropic	   regulator	   and	   promiscuous	   RNA-­‐chaperone	   Hfq,	   their	  interaction	  is	  required	  to	  be	  both	  unspecific	  and	  reversible.	  	  The	   tethering	   of	   RNA	   in	   the	   proximal	   or	   distal	   binding	   sites	   could	   be	  regarded	  as	  secondary	  to	  the	  unfolding	  interaction,	  but	  upon	  unfolding,	  tethering	  provides	  a	  specific	  and	  tight	  interaction,	  which	  is	  necessary	  to	  maintain	  a	  stable	  complex	  between	  Hfq	  and	  unfolded	  RNA	  –	  similar	  to	  the	   tethering	   of	   DsrA34	   in	   the	   proximal	   binding	   site	   of	   HfqEc65.	   By	  transfer	  of	  entropy	  the	  C-­‐termini	  of	  Hfq	  are	  able	  to	  unfold	  the	  RNA,	  and	  by	  tethering	  the	  single	  stranded	  RNA	  in	  the	  proximal	  or	  distal	  binding	  site,	   Hfq	   obtains	   thermodynamic	   control	   over	   the	   kinetic	   unfolding	  interaction.	  The	  unfolded	  RNA	   is	   suspended	  between	   the	  C-­‐termini	  of	  the	  hexamer	  in	  a	  tight	  interaction,	  and	  tethered	  in	  a	  specific	  binding	  site	  at	   either	   face	   of	   the	   Sm-­‐core,	   without	   the	   ability	   to	   fold	   up	   on	   itself.	  Release	  of	   the	  RNA	   from	   this	   complex	   requires	  another	   investment	  of	  enthalpy	   or	   entropy	   –	   cue	   the	   concept	   of	   an	   sRNA.	  The	  presence	   of	   a	  suitably	   complementary	   RNA	   binding	   partner,	   be	   it	   mRNA	   or	   sRNA,	  offers	   a	   new	   interaction	   that	   takes	   precedence	   over	   Hfq’s	  thermodynamic	   control,	   and	   upon	   annealing	   the	   RNA-­‐duplex	   is	  released	  from	  Hfq	  in	  a	  zipper-­‐like	  manner.	  	  One	  might	  speculate	  if	  the	  ability	  of	  the	  C-­‐termini	  to	  move	  from	  lateral	  to	   proximal	   orientation	   relates	   to	   the	   RNA	   protruding	   from	   the	  proximal	  face.	  Another	  possibility	  would	  be	  an	  interaction	  between	  the	  N-­‐	   and	   the	   C-­‐termini,	   however	   such	   an	   interaction	   should	   have	   been	  observed	   in	   the	   crystal	   structure	   of	   HfqEc.	   It	   is	   very	   interesting	   to	  observe	   the	   altered	   crystal	   packing	   in	   the	   presence	   of	   the	   C-­‐termini,	  where	   the	   ‘honeycomb’	   double-­‐layers	   of	   Hfq	   hexamers	   are	   poised	  perfectly	   on	   top	   of	   each	   other,	   a	   phenomenon	   that	   has	   not	   been	  observed	   in	  other	  Hfq	  structures.	  Between	   the	  poised	   layers	  a	  void	  of	  only	  ~30	  Å	  contains	  both	  the	  N-­‐	  and	  C-­‐termini,	  making	  it	  necessary	  for	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the	  C-­‐terminus	  to	  pack	  up	  on	  itself.	  Due	  to	  a	  lattice	  translocation	  defect	  of	   the	  crystal,	   little	  density	  was	  observed	   in	   this	  void.	  However,	  as	  no	  periodicity	  can	  be	  possible	  without	  a	  degree	  of	  order,	  this	  could	  suggest	  a	  residual	  fold	  in	  the	  C-­‐termini	  to	  mediate	  the	  poised	  positioning	  of	  the	  hexamers.	   The	   SAXS-­‐experiments	   reveal	   the	  C-­‐termini	   to	   be	   in	   lateral	  position	   in	   solution,	   suggesting	   this	   to	   be	   the	   energetically	   most	  favoured	  confirmation	  in	  solution	  for	  Hfq.	  The	  extending	  conformation	  is	   in	   agreement	   with	   the	   NMR-­‐relaxation	   experiments	   that	   indicate	  HfqEc	   to	   be	   ‘puffed	   up’,	   appearing	   larger	   than	   expected	   for	   a	   globular	  protein	   of	   that	   molecular	   mass.	   The	   dynamic	   transition	   by	   the	   C-­‐termini,	  from	  a	  possible	  partially	  folded	  state	  in	  proximal	  position	  to	  a	  laterally	   extending	   conformation,	   could	   function	   as	   the	  mechanism	   to	  unfold	  RNA,	  in	  a	  manner	  similar	  to	  opening	  an	  umbrella.	  Suspending	  an	  RNA-­‐molecule	   between	   the	   core	   binding	   site	   and	   the	   tip	   of	   the	   C-­‐termini	  might	   also	   serve	   to	   explain	   how	   a	   short	   RNA,	   tethered	   in	   the	  Sm-­‐core,	   cannot	   reach	   to	   bind	   and	   invoke	   structure	   on	   the	   acidic	   C-­‐terminal	  tip.	  A	  similar	  mechanism	  might	  work	  for	  RNA	  that	  is	  tethered	  in	  the	  binding	  site	  on	  the	  distal	  face.	  	  The	   distal	   face	   binding	   site	   has	  mainly	   been	   implicated	   in	   binding	   of	  poly(A)-­‐RNA	  and	  adenine-­‐rich	  adjacent	  sequence,	  like	  the	  AAYAA-­‐motif	  upstream	  in	  RpoS53,111.	  However,	  this	  does	  not	  rule	  out	  the	  possibility	  of	  a	   cooperative	   function	   of	   the	   distal	   face	   with	   the	   C-­‐termini.	  Crystallographic	  data	  presented	  here	  showed	  that	  the	  distal	  face	  purine	  specific	   ‘R’-­‐site	   binding	   pocket	   allows	   a	   degree	   of	   freedom	   for	  interaction,	   which	   suggest	   the	   distal	   binding	   site	   to	   be	   capable	   of	  accommodating	   variable	   sequences.	   This	   would	   mean	   the	   proximal	  uridine	   binding	   site	   provides	   specificity	   to	   Hfq,	   while	   the	   distal	   face	  binding	   site	   provides	   for	   a	   secondary	   less	   specific	   interaction,	   in	   a	  manner	   similar	   to	   the	   AAYAA-­‐motif	   in	   the	   RpoS-­‐leader.	   On	   the	   other	  hand,	  it	  has	  also	  been	  proposed	  that	  RNA	  binding	  partners	  compete	  for	  the	   proximal	   binding	   site,	   this	   however	   from	   a	   study	   that	   employed	  only	   very	   short	   oligonucleotides52.	   Furthermore,	   based	   on	   the	  structural	  studies	  of	  the	  uridine	  complex,	  the	  proximal	  binding	  site	  has	  been	   proposed	   to	   be	   able	   to	   accommodate	   adenine	   and	   cytosine	  nucleotides108,110.	  This	   taken	   together	  diminishes	   the	   specificity	  of	   the	  proximal	  face,	  and	  provides	  Hfq	  with	  yet	  another	  degree	  of	  freedom	  for	  its	  ubiquitous	  nature.	  Why	  has	  no	  structural	  work	  been	  published	  with	  both	  the	  proximal	  and	  distal	   binding	   site	   of	   Hfq	   occupied?	   Binding	   studies	   have	   shown	   Hfq	  able	  to	  occupy	  both	  binding	  sites	  simultaneously95,	  and	  visualization	  of	  such	  a	  structure	  would	  provide	  very	  interesting	  insights	  to	  the	  function	  of	   the	   Sm-­‐core	   of	   Hfq.	   Furthermore,	   applying	   small	   angle	   scattering	  studies	   to	   such	   a	   ternary	   complex,	   and	   gradually	   extending	   the	   RNA,	  could	   shed	   some	   light	   on	   the	   behavior	   of	   the	   C-­‐termini.	   Finally,	   the	  solution	  behavior	  of	  the	  isolated	  C-­‐terminus	  could	  be	  studied	  by	  NMR.	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  The	   long	  C-­‐termini	  provide	  E.	   coli	  and	  other	  gram-­‐negative	  pathogens	  with	  additional	  degrees	  of	  freedom,	  by	  the	  increased	  entropic	  potential	  that	   makes	   more	   RNA-­‐targets	   available	   for	   unfolding.	   Short	   Hfq	  homologs	   carry	   only	   the	   N-­‐termini,	   which	   are	   sufficient	   for	   certain	  aspects	  of	  riboregulation.	  Considering	  that	  most	  information-­‐flow	  in	  the	  cell	   requires	   getting	   the	  message	   through	   to	   translation,	   it	   is	   easy	   to	  imagine	  a	  player	   like	  Hfq	   to	  have	  a	  pleiotropic	   influence.	  Hfq	  gets	   the	  job	   done	   by	   keeping	   RNA	   unfolded.	   Interplay	   between	   the	   structured	  and	  disordered	  domains	  of	  Hfq	  composes	  its	  versatile	  nature,	  which	  act	  in	   cooperation	   with	   RNA	   to	   provide	   circumstances	   for	   interaction	  following	  the	  dogma:	  Binding	  promotes	  unfolding	  –	  unfolding	  promotes	  
annealing	  –	  annealing	  promotes	  release	  of	  Hfq!	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   Maximum	  dimension	  DMIN	  	   	   Minimum	  dimension	  DLS	  	   	   Dynamic	  Light	  Scattering	  FRET	  	   	   Fluorescence	  Resonance	  Energy	  Transfer	  FT-­‐IR	  	   	   Fourier	  Transform	  Infrared	  Spectroscopy	  Hfq	   	   Host	  factor	  Q	  HSQC	  	   	   Heteronuclear	  Single	  Quantum	  Coherence	  NMR	  	   	   Nuclear	  Magnetic	  Resonance	  P(R)	  	   	   Pair	  distribution	  function	  Rg	  	   	   Radius	  of	  Gyration	  Rbs	  	   	   Ribosomal	  Binding	  Site	  r.m.s.d.	  	   Root	  Mean	  Square	  Deviation	  SAS	  	   	   Small	  Angle	  Scattering	  sRNAs	  	   Small	  regulatory	  Ribo	  Nucleic	  Acid	  SR-­‐CD	  	  	   Synchrotron	  Radiation	  Circular	  Dichroism	  Utr	  	   	   Untranslated	  region	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8.1 Supplementary	  material	  
8.1.1 Purification	  of	  Hfq	  proteins	  Lysis	  was	  achieved	  by	  disrupting	  the	  cells	  in	  a	  French-­‐press	  (1g	  cells	  /	  5ml)	   after	   resuspension	   in	  50mM	  Tris-­‐HCl	  pH	  8,	  1.5	  M	  NaCl,	  250	  mM	  MgCl2,	   1	   mM	   EDTA,	   1	   mM	   β-­‐mercapto-­‐ethanol	   (BME),	   1	   mM	   phenyl-­‐methyl-­‐sulphonyl-­‐flouride	  (PMSF)	  and	  10	  µg/ml	  DNase	  I.	  Subsequently	  cell-­‐debris	  was	  removed	  by	  centrifugation	  (45.000	  x	  G	  /	  20	  min).	  After	  centrifugation	   the	   supernatant	   was	   heated	   to	   85˚C	   for	   45	   min,	   with	  subsequent	  removal	  of	  precipitates	  by	  centrifugation	  (45.000	  x	  G	  /	  20	  min).	   Ni2+-­‐affinity	   purification	   was	   performed	   for	   HfqEc	   and	   HfqEc85	  without	  recombinant	  addition	  of	  histidines	  to	  the	  protein,	  but	  utilizing	  that	   the	   protein	   harbors	   four	   histidines	   at	   the	   C-­‐terminus.	   In	   the	  hexameric	  protein	  this	  totals	  to	  24	  histidines,	  providing	  the	  high	  affinity	  to	  the	  Ni2+-­‐affinity	  column.	  The	  protein	  fractions	  were	  loaded	  onto	  a	  1	  ml	  His-­‐Trap	  FF	  column	  (GE	  Healthcare),	  charged	  with	  0.1M	  NiSO4	  and	  equilibrated	  with	   buffer	   containing	   50mM	  Tris-­‐HCl	   pH	   8,	   1.5	  M	  NaCl,	  1M	  urea,	  0.5	  mM	  EDTA,	  0.5	  mM	  BME,	  0.1	  mM	  PMSF,	  washed	  extensively	  with	  50	  column	  volumes	  with	  the	  same	  buffer	  and	  eluted	  by	  addition	  of	  500	  mM	  imidazole	  to	  the	  buffer.	  Hydrophobic	  Interaction	  Chromatography	  (HIC)	  was	  applied	  to	  HfqEc65,	  HfqEc75	   as	   well	   as	   to	   HfqSa	   and	   HfqBs	   which	   did	   not	   bind	   to	   the	   Ni2+-­‐affinity	   column	   in	   their	   native	   form.	  After	   heating	   and	   removal	   of	   the	  precipitates,	  (NH4)2SO4	  was	  added	  to	  a	  final	  concentration	  of	  1	  M.	  The	  proteins	   were	   loaded	   onto	   a	   1	   ml	   HP	   Butyl-­‐FF	   column,	   previously	  equilibrated	  with	  buffer	   containing	  50	  mM	  Tris-­‐HCl	  pH	  8,	  1.5	  M	  NaCl,	  1.5	   M	   (NH4)2SO4,	   0.5	   mM	   EDTA,	   0.5	   mM	   BME,	   0.1	   mM	   PMSF,	   and	  washed	   extensively	   for	   ~30	   column	   volumes	   with	   the	   same	   buffer.	  Elution	  was	   achieved	  by	   lowering	   the	   salt-­‐concentration	  by	   switching	  to	   a	   buffer	   containing	   50mM	   Tris-­‐HCl	   pH	   8,	   200	   mM	   NaCl,	   0.5	   mM	  EDTA,	  0.5	  mM	  BME,	  0.1	  mM	  PMSF.	  Anion-­‐exchange	   chromatography	   (aIEX)	   was	   employed	   to	   remove	  remaining	   nucleic-­‐acid	   impurities,	   which	   co-­‐purify	   with	   the	   protein.	  The	  aIEX-­‐procedure	  utilizes	  that	  the	   isoelectric	  point	  of	  nucleic-­‐acid	   is	  several	   orders	   of	   magnitude	   below	   that	   of	   the	   protein.	   The	   eluted	  protein	   from	   the	   washing-­‐step	   was	   diluted	   to	   a	   lower	   salt-­‐concentration,	   which	   would	   still	   effectively	   shield	   the	   vague	   negative	  charge	  on	  the	  protein	  and	  keep	  it	  from	  binding	  to	  the	  anion-­‐matrix.	  The	  washed	   protein	   was	   diluted	   with	   50	   mM	   Tris-­‐HCl	   pH~8	   to	   a	   salt	  concentration	  below	  200	  mM	  NaCl	  (or	  a	  conductivity	  below	  140	  µS	  x	  m-­‐1),	   and	   loaded	   on	   to	   a	   6	   mL	   ReSource	   Q	   column,	   which	   had	   been	  equilibrated	  with	  50mM	  Tris-­‐HCl	  pH	  8,	  200	  mM	  NaCl,	  0.5	  mM	  EDTA,	  0.5	  mM	  BME,	  0.1	  mM	  PMSF.	  After	  loading,	  the	  protein	  was	  collected	  in	  the	  flow-­‐through.The	  RNA-­‐impurities	  could	  be	  eluted	  from	  the	  column	  with	  a	  high	  concentration	  of	  salt.	  After	  aIEX	  the	  proteins	  were	  concentrated	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by	   one	   additional	   processing	   by	   the	   respective	   type	   chromatography	  washing-­‐step.	  For	  Ni2+-­‐affinity,	  the	  flow-­‐through	  from	  aIEX	  was	  diluted	  with	  50	  mM	  Tris-­‐HCl	  pH~8	  to	  lower	  the	  imidazole	  concentration	  (<50	  mM),	  and	  the	  solution	  was	  loaded	  onto	  a	  1	  ml	  His-­‐Trap	  FF	  equilibrated	  with	  50mM	  Tris-­‐HCl	  pH	  8,	  1.5	  M	  NaCl,	  1M	  urea,	  0.5	  mM	  EDTA,	  0.5	  mM	  BME,	  0.1	  mM	  PMSF,	  and	  eluted	  by	  addition	  of	  500	  mM	  imidazole	  to	  the	  buffer.	   For	   HIC,	   the	   flow-­‐through	   from	   aIEX	  was	   diluted	  with	   50	  mM	  Tris-­‐HCl	  pH~8,	  4	  M	  NaCl	  to	  increase	  the	  ionic	  strength	  (>1.5M	  NaCl,	  or	  +400	  µS	  x	  m-­‐1).	  The	  solution	  was	  loaded	  on	  a	  1	  ml	  HP	  Butyl-­‐FF	  column,	  previously	  equilibrated	  with	  buffer	  containing	  50	  mM	  Tris-­‐HCl	  pH	  8,	  1.5	  M	  NaCl,	   1.5	  M	   (NH4)2SO4,	   0.5	  mM	  EDTA,	   0.5	  mM	  BME,	   0.1	  mM	  PMSF,	  and	  eluted	  by	  switching	  to	  a	  buffer	  containing	  50mM	  Tris-­‐HCl	  pH	  8,	  200	  mM	  NaCl,	  0.5	  mM	  EDTA,	  0.5	  mM	  BME,	  0.1	  mM	  PMSF.	  The	  protein	  was	  concentrated	  further	  using	  a	  centrifugal	  filter	  unit	  (Amicon	  Ultracell	  10	  kDa	   cut-­‐off)	   to	   a	   volume	   applicable	   to	   size-­‐exclusion	   chromatography	  (below	  5	  ml).	   Size	   exclusion	   chromatography	  was	  performed	  on	   a	  GE	  Healthcare,	   Tricorn	   16/600	   Superdex	   200	   column,	   prior	   equilibrated	  with	  buffer	  50	  mM	  Tris-­‐HCl	  pH~7.2,	  200	  mM	  NaCl,	  0.5	  mM	  EDTA,	  0.1	  mM	   PMSF.	   For	   VUV-­‐CD	   samples,	   size-­‐exclusion	   chromatography	   was	  performed	  on	  a	  GE	  Healthcare,	  Tricorn	  10/300	  Superdex	  200	  column,	  prior	  equilibrated	  with	  buffer	  50	  mM	  Na-­‐PO4	  pH~7.2,	  200	  mM	  NaI.	  For	  NMR	  samples,	   size-­‐exclusion	  chromatography	  was	  performed	  on	  a	  GE	  Healthcare,	   Tricorn	   16/600	   Superdex	   200	   column,	   prior	   equilibrated	  with	  buffer	  50	  mM	  Na-­‐PO4	  pH~7.2,	   200	  mM	  NaCl.	   Fractions	   collected	  from	   size-­‐exclusion	   were	   concentrated	   under	   stirring	   using	   a	   10	   ml	  Amicon	  nitrogen	  pressure	  cell	  equipped	  with	  a	  Millipore	  Ultrafiltration	  membrane	  (10	  kDa	  cut-­‐off)	  to	  ~20	  mg/ml	  in	  same	  buffer.	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